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RESUMEN 
 
 
La familia ING (INhibitor of Growth) de supresores tumorales está formada por cinco 
proteínas homólogas que regulan el estado transcripcional de la cromatina por medio del 
reclutamiento de complejos remodeladores de cromatina a los lugares con la marca 
trimetilada en la histona H3 (H3K4me3). Esta modificación es reconocida por el dominio 
C-terminal conservado en las cinco proteínas ING, el Plant HomeoDomain (PHD). La 
unión a péptidos de histona trimetilados por ING5 ha sido caracterizada por RMN para la 
proteína completa mostrando una afinidad del mismo rango micromolar que la 
determinada para el dominio PHD aislado. El miembro de la familia ING4 dimeriza a 
través de su dominio N-terminal y se pliega de forma simétrica con estructura helicoidal 
de forma que es un lector bivalente de la marca H3K4me3. Los miembros ING4 e ING5 
presentan una alta homología de secuencia en su dominio N-terminal y comparten 
regiones conservadas, motivos de secuencia y dominios estructurales. En esta tesis 
doctoral, mostramos que ING5 también es un dímero, tanto en solución como en células, 
y que, por lo tanto, también es un lector bivalente de la marca H3K4me3. Sin embargo, la 
estructura cristalográfica del dominio N-terminal de ING5 muestra una interfaz de 
dimerización distinta de la descrita para ING4, formando un dímero asimétrico. 
Resultados obtenidos mediante técnicas en solución, como RMN y SAXS, demuestran 
que ING5 forma dímeros simétricos como ING4, e indican que la estructura 
cristalográfica de ING5 es, probablemente, un artefacto de la cristalización. En esta tesis 
doctoral se ha caracterizado, por primera vez, la función de las regiones NLS de ING4 e 
ING5 como sitios de unión a ADN de doble hebra sin especificidad de secuencia de 
nucleótidos. Esta unión bivalente a ADN, junto a la unión bivalente a las colas 
trimetiladas de la histona H3, podría funcionar como un punto de anclaje reforzado para 
complejos remodeladores de la cromatina. Tres mutaciones puntuales en el dominio N-
terminal de ING5 han sido descritas en cáncer de célula escamosa de boca: Q33R, I68V, 
and C75R. El análisis estructural de estos mutantes revela que son dímeros con estructura 
helicoidal al igual que ING5 nativa. Sin embargo, I68V y C75R están fuertemente 
desestabilizados, lo que sugiere un posible papel en el desarrollo de cáncer. El efecto 
funcional que tiene la expresión de estos mutantes en células NIH3T3 ha sido analizado 
mediante diversas técnicas de biología celular, mostrando variaciones en la 
sublocalización celular, en proliferación celular y en ciclo celular, siendo los mutantes 
I68V y C75R los de efectos más pronunciados. 
  
  
 
  
SUMMARY 
 
 
The INhibitor of Growth (ING) family of tumor suppressors consists of five homologous 
proteins that regulate the transcriptional state of chromatin by recruiting chromatin 
remodeling complexes to sites with histone H3 trimethylated at K4 (H3K4me3). This 
modification is recognized by the conserved Plant HomeoDomain (PHD) present at the 
C-terminus of the five ING proteins. ING5 binding to a trimethylated histone peptide has 
been characterized by NMR showing an affinity in the same micromolar range as its 
isolated PHD. ING4 dimerizes through its N-terminal domain, with a symmetric 
antiparallel coiled-coil structure, making it a bivalent reader of the H3K4me3 mark. 
ING4 and ING5 present a high sequence homology in their N-terminal domain, and they 
share conserved regions, sequence motifs and structural domains. Here, we show that 
ING5 is also a dimer, not only in solution but also in cells, and, therefore, it is also a 
bivalent reader of the H3K4me3 mark. However, the crystal structure of the N-terminal 
domain of ING5 shows a different dimerization interface from the previously described 
for ING4, forming an asymmetric dimer. Our solution NMR and SAXS data indicate that 
ING5 forms symmetric dimers as ING4, and suggest that the crystallographic structure of 
the N-terminal domain of ING5 is likely a crystallization artefact. In this thesis, for the 
first time, the specific role of the flexible NLS regions of ING4 and ING5 as DNA 
binding sites has been characterized, revealing that they bind dsDNA without nucleotide 
sequence specificity. The bivalent binding to DNA, together with the bivalent recognition 
of H3K4me3 marks, will result in a strong nucleosome binding and a stable scaffolding 
for recruited chromatin remodeling complexes. Three point mutations in the N-terminal 
domain of ING5 have been described in oral squamous cell carcinoma: Q33R, I68V, and 
C75R4. We have found that the N-terminal domains of the three mutants are dimeric 
coiled-coils. However, the I68V and C75R mutants are strongly destabilized, suggesting 
a possible role in cancer development. The functional effect of the expression of the 
mutants in NIH3T3 cells has been studied by different cell biology techniques, showing 
differences in the cell sublocalization,  cell proliferation and in  cell cycle progression, 
I68V and C75R being the most affected mutants. 
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1. Chromatin Remodeling 
The nuclear DNA of eukaryotic cells is packed with proteins into chromatin, a highly 
organized structure in which the nucleosome is the fundamental unit. In the nucleosome, 
two copies of each of the four core histones (H2A, H2B, H3 and H4) form and octamer in 
which two superhelical turns of 147 bp DNA are wound around for compaction [1] 
(Figure 1).  
 
Figure 1. Model of the nucleosome core particle. Each nucleosome core particle consists of double-
stranded DNA wrapped around two molecules of each of the four core histone proteins: H2A (yellow), 
H2B (magenta), H3 (blue) and H4 (green). The N-terminal tails of histone proteins protrude from the centre 
of the nucleosome core particle (Protein Data Bank entry 1kx5). 
 
Histones are highly conserved proteins in eukaryotic organisms that have a C-terminal 
globular domain, necessary for oligomerization and nucleosome scaffold formation, and 
an N-terminal domain that is flexible and protrudes outward from the nucleosome core 
[2]. Those flexible N-terminal tails provide internucleosomal linkages and, together with 
other proteins, allow for higher levels of compaction of the chromatin [3] (Figure 2). 
These multiple protein-DNA interactions provide the nucleosome with the stability 
necessary for its packaging function. 
The chromatin can adopt two different forms: heterochromatin, characterized by a 
high level of compaction and a low accessibility of genes, and euchromatin, which has a 
lower level of compaction and genes are more accessible. However, the nucleosome 
cannot be conceived as a simple static unit since it possesses dynamic properties 
regulated by various protein complexes related with DNA replication, repair and 
transcription [4, 5]. During these processes the nucleosome can act as a dynamic 
mechanical barrier in which the nucleosomal DNA spontaneously unwraps and rewraps 
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the histone core on a timescale of a few milliseconds, regulating the DNA accessibility 
for DNA-binding proteins and DNA processing enzymes [6]. This is achieved by the 
eukaryotic cell thanks to different and well-regulated mechanisms of chromatin 
remodeling. 
 
 
Figure 2. Structure of the chromatin. In the Eukaryotic cells the DNA is packed into chromatin, the 
nucleosome being its fundamental unit. Each nucleosome is composed of approximately 147 bp of DNA 
wrapped around an octamer of histones (two copies of H2A, H2B, H3 and H4, colored pink). Histone H1 
(colored blue) binds to the DNA that links two nucleosomes allowing the higher levels of compaction of 
DNA into chromatin. (Figure obtained from Figueiredo et al 2009[7]). 
 
The structural, mechanical and functional properties of nucleosomes have been related 
to the nucleosomal DNA sequence itself, which has an influence on the nucleosome 
positioning [8]. Differential methods have allowed analyzing relative free energies for 
nucleosome formation on one DNA sequence compared to another, showing that while 
nucleosomes can be formed with any DNA sequence, the relative affinities of certain 
DNA sequences are high compared to the affinities for arbitrary DNA sequences. The 
best known mechanism that also influences the chromatin structure and dynamics is the 
post-translational covalent modification (PTM) of histones within the nucleosome [9, 10]. 
Complementary to the chemical modification of histones that reorganize the nucleosome 
structures we find ATP-dependent chromatin remodelers that catalyze changes in 
nucleosome position and composition by inducing nucleosome sliding or partial 
disassembly/assembly of histones upon ATP hydrolysis [11]. Other factors may also 
influence the nucleosome structure and dynamics. For example, certain enzymes have to 
exert forces and torques in order to perform their tasks in processing the genome [12]. 
Besides, the existence of intermediate states in the nucleosome assembly process has 
been reported [13, 14] and related to changes in the structure and dynamics of chromatin 
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when the core histones are replaced with histone variants [15]. The dysregulation of these 
processes is associated with several human diseases, including cancer [16].  
  
1.1. Histone post-translational modifications: “ The Histone Code” 
 
 Post-translational covalent modifications of core histones, most frequently at the N-
terminal tails, are a key mechanism in chromatin remodeling which directly affect the 
level of chromatin condensation and/or recruit specific chromatin remodeling complexes 
to their location. There exist different types of PTMs described for core histone N-
terminal tails such as acetylation, methylation, phosphorylation, ubiquitylation, and, less 
frequently, citrulination and sumoylation (Figure 3) [16, 17]. These post-translational 
modifications are reversible; some of them co-exist and are required in a cooperative 
manner, while the presence of certain ones has not been observed together in the same 
nucleosome [1]. These modifications have different impact in gene accessibility and 
expression regulation by directly affecting the chromatin structure or, indirectly, 
recruiting chromatin remodeling proteins to the newly created binding sites [2]. 
 
Figure 3. Major post-translational modifications on histone tails. Post-translational modifications of 
lysine (K), arginine (R), serine (S), and threonine (T) residues are shown. Each modification inhibits 
subsequent modification on the same residue. Histone amino acid sequences are human ones; asterisk 
indicates that the histone amino acid sequence and the modification are from S. cerevisiae. Figure modified 
from Huynh et al 2013 [18] and Latham et al 2007 [19]. 
 
Methylation of histones occurs on the side-chains of lysine and arginine residues and 
there are strong correlations between certain methylations and the transcriptional state of 
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the genome [17]. For example, methylation at Lys4 of histone H3 is associated with 
regions active in transcription. Lysine methylation is one of the most stable histone 
marks, and the lysine can be monomethylated (me1), dimethylated (me2), and 
trimethylated (me3) at the amine group keeping its positive charge at physiological pH 
[20]. These modifications are carried out by lysine methyltransferases (KMTs) [21] and 
removed by histone demethylases [22]. Histone arginine residues can also be 
monomethylated (me1) and dimethylated (me2) in the guanidinium group (keeping its 
positive charge) by protein arginine methyltransferases (PRMTs) [23]. Dimethylation can 
occur in a symmetric (me2s on two separated nitrogen atoms) or asymmetric manner 
(me2a on the same nitrogen atom) [17]. Very little is known about arginine methylation 
relationship with chromatin dynamics. There are evidences reviewed by Tessarz and 
Koutzarides on 2014 [24], in which the asymmetric dimethylation at H3R42 positively 
correlates with transcription in vitro [25] by decreasing the nucleosome stability. The 
readout of methylation by reader modules regulates the chromatin dynamics and the 
transcriptional outcome [26]. Lysine methylation recruits “reader” and “eraser” modules, 
called respectively HATs (Histone Acetylase transferases) and HDACs (Histone 
DeAcetylase Complexes), to sites in the chromatin with this histone mark. These 
complexes introduce or remove acetylation marks from histone tails.  
Lysine acetylation plays a vital role in regulating chromatin structure and 
transcriptional activity [17]. Histone acetylation neutralizes the positive charge of lysine 
residues, weakening the interactions between histones and nucleosomal DNA, linker 
DNA or adjacent histones, increasing accessibility of DNA for the transcriptional 
machinery [17]. Histone acetylation by HATs is generally related to transcriptional 
activation, whereas histone deacetylation by HDACs, promotes chromatin condensation 
and transcriptional repression [27]. On the contrary, histone deacetylation will repress 
transcription through an inverse mechanism [28]. 
Another important PTM of histones is the phosphorylation, which is introduced on 
serine, threonine and tyrosine residues by kinases; while this modification can be 
removed by phosphatases [17]. Phosphorylation has a similar role to acetylation in 
modulating nucleosome dynamics [29]. However, in mammalian cells, histone H3 
phosphorylated at Ser10 have been related to two effects; is necessary for the high 
condensation of chromatin during mitosis, while it is also important in the activation of 
transcription [30]. Phosphorylation of histone H3 creates combinatorial patterns with 
lysine acetylation and methylation marks that are read by specific histone readers [17].  
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Ubiquitylation and sumoylation are large PTMs in which the C-terminus of ubiquitin 
or SUMO are covalently attached by a peptide bond to the ε-amino group of lysine 
residues.  
The sequential and combinatorial nature of all these histone modifications, and their 
correlation with many chromatin-related processes led to the proposal of the existence of 
a “histone code” as the basis of a fundamental regulatory mechanism that extends the 
information potential of the genetic code [31]. Interestingly, more recent data has revived 
an old idea that histone modifications, and in particular histone “core” modifications, also 
have a direct effect on chromatin architecture by affecting histone-DNA and histone-
histone interactions, as well as histone interactions with chaperones [24]. One of the best-
studied histone core modifications with potential effect on histone-DNA and histone-
histone interactions is the acetylation of Lys56 of H3. This histone modification has been 
shown to enhance the unwrapping of the DNA at the entry-exit site of the nucleosome 
[32]. H3K56 acetylation also influences chromatin structure at a higher order level by 
regulating tertiary contacts to keep nucleosome deprived chromatin regions accessible 
[33]. Acetylation can also directly affect the stability of the histone octamer as in the case 
of H4K91. This is the only modification described to date that regulates nucleosome 
stability by affecting histone-histone interactions. This residue is situated in the H3-H4 
and H2A-H2B interaction surface, and acetylation decreases the association of H2A-H2B 
dimers with chromatin leading to nucleosome instability [34].  
 
1.2. Chromatin Remodeling Complexes 
There is at present much investigation about the detailed mechanism by which cells 
unravel the “histone code”. There currently are two models describing how this is carried 
out, the “direct” and the “effector-mediated” models. In the direct model post-
translational modifications have a direct effect on chromatin compaction and this is the 
case of phosphorylation or acetylation. On the other hand, in the effector-mediated 
model, post-translational modifications are recognized by protein modules, facilitating a 
downstream signaling that recruits or stabilizes chromatin-related machinery. Thereby, 
histone tails are modified by specific enzymatic complexes of proteins, some of them 
with domains that recognize one or more of the possible modifications [35]. These 
epigenetic regulators can be divided into three different groups based on their functions 
(Figure 4). Epigenetic “writers” introduce modifications in histone tails, such as acetyl 
and methyltransferases. 
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Figure 4.Epigenetic writers, readers and erasers. Epigenetic writers lay down epigenetic marks on 
amino acid residues on histone tails. Epigenetic readers with specialized domains bind to these epigenetic 
marks. Epigenetic erasers catalyse the removal of epigenetic marks. Addition and removal of these post-
translational modifications of histone tails lead to the addition and/or removal of other marks in a highly 
complicated histone code. Together, histone modifications regulate various DNA-dependent processes, 
including transcription, DNA replication and DNA repair. Abbreviations: HAT, Histone AcetylTransferase; 
HMT, Histone MethylTransferase ; PRMT, protein Arginine MethylTransferase ; HDAC, Histone 
DeAcetylase; KDM, Lysine DeMethylase. Figure from Falkenberg et al 2014 [36]. 
 
These epigenetic regulators can be divided into three different groups based on their 
functions (Figure 4). Epigenetic “writers” introduce modifications in histone tails, such 
as acetyl and methyltransferases. These epigenetic marks can be removed by epigenetic 
“erasers”, such as deacetylases and demethylases [36, 37]. However, for these protein 
complexes to erase or write some modifications they all must have “reader” domains, 
which specifically recognize the histone modifications, recruiting writer and eraser 
protein complexes to particular chromatin positions, initiating signaling responses as 
transcription activation/inhibition. The combination of the different PTMs, together with 
the existence of a variety of “reader” domains in a protein or a protein complex, defines 
the histone code hypothesis. 
 
1.3.  Recognition of Histone modifications  
The histone code “readers” are specific domains that recognize histone post-
translational modifications. The recognition and deciphering of the histone code is done 
in a residue and a particular modification dependent manner. There are different groups 
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of “reader” domains including: bromodomains, Chromodomains, PHD (Plant 
HomeoDomain), BRCT (Breast Cancer 1 C Terminus) and Tudor domains (Figure 5).  
 
 Bromodomain 
Bromodomain is an acetyl-lysine binding module found in chromatin-associated 
complexes as nuclear Histone Acetyltransferases (HATs). These domain folds into a left-
handed four helix bundle with a hydrophobic pocket that recognizes acetylated histones 
H2A, H2B, H3 and H4. Examples of HATS that contain this domain are Gcn5p that 
recognizes H4K16ac [38] (Figure 5A) and TAF-1 that contains two bromodomains that 
recognize H4K5acK12ac [39].  
 
 Chromodomain 
Chromodomain is a sequence motif implicated in methylated-lysine histone 
recognition. It folds in an antiparallel β-sheet crossed by one α-helix and the methylated 
tail of histone H3 binds as a β-strand in a conserved groove on the surface of the 
chromodomain, where the residues at the loops connecting the β-strands are the ones 
involved in methyl-lysine binding. Examples of proteins with Chromodomains are HP1 
(heterochromatin protein 1) (Figure 5B), Polycomb proteins, and CHD1 (chromodomain 
Helicase DNA binding protein 1). While HP1 and Polycomb proteins use canonical 
chromodomains for the recognition of H3K9me2/3 and H3K27me3, respectively [40, 
41], CHD1 has two chromodomains that are both required and cooperate for the 
recognition of H3K4me3 [42, 43]. In the case of CHD1 histone H3 binds to a groove at 
the inter-chromodomain junction [43]. 
 
 Plant HomeoDomain 
The PHD is known to be involved in protein–protein interactions and is frequently 
present in proteins associated with chromatin remodeling functions [44], so it is 
commonly found in all eukaryotic genomes [45]. This domain, of about 60 amino acids, 
consists of a a two-stranded antiparallel β-sheet and a C-terminal α-helix stabilized by 
two Zn
2+
 cations with  a Cys4-His-Cys3 motif [45] (Figure 10B). The PHD finger is the 
recognition module of histone H3 methylation state in Lys4 (K4me0/1/2/3) with different 
affinities [46] (Figure 5C), although there is published data showing that the PHD of 
SUMO ligase Siz1 in rice (OsSiz1–PHD) is able to recognize Arg2 asymmetric 
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dimethylation in histone H3 tail (H3R2me2a) [47] and the PHD of DPF3b recognizes 
acetylation state of H3K14 (H3K14ac) [48].  
 
Figure 5. Structure models of the best characterized “reader” domains bound to modified histone 
tails. A. Bromodomain of Gcn5 bound to H4K16ac (PDB: 1E6I). B. Chromodomain of HP1 bound to 
H3K9me3 (PDB: 1KNA). C. PHD finger of ING5 bound to H3K4me3 (PDB: 3C6W). D. BRCT repeat of 
MDC1 bound to H2A.X S139ph (PDB: 2AZM). E. Tudor domain of JMJD2 bound to H4K20me3 (PDB: 
2QQS). Side chains involved in the binding are displayed in yellow, while bound histone peptide are in red 
color. 
 BRCT (BRC1 C-Terminus) domain  
The BRCT domain functions as a phosphoserine/phosphothreonine-binding module. 
Its fold consists of a central four stranded β-sheet flanked by a single α-helix on one side 
and two α-helices on the opposite side [49] (Fig. 5D). The phosphopeptide binds in an 
extended conformation to a hydrophobic groove located in a highly conserved interface 
between the N- and C-terminal regions of the BRCT [50]. The BRCT domain may occur 
as isolated individual domain or as multiple tandem BRCT repeats, as it happens in 
several proteins involved in cell cycle regulation and DNA damage response [51]. One 
example of a protein with this domain is BRCA1 (BReast CAncer type 1 susceptibility 
protein), a tumor suppressor protein related to breast and ovarian cancer [51]. 
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 Tudor domain 
Tudor domain is a methyl-lysine and methyl-arginine reader. Four antiparallel β-
strands form the core of the Tudor fold, which has a barrel-like structure with aromatic 
residues to accommodate methylated ligands [52] (Figure 5E). Tudor domain binds 
symmetric dimethyl-ariginines [53]. With a lower affinity it has also been found to bind 
monomethlyl-arginine and asymmetric dimethyl-ariginines [52]. This domain was shown 
to have a unique property of binding trimethylated peptides from two different histone 
methylated sequences, H3K4me3 and H4K20me3, in the case of the lysine demethylase 
JMJD2A [54].  
 
2. Chromatin remodeling and Cancer 
Cancer is widely described as a complex genetic disease. In a multistep process a cell 
accumulates mutations leading to gene activity malfunction and to a transformation of a 
normal cell into a malignant phenotype that provides selective advantages [55, 56]. The 
mechanisms that lead to the transformation of a normal cell into a cancer cell are very 
different and it is necessary that a few of them converge for a cancer cell to escape from 
the control check points [55]. A cancer cell typically has defects in regulatory systems 
that govern the normal cell proliferation and homeostasis. It has been suggested that 
cancer genotypes are the result of ten essential alterations, “the ten hallmarks of cancer”, 
in cell physiology that collectively dictate malignant growth: sustaining proliferative 
signalling, evading growth suppressors, avoiding the immune destruction of malignant 
cells, enabling replicative immortality, tumor-promoting inflammation, activating 
invasion and metastasis, inducing angiogenesis, generation of genome instability and 
mutation, resisting cell death and deregulating cellular energetics [57] (Figure 6). 
There are key genes that are usually altered in this process, the so called oncogenes 
and tumor suppressor genes. Oncogenes are the mutated version of a proto-oncogene, a 
group of genes that cause normal cells to become cancerous when they are mutated. 
Oncogenes induce hyperactive growth and division, protection against programmed cell 
death, and the ability to invade diverse tissue environments [58, 59]. Tumor suppressor 
genes (TSG) encode proteins that are involved in the regulation of many cellular 
processes as DNA repair, cell signaling, cell cycle arrest, senescence and apoptosis. They 
are classified into two different groups: Type I TSG, the ‘‘caretakers’’ of the genome, 
that usually are DNA repair genes which protect the genome from mutations; and Type II 
TSG, the “gatekeepers”, which prevent cancer through the control of cell growth [60]. In 
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the latter, we find proteins that are directly implicated in chromatin remodeling and gene 
expression regulation as proteins of the Inhibitor of Growth (ING) family [61]. 
 
 
Figure 6. The ten Hallmarks of Cancer. Acquired capabilities of cancer that lead to essential alterations 
in cell physiology that collectively dictate malignant growth [55].  
Alterations in the “histone code” and dysregulation or their “readers”, “writers”, and 
“erasers” are related to oncogenesis. Despite the difficulty of establishing a causal role of 
histone modifications in cancer, the global alterations of histone modification patterns 
appears to be linked to tumorigenesis [16]. For example, the global loss of trimethylation 
of histone H4 at K20 and a loss of acetylation at K16 have been observed to be associated 
with hypomethylation of DNA repetitive sequences, a known characteristic of cancer 
cells [62]. Moreover, histone serine phosphorylation is crucial for DNA damage repair, 
chromosome stability and apoptosis. Histone variant H2A.X phosphorylation is necessary 
for a normal radiation resistance and accumulation of DNA-damage response proteins for 
DNA repair [63], while histone H3S10 phosphorylation is related to chromosomal 
stability and aneuploidy during mitosis [64], and histone H2B is phosphorylated in S14 in 
response to apoptotic stimuli [65]. Although no other global histone epigenetic mark has 
been directly related to oncogenesis, impairments of chromatin remodeling machinery 
have also been reported [16]. Apart from that, disturbance of the balance of the 
acetylation status of chromatin through the disruption of HAT or HDAC activity can lead 
to tumorigenesis [66, 67]. Proteins of the Inhibitor of Growth (ING) family belong to this 
type of complexes. 
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3. Inhibitor of Growth (ING) family of tumor suppressors 
The Inhibitor of Growth (ING) family of tumor suppressors consists of five 
homologous proteins (ING1-5) which play important roles in preventing tumor formation 
and progression [61, 68]. Members of the ING family are classified as type II tumor 
suppressors [60, 69] and are generally down regulated or even missing in different kinds 
of tumors, leading to a neoplastic growth. The founding member of the family, ING1, 
was discovered back in 1996 thanks to a new hybridization technique based on 
suppressive subtractive hybridization and selection of tumor suppressor elements when 
comparing normal cells and epithelial breast cancer cell lines from mice. The identified 
gene expressing ING1 was found to block proliferation in preneoplastic mammalian 
epithelial cells when it was overexpressed, being proposed as a tumor suppressor gene 
[70]. The rest of the members of the conserved ING family were identified progressively 
using sequence analysis showing a shared sequence homology between 32% and 76% 
[61, 71]. The sequence analysis and phylogenetic studies revealed that these genes are 
conserved from yeast to humans [72], that is, only present in eukaryotic organisms, 
highlighting the involvement of this family of proteins in nuclear processes. The 
localization of the five human genes of the ING family have been mapped in different 
chromosomes, and ING1, ING2, ING4 and ING5 are located in sub-telomeric regions 
while ING3 is located in the long arm of chromosome 7 [72]. Since ING1, ING2, ING4 
and ING5 are located close to telomeric regions in the chromosome, the dysregulation of 
these proteins due to telomere aging could be one of the explanations for tumorigenesis 
[71]. There are different transcript variants for the ING genes produced through 
alternative mRNA splicing [72], but all ING proteins contain in their sequence a NLS 
(Nuclear Localization Signal) [68] and, in addition, several of ING members also contain 
a Nucleolar Translocation Sequence (NTS) within the NLS, which has been shown to 
translocate them to the nucleoli in response to DNA damage [73]. The mutation, 
alteration of the expression levels, and the subcelullar localization of ING proteins have 
been found in several human cancer types. The characteristic pathways by which ING 
family proteins differentially affect the Hallmarks of cancer, and the various epigenetic 
mechanisms by which they regulate gene expression have been summarized in Figure 7 
[74]. In the figure, the different HAT and HDAC complexes of which the ING proteins 
form part (see below) are represented. 
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Figure 7.The hallmarks of cancer affected by ING HDAC and HAT complexes. White symbols in the 
purple ring are the ten hallmarks of cancer from Hanahan and Weinberg 2011 and summarized in figure 6. 
The red ‘‘stop’’-signs mean that those hallmarks are inhibited by ING activity, and the question-mark 
indicates possibly inhibited by ING activity. For instance, ING5 has been found to inhibit aberrant 
proliferative signaling, dysregulated growth suppression, invasion & metastasis, resistance to cell death, 
Figure adapted from Tallen & Riabowol 2014 [74]. 
 
3.1. Sequence analysis and structural organization of ING proteins 
The alignment of the amino acid sequences of the five members of the ING family 
shows three different regions: a conserved N-terminal domain, a non conserved central 
region containing the nuclear localization signal (NLS) and a highly conserved C-
terminal region corresponding to the Plant HomeoDomain (PHD) (Figure 8).  
The N-terminal region contains a Leucine Zipper Like (LZL) domain, rich in 
conserved leucines and isoleucines spaced seven amino acids apart, that can form a 
hydrophobic patch when folded into an α-helix [75]. This motif is present in all INGs 
except for ING1 and was proposed to be a homodimerization or heterodimerization 
region with INGs or other proteins. The PIP (PCNA-interacting protein) is a domain that 
is unique to ING1b and allows ING1 to bind to PCNA (proliferating cell nuclear antigen) 
in a DNA damage response [76]. Then, ING1 also presents a Partial BromoDomain 
(PBD), a motif which has been shown to interact with SAP30 of the Sin3-HDAC1 and 
HDAC2 complexes [74].  
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Figure 8. A. Sequence alignment of the human ING proteins. Sequences can be generally divided in 
three regions, which reflect structural motifs: a highly conserved N-terminal domain formed by LZL (red) 
and LID (orange) sequences (PIP in yellow and PBD in purple sequences are only present in ING1), a non 
conserved central region containing the NLS (Nuclear Localization Signal, green), and a highly conserved 
C-terminal region, containing a Plant HomeoDomain (PHD) (cyan). With a PolyBasic Region (PBR, blue) 
only in the case of ING1 and ING2. For ING1 the most frequently observed p33ING1b splicing variant was 
used. For the rest the full sequence is used. The alignment was performed using Clustal W. Asterisk at 
residue 112 of ING3 indicate non aligning sequence (residues 112-266). B. Scheme of the most 
representative sequence motifs of INGs. 
 
All INGs have a lamin interaction domain (LID) in the N-terminal region [74]. This 
region was shown to bind lamin A and is believed to help tether ING1 in the nucleus, 
thereby localizing its functions [77]. This region was first referred to as potential 
chromatin regulatory (PCR) region by He et al 2005 and it was hypothesized to be 
involved in binding HAT/HDAC complexes during chromatin remodeling [72]. 
The central region of all INGs, rich in basic residues, contain a bipartite Nuclear 
Localization Signal: two clusters of basic amino acids, separated by a spacer of about 10 
amino acids [68] (Figure 9). In addition, several of the ING proteins also contain short, 
highly basic nucleolar translocation sequences (NTS) within the NLS. However, these 
NTS have been only shown to be active for ING1, translocating it to the nucleoli in 
response to DNA damage for apoptosis activation [73]. These NTS are not well defined 
in ING3, ING4 and ING5.  
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Figure 9. Amino acid sequence alignment of the conserved bipartite NLS regions from each ING 
protein. Highlighted residues correspond to the related nucleolar translocation sequences. 
 
At the C-terminal end all INGs have a PHD (Plant HomeoDomain) zinc finger, which 
is the most highly conserved feature of the ING family. The PHD is typically folded into 
a Cys4-His-Cys3 signature with characteristic cysteine spacing (Figure 10). The PHD 
finger of INGs directly bind histone N-terminal methylated tails with different affinities 
depending on the methylation state. The first time in which ING proteins were described 
to recognize histone post-translational modifications and, therefore, to be histone code 
“readers” was in 2006 by Peña et al and Shi et al [78, 79]. 
At the very end of the C-terminal region of ING1 and ING2, there is a PBR 
(PolyBasic Region) necessary for recognition of phosphoinositides in DNA damage 
signalling [80, 81]. The corresponding region in the rest of INGs is also rich in basic 
residues but notably shorter and, in the case of ING4 and ING5, they could work as 
additional nuclear localization signals [82]. 
The presence of different conserved domains and motifs in ING proteins makes them 
suitable to carry out many functions depending on their interaction with other partners. In 
this way, ING proteins are involved in a wide number of chromatin related events in the 
cell (Figure. 11). 
 
Figure 10. Amino acid sequence alignment of the INGs PHD motif. Highlighted residues in red 
correspond to the characteristic the zinc-binding cysteine and histidine residues that define the PHD motif. 
Modified from Russell 2006 [68]. 
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Figure 11. Network of interactions and functions of ING proteins [83]. 
 
3.2. INGs in H3K4me3 recognition by their Plant HomeoDomain 
INGs regulate the transcriptional state of chromatin by recruiting remodeling complexes 
to sites with histone H3 trimethylated at K4 (H3K4me3). This mark is recognized by 
their C-terminal Plant HomeoDomain (PHD) [79]. Indeed, the structures of the PHD 
fingers of ING1 [84], ING2 [78], ING4 [85] and ING5 [86] bound to H3K4me3 peptides 
have been determined, displaying similar features with little differences in the 
conformation of the bound peptide [85]. The recognition of H3K4me3 by PHDs appears 
to be very specific since the interaction with unmodified H3K4 or other methylated lysine 
residues occurs with a much lower affinity [46]. The first member of ING family to be 
studied on their functionality as histone H3 methylation reader was ING2 which is related 
to transcription repression due to the fact that forms part of HDAC complex 
(mSin3/HDAC1/2) [79]. ING2 specifically recognizes H3K4me3 (KD = 1.5 ±1 μM) with 
a higher affinity than H3K4me2 (KD = 15 ±4 μM) and H3K4me1 (KD = 208 ±80 μM); 
however, it does not recognize non methylated H3K4 (KD = 2240 ±350 µM) [78]. In the 
complex formation, H3K4me3 peptide forms a third anti-parallel β-strand that pairs with 
the already existing double stranded β-sheet of the PHD finger. The binding region forms 
a pocket with two grooves connected by a narrow channel. The trimethylated Lys4 
occupies the elongated groove formed by conserved hydrophobic and aromatic residues, 
whereas Arg2 is accommodated by the adjacent groove [46]. The H3K4me3 tail, which 
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involves the first six N-terminal residues, forms an extensive network of H-bonds and 
complementary surface interactions with the PHD that stabilize the complex [78]. The 
small size of the channel between grooves is probably involved in the specificity and 
unique recognition of the ARTK(me3)QT sequence in histone H3 tail by the PHD 
relative to other lysine methylation in the same or other histone tails. The presence of a 
bulky Arg or a Val in place of Thr3, as it happens for other methylated sequences, will 
disrupt the binding [46]. In the following years more information about the complex 
formation between the PHD of ING1, ING4, ING5 and H3K4me3 revealed that the 
peptide occupies analogous binding sites in all structures [84-86].  
 
3.3. ING proteins are components of macromolecular acetylase/deacetylase 
complexes 
Histone PTMs affect the compaction state of chromatin and, among them; acetylation 
has the highest potential to unfold chromatin, removing the basic charges of lysines. 
Histone tail acetylation is often associated with gene transcription activation and DNA 
repair and replication [37]. The acetylation state of chromatin is the result of the precisely 
regulated activity of protein complexes with acetylase or deacetylase activity, HATs 
(Histone acetyl transferases) or HDACs (Histone DeAcetylase Complexes) respectively.  
The HDACs are a group of enzymes that catalyze the deacetylation of lysine residues 
in histones, allowing interaction between negatively charged DNA and positively charged 
histone proteins, which can result in heterochromatin formation and transcriptional 
silencing of genes [87]. In addition, HDACs have a number of non-histone proteins as 
substrates including proteins of transcription complexes that have a role in regulating 
gene expression, and proteins in pathways that regulate cell proliferation, cell migration, 
cell death and angiogenesis [88]. HDACs can be classified into eighteen groups, 
according to the functional and the phylogenetic, and they are subdivided into Zn
2+
- 
dependent (class I, II and IV), Zn
2+
- independent and NAD-dependent (class III) enzymes 
[89]. 
The human HATs can be classified as lysine (K) AcetylTransferases (KATs) and can 
be classified into cytoplasmic enzymes, which modify free histones in cytoplasm just 
after their synthesis [90], and nuclear enzymes, which are responsible for acetylation of 
histone and non-histone proteins in the nucleus [91]. Based on their sequence homology, 
nuclear HATs can be subdivided into five different families: GNAT (Gcn5 N-
acetyltrasferases), MYST, p300/CBP, transcription co-activators and steroid receptor co-
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activators. The MYST (MOZ, YBF2/SAS3, SAS2, TIP60) family is the largest one and 
consists of TIP60 (KAT5), MOZ (KAT6A), MORF (KAT6B), HBO1 (KAT7) and MOF 
(KAT8) [91].  
In the context of the chromatin, ING proteins recruit specific HAT and HDAC 
complexes to sites with the H3K4me3 mark. It is very interesting that INGs can be 
classified into the same three groups, (ING1/2, ING3, and ING4/5) not only according to 
the sequence homology and phylogenetics [72], but also according to the distinct types of 
association to HAT and HDAC complexes [92] (Figure 7). In the first group, ING1 and 
ING2 associate with mSin3A/HDAC1/2 histone deacetylase complexes [92]. While 
ING1 suppresses cell growth in a manner dependent on the mSin3A-HDAC interacting 
domain [93], ING2 directs HDAC1/2 complexes to actively transcribed genes as a rapid 
way of gene transcription suppression [79]. In the second group, ING3 forms part of 
hNuA4/Tip60 HAT complex, necessary for acetylation of histones H4 and H2A [92]. In 
the third group, ING4 and ING5 associated with HAT complexes containing 
MOZ/MORF (monocytic leukemia zinc finger protein/MOZ related factor) and HBO1 
[46, 94]. HBO1-HAT is a complex composed of HBO1-JADE-ING4/5-hEAF6 subunits 
which regulate S phase progression and is likely responsible for the majority of histone 
H4 acetylation in higher eukaryotes [92, 95], although it also has H3 as a substrate to a 
lesser extent [92]. It was shown that the H3K4me3 recognition by the ING4-HBO1 
complex drives acetylation on H3 at a set of genes in response to genotoxic stress [96]. In 
this context, the PHD finger of ING4 serves to sense the methylation state of H3K4 to 
facilitate HBO1-HAT activity on H3, thus, redirecting the HBO1 HAT complex activity 
from histone H4 to histone H3 [96]. Besides, the activity of HBO1 complex is related not 
only to transcription regulation, but also to apoptosis and proliferation regulation 
pathways due to its repression activity towards NF-κB and p53 [97, 98]. Interestingly, 
ING5 is present in two independent HAT complexes with a different acetylation activity 
for histones. MOZ/MORF HAT acetylates histone H3 at Lys14, while HBO1 HAT 
acetylates histone H4 at Lys5, Lys8 and Lys12 [46]. ING5 will likely act as an adapter, 
recruiting these different complexes to sites in chromatin with H3K4me3 mark promoting 
distinct effects. Interestingly, ING5-HBO1 complex was co-purified together with MCM 
(minichromosome maintenance) complex, suggesting an important connection to DNA 
replication regulation [92]. 
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Figure 12. Model for MYST acetyltransferase assembly in alternate complexes, leading to different 
histone tail specificities. The HBO1 and MOZ/MORF catalytic subunits can be associated with different 
scaffold proteins, leading to a switch in histone tail specificity for acetylation of chromatin substrates. Thus, 
protein complexes associated with HAT proteins not only enable them to acetylate chromatin substrates, 
but also select which histone tail is targeted, specificity previously thought to reside in the acetyltransferase 
itself. The arrow between MOZ/ MORF and JADE1/2/3 is gray, since this interaction has only been 
reported in co-transfection experiments. Modified from Lalonde et al 2013 [94]. 
 
More recently, a new model has been proposed in which HBO1 acetyltransferase 
competes for BRPF or JADE scaffold subunits in cells. There is evidence in which 
HBO1–JADE and HBO1–BRPF HAT complexes coexist within HeLa cells [94]. HBO1-
JADE complex targets mainly H4 residues, while HBO1-BRPF1 complex acetylates only 
H3 in the context of chromatin. These results highlight the new role of the associated 
scaffold subunits (JADE and BRPF) within MYST-ING acetyltransferases complexes in 
directing the acetylation of specific histone tails (Figure 12).  
 
3.4. ING4 
The ING4 gene is located at chromosome 12p 13.31 and consists of eight exons [99]. 
ING4 is a 29 kDa protein that was first identified by computational homology search 
[100].  
The structure of the PHD of ING4 was determined in 2006 [101]. However, little was 
known about the full-length protein until it was purified and analyzed in 2010 [102]. The 
crystal structure of the N-terminal domain of ING4 was later reported in 2012 [103]. 
ING4 dimerizes in an antiparallel manner through its N-terminal domain with a coiled-
coil structure and each protomer contains a helix-loop-helix structure [103]. In the full-
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length version of ING4, the dimer results in a molecule arranged head-to-tail, with the 
two long and unfolded NLS regions pointing to opposite sides of the dimerization domain 
(Fig. 13), allowing the two PHD fingers to sample a great space around the protein and 
independently bind to two H3K4me3 histone marks. The binding of ING4 for the 
H3K4me3 peptide shows essentially the same binding site, an affinity of KD = 1.3±0.5 
μM, and discrimination between the different methylated forms of histone H3 at K4 as 
the isolated PHD finger [85, 102]. In the context of the chromatin, ING4 could bind 
simultaneously two histone tails on the same or different nucleosomes [103]. 
Dysregulation of ING4 or a decreased expression of ING4 is frequent in multiple 
cancers including head and neck squamous cell carcinomas, hepatocellular carcinoma, 
gastric adenocarcinoma, lung cancer, breast cancer, etc [104-107]. The exact mechanisms 
by which ING4 is downregulated have not been yet clearly understood. However, there 
are a few investigations that have revealed some of the implicated factors. The deletion of 
chromosome 12p 12-13 region is described for different cancers as head and neck 
squamous cell carcinomas and breast tumors [104]. Punctual mutations could also bring 
to ING4 function loss and tumorigenesis. ING4 N214D mutant attenuated inhibition of 
ING4-mediated cell proliferation, anchorage-independent growth and migration and 
induction of cell death [108]. Mislocalization or an altered ratio of nuclear and 
cytoplasmic ING4 expression can also lead to tumorigenesis in head and neck squamous 
cell carcinoma [109]. Post-transcriptional regulation may also be related with ING4 
down-expression [110].  
 
Figure 13. Model of ING4 dimer structure. The flexible nuclear localization sequence regions of ING4 
were modeled as curvy lines. Figure modified from Culurgioni et al 2012 [103]. 
 
Although ING4 shares the capacity of chromatin modification and cell proliferation 
inhibition with other ING proteins, it is worth highlighting its unique role in the 
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regulation of angiogenesis and cell migration [99]. The correlation between ING4 and 
angiogenesis has been proved in different cancer types and depend on the interaction 
between ING4 and the nuclear factor NF-κB. ING4 could decrease NF-κB binding 
activity, transcriptionally repressing NF-κB-responsive genes, including angiogenesis-
related genes [111]. In addition to NF-κB, the interaction of ING4 with Hypoxia 
Inducible Factor (HIF) has also been shown to play a key role in ING4-mediated 
suppression of myeloma-induced angiogenesis. The mechanism of this mode of action 
depends on the ability of ING4 to recruit chromatin-remodeling factors [112]. ING4 has 
also been related to the suppression of cell migration and contact inhibition through 
suppressing the activity of invasion-related genes such as MMPs (Matrix 
metalloproteinases), which are known to be regulated by NF-κB [113].  
3.5. ING5 
ING5 was first identified by computational homology search and shares high 
homology sequence with ING4. The ING5 gene is located at chromosome 2p37.3 and 
consists of eight exons as ING4 does [114]. ING5, like other INGs, is a H3K4me3 sensor 
and it associated with HATs complexes. Depending on the biological context, ING5 may 
have suppressive or oncogenic abilities [74].  
ING5 is involved in the p53-dependent stress signaling, partially by interacting with 
p53 and promoting its acetylation by p300 which is a member of a HAT complex, 
inducing activation of p53 downstream effectors and leading to chromatin remodeling 
[100]. ING5 also associates with minichromosome maintenance (MCM) proteins, with 
which it plays an essential role in DNA replication [92]. What is not yet clearly 
understood is the function of the recently discovered ING5 phosphorylation at threonine 
152. This modification is carried out by CDK2 (cyclin dependent kinase-2) and it is 
known that, although the phosphorylation takes place in the NLS region of ING5 it does 
not affect its subcelullar localization [115]. Very recently, ING5 has been related to 
MiRNAs, non coding RNAs being shown to be sometimes involved in proliferation and 
apoptosis. ING5 expression is negatively regulated by MiR-1307, promoting ovarian 
cancer tumorigenesis and chemoresistance [116]. 
ING5 deletion, mutation and/or down-regulation are frequent in different cancer types 
such as oral carcinogenesis or lung cancer [117, 118]. The reduction in nuclear ING5 
expression and its cytoplasmic translocation has been observed in head and neck 
squamous carcinoma, and linked to tumorigenesis and aggressiveness in colorectal and 
gastric cancers [119, 120]. Three point mutations have been described in the N-terminal 
domain of ING5 in oral squamous carcinoma, C75R, I68V and Q33R [117]. Mutations in 
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this domain might influence the 3-dimensional structure of ING5 or may alter the 
interaction interface between ING5 and its partners on the formation of HAT complexes, 
thus, altering its role in downstream genes through chromatin remodeling.  
 The structure of PHD finger of ING5 bound to H3K4me3 peptide was determined 
[86], being similar to other PHDs of INGs [78, 84, 85, 96, 101]. In the crystal structure of 
the ING5 PHD in complex with H3K4me3 (Fig. 14), the overall architecture shows the 
characteristic features of a PHD finger. It contains two zinc-binding clusters, the first 
coordinated by one histidine and three cysteines, while the second is coordinated by four 
cysteines. In the complex, the H3K4me3 peptide binds to the PHD of ING5 via formation 
of a third antiparallel β-strand that pairs with the central β-sheet of the protein. The 
affinity of the binding is 2.4 ± 1.0 μM as measured by fluorescence spectroscopy [86] and 
is favoured for trimethylated over di-, mono- and non-methylated histone peptides. 
 
Figure 14. The ING5 PHD finger bound to H3K4me3 (PDB: 3C6W). Left: Recognition of the histone 
peptide by the ING5 PHD finger. Human ING5 PHD represented in purple bound to the H3K4me3 peptide 
in cyan, and the zinc ions are depicted in magenta. Right: The H3K4me3 binding groove. The histone 
peptide is depicted as a stick model.  
There are not structural studies on the full-length version of ING5. However, the fact 
that ING5 shares a high grade of sequence homology with ING4 suggests that the 
structure is also conserved. Then, ING5 might be also folded into three domains: an N-
terminal dimerization domain, a central and unstructured flexible NLS region, and a PHD 
finger in the C-terminal region.  
Previous to this thesis work, the structure of the N-terminal domain of ING5 was 
determined in our group [121]. The overall crystallographic structure showed that the N-
terminal domain of ING5 is a dimer in which each protomer is folded into 3 α-helices 
forming a coiled-coil structure similar to ING4. However, the crystal showed a 
completely different dimerization interface, being an asymmetric dimer while ING4 
forms a symmetric dimer (Figure 15B and C). This result was unexpected if we take into 
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account previous results on ING4 N-terminal crystal structure and the high level of 
homology sequence between ING4 and ING5 N-terminal domains (75 % sequence 
identity; Figure 15A). In addition, usually homodimers are mainly formed in a 
symmetric manner [122]. On the other hand, some complexes have been reported to 
alternate between symmetric and asymmetric conformations to accomplish specialized 
functions [123], although the biologically relevant asymmetric complexes are only the 
3% of the structure databases [124].   
 
Figure 15. Coiled-coil assembly of ING4 and ING5 dimerization domain. A. ESPript 3.0 [125] 
alignment of the ING N-terminal sequences of ING4 and ING5 with the experimentally determined α-
helices in ING4 N-terminal crystal structure. B. Crystallographic structure of the N-terminal domain of 
ING5. Protomers arrangement forms an asymmetric dimer. Figure based on Rodriguez, J.A. 2014 [121]. C. 
Crystallographic structure of the N-terminal domain of ING4 (PDB: 4AFL) [103]. Protomers arrangement 
forms a symmetric dimer. 
 
4. Protein oligomerization in function regulation 
Oligomerization provides with several structural and functional advantages to proteins 
and leads to a better cellular economy; the advantages of modular complex formation are 
maintained without increasing genome size. Oligomerization not only contributes with 
higher stability, but also increases cooperativity and allows for multivalent binding to 
ligands. 
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For instance, the initial level of DNA compaction in eukaryotic cells occurs through its 
association with dimers of the four core histones, to form nucleosomes. The symmetry 
achieved by this dimerization pattern of the histone octamer generates repeated structural 
motifs on the surface that allows the DNA to bind and wrap around in a symmetrical 
manner. This organization might explain the preference of core histones for double 
stranded DNA [126, 127]. Many DNA binding proteins involved in DNA repair, DNA 
replication and gene expression form oligomers. An example is the case of type II 
restriction enzymes, which bind to palindromic DNA sequences. Oligomerization 
increases the DNA binding affinity not only through cooperativity, but also by doubling 
the length of the DNA site bound to the protein [128]. 
In other cases, self association of proteins related to DNA is accomplished by both 
structural and functional means. Protein oligomerization is particularly important for the 
assembly of protein complexes involved in gene expression as transcription factors. In 
eukaryotic cells many different proteins self-associate to form heteromeric transcriptional 
complexes. The function of these kind of complexes depends on its composition, and 
having multiple binding partners transforms the complex providing distinct properties to 
perform specific functions, thereby mediating different gene regulation [129]. Well 
known examples are: the Jun-Fos heterodimer, which increases its transcriptional activity 
upon binding to cofactor NFAT; and the Myc-Max and Mad-Max heterodimerization, 
which defines whether a large number of targeted genes will be expressed or silence. 
Members of these dimerizing families of proteins present conserved domains for 
dimerization, among them: the helix-loop-helix (HLH), a four helix bundle as a dimer, 
the leuzine-zipper-like (LZL), a coiled coil domain, and the ligand-binding domain 
(LBD) [130]. 
In the simplest form, oligomerization functions as a general mechanism for sensing the 
protein concentration. This may be a mechanism for enzyme activation, by altering the 
association/dissociation equilibrium. One of the best known example is caspase-9, which 
exists as an inactive monomer under physiological conditions but dimerizes during 
apoptosis [131]. On the contrary, protein dimerization can inhibit an active monomer. 
This is the case of the receptor-like protein tyrosine phosphatase-α, which exists as a 
downregulated homodimer in the cell surface, but it dissociates and activates upon ligand 
binding [132]. Oligomerization and activation of receptors in the cell surface in response 
to a ligand binding is a common feature in pathways of signal transduction across the cell 
membrane, as in the case of growth hormone, interferon, cytokine and tyrosine kinase 
receptor families [133].  
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The crystal structure of the ING4 N-terminal domain showed and antiparallel 
symmetric homodimer with each protomer folded into a helix-loop-helix structure [103, 
134]. Dimerization of ING4 has a great impact on its tumour suppressor activity, 
monomeric mutants being unable to enhance apoptosis in response to DNA damage. This 
arrangement suggested that ING4 could bind simultaneously not only one, but two 
H3K4me3 on the same or different nucleosomes (Figure 16). In a bivalent model, it was 
hypothesized that ING4 might bind two different nucleosomes close in space, favouring 
at the same time the recognition of DNA sequences that are far away, activating distant 
enhancing elements. 
The high sequence homology between ING4 and ING5 makes it possible to model the 
ING5 N-terminal structure based on ING4 N-terminal domain crystallographic model and 
perform analysis on the coiled coils with the help of helical-wheel models (Figure 17). 
Interestingly, the regions of highest homology keep the same or similar amino acid 
residue in positions a, d and g, essential for the formation of the heptad pattern typical of 
coiled- coil structures in leucine-zipper-like domain. Furthermore, the polar residues that 
stabilize the dimer formation are also highly conserved which suggests the possibility of 
ING5 to form symmetric homodimers in solution as ING4 does. 
Figure 16. Model of ING4 dimer binding to chromatin. A. The ING4 dimer could bind the two H3 tails 
of the same nucleosome through its PHDs. B. ING4 could bind two nucleosomes due to its elongated 
structure. The depicted nucleosomes are positioned consecutively in the chromatin fiber, but they could 
also be non-consecutive if the distance is short enough. Figure from Culurgioni et al 2012 [103]. 
A quantitative estimation of the potential for dimerization was calculated by 
computation of the free energy of the interaction of the two protomers for ING5 model 
and the prediction was that ING5 may form a dimer as stable as ING4 (Figure 17) [103].  
ING4 and ING5 have been shown to be part of the same chromatin remodeling 
complex, the HBO1 HAT [92]. Taking into account the high homology in sequence with 
ING4, we could hypothesize of a possible heterodimer formation between ING4 and 
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ING5. Molecular modelling suggests that ING4/ING5 heterodimers may be as stable as 
the corresponding homodimers (Figure 17) [103]. In this case, the heterodimerization 
could have several consequences and different regulatory effect, as it happens for other 
transcription factors as p63 and p73 (from the p53 family of tumor suppressors) that can 
form heterotetramers in a yet not fully understood alternative function [135]. 
Interestingly, ING4 and ING5 have been shown to be part of the same chromatin 
remodeling complex, the HBO1 HAT [92] (Figure 7). 
 
Figure 17. Coiled-coil assembly of ING4 dimerization domain and models of other putative ING 
dimers. Top: Helical wheel representation of the distribution of residues in the coiled coil and the heptad 
pattern (abcdefg)n of the N-terminal domain of ING4 crystal structure. Light blue indicate the leucine and 
isoleucine residues forming the zipper; purple and green circles indicate the negatively and positively 
charged (or hydrogen bond donor) residues, respectively, that interact, stabilizing the dimer. The salt bridge 
Asp-32/Lys-39 and the hydrogen-bonded pair Asp-94/Gln-69 are indicated by red arrows.  Bottom: 
Models and relative predicted stability of ING5 dimer and ING5/ING4 heterodimer. Helical wheel 
representation of the distribution of residues in an idealized coiled coil homodimer structure of the N-
terminal domain of ING5 (left) and the putative heterodimer model ING4/ING5 (right) were done based on 
the high homology with ING4. Coiled coil representation obtained from Drawcoil 1.0 program server 
(http://www.grigoryanlab.org/drawcoil/). The difference in free energy for the interaction between both 
protomers relative to ING4 dimer (in kcal/mol) was calculated with FoldX programme [136, 137]. 
According to this calculation an ING4/ING5 heterodimer would be even more stable than the two 
corresponding homodimers.  
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The aim of this thesis work is to study the structural organization of the tumor suppressor 
ING5 and its function with the following particular objectives:  
1- Study the structural organization of ING5. 
2- Characterization of the full length ING5 binding to the H3K4me3 mark. 
3- Study the solution structure of the N-terminal domain of ING5. 
4- Characterize the DNA recognition by the NLS regions of ING4 and ING5 
5- Evaluate the structural and functional impact of three point mutations at the N-
terminal domain of ING5 detected in primary tumors. 
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1. Genes, plasmids, cloning and mutagenesis 
 
1.1.  ING5, Nt, Nt mutants and PHD 
A sequence analysis of the ING5 human DNA showed around one third of codons that 
correspond to rare ones in bacteria. Therefore, a synthetic gene of the full-length ING5 
(Uniprot Q8WYH8, isoform 1) with codons optimized for expression in E. coli 
(Entelechon GmbH) was cloned into the expression vector pET11d (within NcoI and 
BamHI sites) and used to subclone different ING5 constructs. The full-length ING5 
(residues 1-240) construct was designed with a His-tag at the N-terminus to facilitate 
protein purification by affinity chromatography followed by a specific sequence for TEV 
protease cleavage (ENLYFQG) for the His-tag removal after purification. Between the 
TEV site and the initial methionine of ING5 an alanine was inserted to prevent possible 
cleavage difficulties. The TEV protease cleavage is done between the glutamine and the 
glycine so the purified product after cleavage has two extra residues before the initial 
methionine of ING5.  
The construct for the N-terminal domain of ING5 (residues 1-105, ING5 Nt1-105) was 
obtained by inserting a stop codon in the amino acid sequence site corresponding to R106 
in the ING5 cloned in pET11d. This clone was used as a template for the production of 
different ING5 Nt1-105 mutants (Q33R, I68V, C75R, C19S, C75S, and 1) by using 
Quick Change Site-Directed mutagenesis kit (Agilent Technologies). Primers for 
mutagenesis (Thermo Scientific) were designed with Quick Change primer design 
(Agilent Technologies). We later designed the construct for the ING5 Nt1-105 for 
expression without affinity His-tag. To obtain this construct, primers were designed to 
amplify and remove His-tag and TEV-site at the same time, using ING5 Nt1-105 cloned in 
pET11d as template. We use ING5 Nt 2-105 to name this construct since it loses the first 
methionine when expressed in E. coli.  
The C-terminal construct of ING5 (ING5 PHD, residues 178-240) was cloned into a 
modified pET29a expression vector. For that, the sequence between residues 178 and 240 
of ING5 (of the full length ING5 construct on pET11d) was amplified with designed 
primers (Thermo Scientific) by PCR introducing two different sequences for restriction 
enzymes en each end of the gene (NcoI and BamHI sites). The amplified sequence 
corresponding to PHD was cloned into a plasmid based on pET39_Ub19 construct 
described in a recent publication [138] as universal tag for efficient protein production in 
bacteria. It consists of ubiquitin at the N-terminus with a His-tag sequence inserted in its 
first loop. The PHD sequence was preceded by a strep-tag sequence and TEV protease 
cleavage site was also included between the strep-tag sequence and the ING5 PHD 
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sequence. The purpose was to purify the protein by two sequential affinity 
chromatography steps. 
For experiments on eukaryotic cells, the human ING5 clone was obtained from 
Addgene. The gene was amplified by PCR with oligonucleotides containing the N-
terminal sequence for AU5 or HA tags (TDFYLK and YPYDVPDYA epitopes 
respectively) and cloned into the pLPC retroviral vector (using BamHI and EcoRI sites) 
which has puromycin resistance. The described cancer mutant constructs of HA-tagged 
ING5 (C75R, I68V, Q33R) were generated with the QuikChange site-directed 
mutagenesis kit (Agilent, United States).  
 
1.2. ING4, Nt, PHD and ING4∆NLS 
The synthetic gene of the full length untagged human ING4 (residues 1-249; Uniprot 
Q9UNL4, isoform 1) cloned into vector pET11d has been previously described [102]. 
The N-terminal construct (ING4 Nt) used in this study consists of ING4 residues 1-108 
with a Strep-tag (WSHPQFE), inserted after the initial methionine by PCR. A clone of 
full length ING4 with the same Strep-tag inserted after the initial methionine was 
produced in the same way. The construct for the C-terminal PHD finger of ING4 (ING4 
PHD, residues 188-249 with an extra methionine at the N-terminus), was previously 
described [101]. The synthetic gene of the ING4 central region deletion mutant (named 
ING4ΔNLS and lacking residues 106-187) was purchased from Entelechon GmbH, and it 
was modified with the insertion of a His-tag and a TEV protease site at the N-terminus. 
All these ING4 constructs have been codon-optimized for expression in E. coli. The HA-
ING4 and AU5-ING4 clones in pLPC vector have already been described [102]. 
1.3. JADE 1L IIb domain 
For the binding analysis to ING5 Nt1-105, the synthetic gene of JADE1L corresponding 
to the conserved IIb domain (Uniprot: Q6IE81, residues 489-534), was cloned as an N-
terminal fusion with ubiquitin using vector pETM60_Ub3, a gift from Vladimir V. Rogov 
[138]. This JADE1L domain was reported to be the binding partner of ING4 and ING5 
within the HBO1 HAT complex by Avvakumov et al [139]. Our JADE1L IIb construct 
(UBJADE) contains an ubiquitin as a tag for increasing solubility when expressed in E. 
coli, a His-tag and a TEV site for tag removal during purification 
(pETM60_Ub3_His_TEV_UBJADE1L_IIb).  
The identity of all clones was confirmed by DNA sequencing and the amino acid 
sequences are described in table 1.  
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Table 1. List of protein sequences used in this thesis project. Sequences in bold correspond to affinity tags 
and TEV sites (in red). 
Name Sequence 
ING5 
MGSSHHHHHHSSGENLYFQGAMATAMYLEHYLDSIENLPCELQRNFQLMRELDQRTEDK
KAEIDILAAEYISTVKTLSPDQRVERLQKIQNAYSKCKEYSDDKVQLAMQTYEMVDKHI
RRLDADLARFEADLKDKMEGSDFESSGGRGLKKGRGQKEKRGSRGRGRRTSEEDTPKKK
KHKGGSEFTDTILSVHPSDVLDMPVDPNEPTYCLCHQVSYGEMIGCDNPDCPIEWFHFA
CVDLTTKPKGKWFCPRCVQEKRKKK 
ING5 Nt1-105 
MGSSHHHHHHSSGENLYFQGAMATAMYLEHYLDSIENLPCELQRNFQLMRELDQRTEDK
KAEIDILAAEYISTVKTLSPDQRVERLQKIQNAYSKCKEYSDDKVQLAMQTYEMVDKHI
RRLDADL 
ING5 Nt2-105 
MATAMYLEHYLDSIENLPCELQRNFQLMRELDQRTEDKKAEIDILAAEYISTVKTLSPD
QRVERLQKIQNAYSKCKEYSDDKVQLAMQTYEMVDKHIRRLDADL 
ING5 PHD 
MQIFVKTLTGKTITLEVEPGSAHHHHHHHHHHAGSSDTIENVKAKIQDKEGIPPDQQRL
IFAGKQLEDGRTLSDYNIQEKSTLELVLELQNESGWSHPQFEKSGENLYFQGAMDMPVD
PNEPTYCLCHQVSYGEMIGCDNPDCPIEWFHFACVDLTTKPKGKWFCPRCVQEKRKKK 
ING4 
MWSHPQFEKAAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMS
SARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLARFEAD
LKEKQIESSDYDSSSSKGKKKGRTQKEKKAARARSKGKNSDEEAPKTAQKKLKLVRTSP
EYGMPSVTFGSVHPSDVLDMPVDPNEPTYCLCH 
QVSYGEMIGCDNPDCSIEWFHFACVGLTTKPRGKWFCPRCSQERKKK 
ING4 Nt 
MWSHPQFEKAAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMS
SARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLARFE 
ING4 PHD 
MDMPVDPNEPTYCLCHQVSYGEMIGCDNPDCSIEWFHFACVGLTTKPRGKWFCPRCSQE
RKKK 
ING4∆NLS 
MSYYHHHHHHDYDIPTTENLYFQGAMAAGMYLEHYLDSIENLPFELQRNFQLMRDLDQR
TEDLKAEIDKLATEYMSSARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMV
DKHIRRLDTDLADMPVDPNEPTYCLCHQVSYGEMIGCDNPDCSIEWFHFACVGLTTKPR
GKWFCPRCSQERKKK 
UBJADE 
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQGLIFAGKQLEDGRTLSDY
NIQKESTLHLVLQLESASGSGHHHHHHSAGENLYFQGAMGLQLFTLRQDLERVRNLTYM
HVTRREKIKRSVCKVQEQIFNLYTKLLE 
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2. Protein expression and purification 
All ING5 constructs were produced in E. coli BL21 (DE3) cells and purified by 
different chromatographic steps detailed below. All pure proteins were concentrated by 
ultrafiltration, flash-frozen in liquid N2 and stored at -80 °C until used. The identity and 
labeling of each protein was confirmed by MALDI-TOF and the purity was checked by 
SDS-PAGE. Protein concentration was measured by UV absorbance using extinction 
coefficients calculated using the Expasy Protparam tool [140]. 
 
2.1.  Expression and purification of ING5, Nt, Nt mutants and PHD 
For ING5, Nt, Nt C75R, Nt I68V, Nt Q33R, Nt C19S, Nt2-105, and Nt 1  expression, 
cells were grown in LB or in ZYP-5052 auto-induction rich medium [141]. Cells that 
were grown in LB at 37 °C were induced at O.D. 600 = 0.8 with 0.5 mM IPTG for 3 h at 
37 ºC, while cells that were grown in auto-induction ZYP-5052 medium for 2 h at 37 ºC, 
were left for expression induction at 20 ºC for 22-23 h. [U-
15
N]-labeled ING5, Nt (1-
105), Nt (2-105), Nt C75S, Nt C19S and PHD proteins were produced for NMR 
experiments in a modified auto-induction media, P-5052 [142]. There were proteins as 
Nt, Nt C19S and PHD that were [U-
15
N]-labeled only or [U-
13
C, U-
15
N]-labeled by using 
Marley´s method [143], in which cells were grown in LB until they reached O.D. 600 = 
0.8, when they were pelleted and washed with a M9 salt solution and grown in 
15
N 
labeled minimal media for 30 min at 37 ºC before inducing with 0.5mM IPTG for 3 
hours. 
All cultures were harvested by centrifugation and resuspended in lysis buffer (20 mM 
Tris pH 8.0, 300 mM NaCl, 1 mM DTT (or 20 mM Tris pH 8.0, 1 mM DTT in the case 
of Nt 2-105), always in the presence of protease inhibitors (1 tablet Complete EDTA-free 
per 50 mL). After sonication and ultracentrifugation, proteins were found in the insoluble 
(ING5, Nt 1-105,  Nt C75R, Nt Q33R, Nt I68V, Nt C19S, Nt C75S, Nt 1) or in the 
soluble fraction (Nt 2-105, PHD, 1, C75S). Insoluble proteins were recovered from the 
inclusion bodies by solubilization in 8 M urea containing lysis buffer and 
ultracentrifugation for 3 h. Supernatant was refolded by a 1:50-1:100 dilution into cold 20 
mM, Tris pH 8.0, 300 mM NaCl, 1 mM DTT, and 50 µM ZnCl2 (for the constructs 
including the PHD finger), containing protease inhibitors.  
Refolded ING5 was purified by affinity chromatography with a HisTrap column (GE 
Healthcare) and eluted with linear imidazol gradient (0-500 mM) in 15CV. Selected 
fractions, without being concentrated, were loaded into a Superdex 200 26/60 column in 
different runs for polishing and a resulting yield of 0.7-1 mg/ Lculture (no TEV cleavage 
was done since this caused protein precipitation; Figure 1).  
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Figure 1. Last step of the purification of ING5. (Top panel) Selected fractions from the affinity 
chromatography step were pooled (lane I in the gel) and loaded into a gel filtration column (Superdex 200 
26/60 column). (Bottom panel) A Tris-glycine 12 % SDS-PAGE was run with the indicated fractions from 
the chromatogram, at room temperature and 220 volts for 45 min. The fractions corresponding to the main 
chromatographic peak were pooled and concentrated for structural analysis or fast frozen and stored at -
80ºC. 
 
Soluble or refolded Nt1-105 and all Nt1-105 mutants (C19S, C75S, 1,C75R, I68V, 
Q33R) containing a His-tag were purified by affinity chromatography with a HisTrap 5 
mL column (GE Healthcare) and eluted with an imidazol linear gradient (0 - 0.5 M) in 5 
CV. Selected fractions were incubated with TEV protease in a 1:30 ratio (1 mg TEV: 30 
mg protein) and dialyzed against  20 mM, Tris pH 8.0, 40 mM NaCl, 1 mM DTT  at 4 °C 
for 16 h. Dialyzed samples were loaded again on a HisTrap column (GE Healthcare) in 
order to remove the cleaved His-tag. The flow through was loaded on a Hitrap Q HP 5 
mL column (GE Healthcare) and the elution was done with NaCl linear gradient (0.04 - 1 
M) in 5 CV. Selected fractions were concentrated and separated by gel filtration 
(Superdex 75 16/60, GE Healthcare) in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT 
with a yield of 6-18 mg/Lculture. The degree of purity of Nt1-105 sample is shown in Figure 
2. ING5 Nt 2-105 was purified from the soluble fraction with a first step on a Q-Sepharose 
26/10 column equilibrated in 20 mM Tris pH 8.0, 1 mM DTT and a gradient elution from 
0 M to 1 M NaCl in 9.5 CV. Selected fractions were pooled and dialyzed o/n at 4 °C 
against 20 mM Tris pH 8.0, 40 mM NaCl, 1 mM DTT. Dialyzed sample was loaded onto 
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a Mono Q 5/50 HR equilibrated in 20 mM Tris pH 8.0, 40 mM NaCl, 1 mM DTT. 
Elution was done with a linear gradient to 1 M NaCl in 25 CV. Selected fractions were 
polished by successive gel filtration chromatography on Superdex 75 26/60 and Superdex 
75 16/60 columns equilibrated in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT. The 
final yield was 21 mg/Lculture. The degree of purity of Nt2-105 sample is shown in Figure 2. 
Soluble PHD was purified first by affinity chromatography with a HisTrap column (GE 
Healthcare) equilibrated in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT and eluted 
with one step of imidazol of 500 mM. Selected fractions were diluted 2 times with 20 
mM Tris pH 8.0 and loaded into a StrepTactin column equilibrated in 100 mM Tris pH 
8.0, 150 mM NaCl. Elution was done with one step of 2.5 mM Desthiobiotin. Eluted 
fractions were selected and digested with TEV in a 1:30 ratio (at the same time as a 
dialysis was done o/n at 4 °C to remove Desthiobiotin. After injection in the StrepTactin 
column the flow through was concentrated for gel filtration separation on a Superdex 75 
16/60 column equilibrated in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT. The yield 
of pure proteins was 2 mg/Lculture. The degree of purity of this sample is shown in Figure 
2. 
 
Figure 2.  Representative purity grade of protein samples.  SDS-PAGE on a Tris-tricine 10 % gel was 
loaded with PHD (2 μg) protein and  run at room temperature at 120 volts for 80min. Tris-glycine 12 % 
gels were used in the case of Nt1-105 (3 μg) and Nt2-105 (2μg)  and run at room temperature at 220 volts for 
45 min . All gels were stained with coomassie brilliant blue and destained with 30% acetic acid in ethanol.  
 
2.2.   Expression and purification of ING4, Nt, PHD and ING4∆NLS 
For Nt, PHD and ING4∆NLS expression, cells were grown in auto-induction medium 
[141]. Uniformly 
15
N enriched ING4 was expressed in a modified auto-induction medium 
[142] and in minimal media as described [143]. Cultures were harvested by 
centrifugation and resuspended in lysis buffer (20 mM Tris pH 8.0, 1 mM DTT), with the 
addition of 150 and 300 mM NaCl in the case of N-t and ING4ΔNLS respectively, 
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always in the presence of protease inhibitors (1 tablet Complete EDTA-free per 50 mL). 
After sonication and ultracentrifugation, proteins were predominantly found in the 
insoluble fraction (ING4, Nt, PHD, and ING4ΔNLS) or in both the insoluble and soluble 
fractions (Strep-ING4, Nt). Insoluble proteins were solubilized in lysis buffer with 8 M 
urea and separated by ultracentrifugation at 35000 rpm for 3h. Supernatant was refolded 
by a 1:10-1:100 dilution into cold 20 mM, Tris pH 8.0, 1 mM DTT, and 50 µM ZnCl2 
(needed for PHD finger folding).  
Refolded ING4 was loaded onto a HiLoad 26/10 Q Sepharose anion exchange column 
equilibrated in 20 mM Tris pH 8.0, 1 mM DTT and elution was carried out with a 0-0.5 
M NaCl gradient in 4.7 column volumes. Eluted fractions were diluted 3 times in 20 mM 
Tris pH 8.0, 1 mM DTT and loaded onto a Hi-Trap SP FF column equilibrated in 20 mM 
Tris pH 8.0, 50 mM NaCl and 1 mM DTT for cation exchange chromatography. Elution 
was done with a 0.05-1 M NaCl gradient in 20 CV. Selected fractions were concentrated 
and separated by gel filtration in a Superdex 75 26/60 column equilibrated in 20 mM Tris 
pH 8.0, 300 mM NaCl, 1 mM DTT. The degree of purity of this sample is higher than 90 
% (Figure 3).  
 
Figure 3. SDS-PAGE analysis of the purity of ING4 protein. A 12 % gel was loaded with 15 (left lane) 
or 3 (right lane) μg of ING4 protein and run at room temperature and 220 volts for 45 min. The gel was 
stained with coomassie brilliant blue and destained with 30% acetic acid in ethanol. Densitometry analysis 
of the gel indicates that the major, corresponding to ING4, represents between 90 (left lane) and 94 % 
(middle lane) of the total protein. 
 
Soluble Strep-ING4 was purified on a Strep-tactin 5 mL column (IBA-lifesciences) 
equilibrated in 100 mM Tris-HCl, pH 8.0, 150 or 300 mM NaCl, and eluted with 2.5 mM 
desthiobiotin. Selected fractions were concentrated and loaded onto Superdex 75 16/60 
equilibrated with 20 mM Tris-HCl pH 8.0, 300 mM NaCl, 1mM DTT. Soluble Strep-
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ING4 Nt was purified on a Strep-tactin 5 mL column in the same way as the full length 
protein. Refolded PHD was purified as previously described [101]. Refolded His-
ING4ΔNLS was loaded into a His-Trap FF crude 5 mL column equilibrated in 20 mM 
Tris, pH 8, 300 mM NaCl, 1 mM DTT and washed with 50 mM imidazol. Elution was 
done with a 50-300 mM gradient in 20 CV. Selected fractions were diluted 1:2 in 20 mM 
Tris pH 8.0, 1mM DTT and loaded onto a HiTrap Q HP 5 mL column equilibrated with 
20 mM Tris, pH 8, 30 mM NaCl, 1 mM DTT. Protein was eluted with a 0.05-1 M NaCl 
gradient in 50 CV. Selected fractions were concentrated and loaded on a Superdex 200 
26/60 column equilibrated in 20 mM Tris, pH 8, 300 mM NaCl, 1 mM DTT. 
 
2.3. Expression and purification of JADE1L_IIb domain 
 
The expression of UBJADE construct, cloned in into pETM60_Ub3, was done at low 
temperatures using E. coli Artic (DE3) RIL grown in LB medium. With this approach we 
tried to increase the expression yield of soluble recombinant UBJADE since this E. coli 
strain expresses cold-adapted chaperonins which confer an improved protein processing 
at low temperatures.  However, after the induction of expression with 0.5 mM IPTG, the 
majority of the protein was insoluble, and the little amount of soluble expressed UBJADE 
resulted in very low purification yields due to its low solubility in the purification 
conditions as well as protein degradation. Therefore, this strategy for obtaining 
JADE1L_IIb was abandoned.  
 
3. Circular dichroism (CD) 
 
Circular dichroism is defined as the difference in absorption of left-handed and right-
handed circularly polarized light. When optically active molecules such as proteins 
interact with the light, they absorb right and left hand circularly polarized light 
differently. CD spectra are reported in units of mean residue molar ellipticity ([θ], 
deg.cm
2
.dmol
-1
) [144]. This technique is an excellent method for evaluating secondary 
structure in solution because when the chromophores of the polypeptide backbone are 
aligned forming regular secondary structure motifs, they have characteristic far UV (178-
250nm) CD spectra. For example, α-helical proteins have negative bands at 222 nm and 
208 nm and a positive band at 193 nm. Proteins with antiparallel β-sheets have negative 
bands at 218 nm and positive bands at 195 nm, and disordered proteins have very low 
ellipticity above 210 nm and negative bands near 195 nm (Figure 4) [144]. 
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Figure 4. Circular dichroism reference spectra for each type of secondary structure motif. Figure 
based on old experiments from Greenfield & Fasman, 1969[145]. 
 
CD measurements were performed in a Jasco J-815 spectropolarimeter (Jasco 
International, Japan) equipped with a Peltier temperature controller. The CD spectra were 
recorded on protein samples at 11-40 μM in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM 
DTT using a 0.1 cm path length quartz cuvette at 25°C. A reference spectrum with buffer 
alone was subtracted before data were converted to mean residue molar ellipticity 
([θ]MRE). Thermal denaturation from 5 to 95 ºC was recorded on protein samples in the 
range of 1-40 μM using a stoppered 2 mm path length cuvette by increasing temperature 
at a rate of 1 °C/min and measuring the change in ellipticity at 222 nm. The midpoints of 
the thermal-denaturation curves (Tm) were determined from the first derivative, the 
second derivative, or by fitting to a sigmoidal transition curve.  
Dimer dissociation KD values at 25 ºC were derived from thermal denaturation 
analysis followed by CD curves were following a method described by Marky and 
Breslauer[146]. This method assumes a two-state transition (i.e. the denaturation showed 
by the loss of CD signal at 222 nm is concomitant with dimer dissociation) and that the 
change in heat capacity during melting is negligible [147]. For this purpose, a series of 
CD thermal denaturation curves across a range of peptide concentrations (40, 20, 10, and 
2 μM) were recorded. The midpoints of the thermal-denaturation curves (Tm) were 
determined for each curve and plotted as their reciprocal versus the natural logarithm of 
the protomer concentration. The KD values at the temperature of interest can be obtained 
by extrapolation from linear regression of the obtained plot. 
 
 
 
   
44  Materials and Methods 
4. Size Exclusion Chromatography-Multi angle static Light Scattering (SEC-
MALS) 
 
Light scattering is a powerful technique for determining the molar mass of proteins in 
solution and studying the formation of oligomers. In a typical MALS experiment the 
sample is irradiated by a laser light at different angles and the intensity of the scattered 
light by the sample is measured at several angles give direct information about the molar 
mass of the macromolecule independently of its shape [148]. SEC may also be used to 
determine the size of a protein after calibration of the column, however the results are 
only valid when the protein is globular and approaches the shapes of a sphere. SEC 
coupled with “on-line” MALS detector serves as a further step of fractionation to avoid 
ambiguity that might result from the light scattered by a mixture of species, and the 
molecular mass determination by MALS will be independent of the SEC elution position 
[149].  
These experiments were performed at 25 C using a Superdex 200 Increase 10/300 GL 
column (GE HealthCare) attached in-line to a DAWN-HELEOS light scattering detector 
and an Optilab rEX differential refractive index detector (Wyatt Technology, California, 
USA). The column was equilibrated either with 20 mM Tris pH 8.0, 300 mM Nacl, 0.5 
mM TCEP, 0.03% NaN3, (0.1 µm filtered) in the case of ING5 constructs or PBS pH 7.4 
(0.1 μm filtered) in the case of ING4∆NLS. The SEC-MALLS system was calibrated 
with a sample of Bovine Serum Albumin (BSA) at 1 g/L in the same buffer. A sample of 
100 µL of protein at 1-3 g/L was injected at 0.5 mL/min. Data acquisition and analysis 
employed ASTRA software (Wyatt Technology). Based on numerous measurements on 
BSA samples at 1 g/L under the same or similar conditions we estimate that the 
experimental error in molar mass is around 5%. 
 
5. X-ray crystallography: Crystallization, Data Collection and Structure 
Determination.  
 
X-ray crystallography is a technique that requires de generation of protein crystals 
under precipitant conditions [150]. Crystals are ordered arrays of atoms related by 
translations in one dimension (fibers), two dimensions (sheets) and three dimensions 
(lattice) [151]. The smallest repeating unit of the crystal is the unit cell and its shape is 
defined by the length of three axes (a, b, c) and three angles (α, β, γ). The unit cell has 
also internal symmetry and the smallest portion of structural information required to 
reconstruct the lattice through crystallographic symmetries and translations is the 
asymmetric unit. When X-rays are applied to a crystal they are diffracted by the atoms 
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from multiple parallel planes simultaneously and can be constructive (in phase) or 
deconstructive (out of phase). The planes that scatter X-rays are determined by the 
wavelength of the incident X-rays, the unit cell parameters, and the orientation of the 
crystal. In the unit cell, the size, shape and orientation of the molecule will determine the 
reflections that will occur on the detector. The arrangement of the atoms in the unit cell 
will determine the intensities of the diffracted X-rays. Those positions control the 
amplitude and phase. However, data collection only measures the intensities while the 
relative phase information necessary for the calculation of the electronic distribution in 
the unit cell is missing. This is the so called “phase problem” that has to be solved in 
order to determine the structure by using one of three different methods: experimental 
methods, direct methods and molecular replacement [151]. 
 
Crystallization screenings for ING5 Nt1-105 mutants C19S and Δα1, and Nt2-105 were 
performed at 21 ºC with a MOSQUITO robot (TTP Labtech) using the vapor diffusion of 
sitting drop technique. The initial screens tested for Nt C19S were JCSGII, JCSGIII, 
JCSGIV, PACT suite, AmSO4 suite, PEGs suite (Qiagen), PEG/ ION,  PEGRx, 
SALTRx, Index, additive screen (Hampton Research) and Morpheus, JCSG plus 
(Molecular dimensions) in 96-well MRC plates (Molecular Dimensions). Drops consisted 
of 0.1 -0.3 µL protein solution plus 0.1- 0.3 µL reservoir solution and a reservoir volume 
of 60 µL. The already known good conditions for crystallization of ING5 Nt were tested 
for screening on ING5 NtC19S (0.1 M MES pH 6.5, 10-30% MPD, 0-6% PEG3350) in 
48-well MRC plates (Molecular dimensions). Drops consisted of 1-2 µL protein solution 
plus 1-2 µL reservoir solution and a reservoir volume of 200 µL. In all plates protein 
concentration was 10 mg/mL. Crystals were only obtained in very few conditions in 
nanodrops (Figure 5, A-|B). Condition JCSGII n.50 was selected as the best one for 
ING5 Nt C19S based on the similitude with the already tested and successful condition 
for ING5 Nt crystallization, and it was the starting point for optimization. The crystals 
were difficult to reproduce in bigger sitting drops but they were finally obtained in 0.1 M 
MES pH 6.5, 20-30% MPD and were cryoprotected with the reservoir condition plus 
20% glycerol before collecting data at ID29 beamline at ESRF. These crystals were very 
delicate and depicted no diffraction (Figure 5, C-D).  
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Figure 5. ING5 Nt1-105 C19S crystallization. A, B. Crystals obtained in JCSGII commercial screening 
conditions no. 37 and no. 50, respectively. Condition JCSGII n.50 (0.1M MES pH6.0, 10% MPD) was 
selected as the best one based on the successful condition for ING5 Nt crystallization. This condition was 
further optimized: C, D. Crystals obtained in the optimized condition of 0.1 M MES pH 6.5, 20-30% MPD. 
These crystals were taken to ID29 beamline at ESRF synchrotron but did not diffract. A new set of crystals 
were obtained in Morpheus commercial screening condition no. C8 and this crystallization condition was 
optimized: E, F. Crystals obtained in the optimized condition of  0.1 M sodium MOPS/HEPES  pH 7.5, 
37.5% MPD_PEG1K_PEG3350, 0.03 M NaNO3, 0.03 M Na2HPO4, 0.03 M (NH4)2SO4. These crystals 
were taken to PROXIMA1 beamline at SOLEIL synchrotron depicting 3.1 Å diffraction.  
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A new set of crystals was obtained in Morpheus crystal screening plates.  Conditions 
n.C4 and n.C8 (surprisingly both containing MPD) were selected as the best 
crystallization conditions and these crystals were reproduced in bigger sitting drops on 
12-well plates (Figure 5, E-F). Best crystals grew on Morpheus n.C8 condition (0.1 M 
sodium MOPS/HEPES  pH 7.5, 37.5% MPD_PEG1K_PEG3350, 0.03 M NaNO3, 0.03 M 
Na2HPO4, 0.03 M (NH4)2SO4). These were big crystals with 77% solvent which were 
cryoprotected  directly with the reservoir condition and data was collected at beamline 
PROXIMA1 in SOLEIL synchrotron with a DECTRIS PILATUS3 6M detector, 
depicting 3.1 Å diffraction (Figure 6A). 
The initial screenings tested for ING5 Nt Δα1 were JCSGI, JCSGII, JCSGIV, PACT 
Suite, AmSO4 Suite (Qiagen), SALTRx, PEG/ ION, Index (Hampton Research), and 
JCSG plus, Morpheus, MIDAS, Structure Screen, Proplex, NR-LBD (Molecular 
Dimensions) in 96-well MRC plates (Molecular Dimensions). Crystals were obtained in 
several conditions in nanodrops but the best crystallization conditions (JSCGIV n.65, 
JCSG Plus n.F1, INDEX n.D2, MIDAS n.2-5) were selected based on the quality of the 
crystal (best ordered, biggest ones, and most reproducible). Surprisingly all of these 
conditions contained jeffamine M-600 (a 600 molecular weight polypropylene glycol 
monoamine) and were reproduced in bigger sitting drops in 48-well plates. Best crystals 
of ING5 Nt Δα1 appeared in both, 0.1 M Tris or HEPES pH 7.0, and 35% jeffamine with 
Ionic Liquid Screen #20 from Hampton Research (1-Butyl-3-methylimidazolium 
trifluoroacetate) (Figure 7). These crystals were cryoprotected with 20% ethylenglycol 
and data was collected at XALOC beamline in ALBA synchrotron with very low 
resolution (5.09 Å or lower) (Figure 6B).  
 
Figure 6. A. Diffraction pattern (3.1 Å) of the obtained crystals for C19S mutant using synchrotron 
radiation at the PROXIMA1 beamline (SOLEIL, París). B. Diffraction pattern (5.09 Å) of the obtained 
crystals for the Δα1 mutant using synchrotron radiation at the XALOC beamline (ALBA, Barcelona). 
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Figure 7. ING5 Nt1-105 ∆α1 crystallization. A-B. Best crystals obtained in the optimized condition of 0.1 
M Tris pH 7.0, and 35% jeffamine with Ionic Liquid Screen #20 from Hampton Research (1-Butyl-3-
methylimidazolium trifluoroacetate). These crystals were taken to XALOC beamline at ALBA synchrotron 
depicting low resolution diffraction.  
 
ING5 Nt2-105 initial screens were Morpheus, JCSG plus, Structure screen 1 and 2 
(Molecular dimensions) PEG ION 1 and 2, PEG Rx1 and Rx2, Index (Hampton 
Research) and Pact (Qiagen). Crystals were obtained in several conditions in nanodrops 
but the best crystallization conditions were found in JCSG plus condition F4 (2.16) and 
Structure Screen conditions F1 and F12. All of these conditions contained jeffamine M-
600 and were reproduced in bigger sitting drops in 48-well plates. These crystals were 
cryoprotected with 20% glycerol and brought to XALOC beamline in ALBA synchrotron 
where they did not diffract. 
Diffraction data of the ING5 Nt C19S mutant obtained in SOLEIL was reduced using 
the MOSFLM [152] and scaled with SCALA [153]. The crystal structure of the wild type 
(PBD entry 5ME8) was used for molecular replacement with MOLREP [154]. The final 
model was reconstructed with Coot [155] and refined with REFMAC [156]. The final 
structural models were validated for geometry and stereochemistry restrictions [157] with 
MOLPROBITY [158], and were analyzed with PISA [159], CoilCheck [160], and Socket 
[161]. Figures were produced with PYMOL [162]. The coordinates and structure factors 
have been deposited at the Protein Data Bank (PDB) with the entry code 5MTO. 
 
6. Small angle X-ray Scattering (SAXS) 
SAXS is a method for low resolution structural characterization of proteins and 
oligomers in solution [163]. It is a complementary technique to other high resolution 
structural techniques such as X-ray crystallography or NMR; however, the sample does 
not need any intermediate step of preparation like crystallization or isotopic labeling, so 
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in a synchrotron scattering data can be collected in seconds, allowing for a rapid 
characterization of the sample. In practice, the sample is exposed to highly collimated X-
rays and the scattered radiation is registered by a detector at small angles. The X-ray 
scattering curve (intensities versus scattering angle) is used to create a low resolution 
model (“SAXS envelope”) of the macromolecule. Besides, several parameters can be 
extracted directly from the scattering curve such as: molar mass (MM), radius of gyration 
(Rg), and maximum particle diameter (Dmax). 
SAXS data was collected at 20 ºC on BM29 beamline at The European Synchrotron 
(ESRF), in Grenoble, France with a 2D detector (Pilatus 1M) over an angular range qmin 
= 0.01 Å
-1 
to qmax = 0.5 Å
-1
 [164]]. Prior to measurements the samples were loaded onto 
a PD10 column equilibrated in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM TCEP and 
concentrated by ultrafiltration. Aliquots of the samples were prepared by dilution at 
different concentrations and the buffer was used as a blank for the SAXS experiments. 
The protein concentrations used were 4 and 7 g/L for ING5 Nt and 5 and 12 g/L for the 
ING5 Nt C19S mutant. The analysis of the data sets at different concentrations gave 
similar results. Data collection, processing and initial analysis were performed using the 
beamline software BsxCUBE. Further analysis was performed with ATSAS [165]. The 
Guinier approximation was used to calculate the radius of gyration using the PRIMUS 
software [166]. The distance distribution function, p(r), was computed with the program 
GNOM [167] by optimizing the maximum particle dimension, Dmax, to 89 Å. Low 
resolution ab initio reconstructions of the Nt domain and C19S mutant were built from 
the scattering data using GASBOR [168]. Ten independent GASBOR reconstructions 
were performed, and the most probable model was filtered with DAMSEL [169]. The 
low resolution shape of the ING5 Nt and C19S mutant are represented as an assembly of 
230 dummy residues inside a search volume with a maximum diameter of 89 Å. Ten 
independent GASBOR reconstructions were performed and the most probable envelop 
was determined with DAMAVER [169]. The crystal structure of ING5 Nt C19S (PDB: 
5MTO), or the homology model we have modeled based on the crystal structure of ING4 
Nt (PDB: 4AFL), were fitted to the SAXS data with CRYSOL [170]. The goodness of 
the fitting is characterized by the discrepancy value 2. Superposition of the bead model 
on the structures was carried out with SUBCOMB [171] and Chimera [172]. The model 
of ING5 Nt based on the crystal structure of ING4 Nt was built with FOLDX [136] and 
the 3 or 4 missing residues at the N-termini of the two protomers (absent in the crystal 
structure of ING4) were modeled with Coot in an extended conformation.  
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7.  Nuclear magnetic resonance (NMR) spectroscopy 
 
NMR spectroscopy is based on the fact that certain atomic nuclei have a quantum 
mechanical magnetic property known as spin [173]. The most common nuclei analyzed 
in proteins by NMR are 
1
H, 
13
C and 
15
N because of their favorable magnetic properties 
(spin quantum number I=1/2) and their ubiquity in the polypeptide chain. However, while 
1
H is naturally abundant in 99%, the natural abundance of 
15
N and 
13
C are less than 0.4% 
and 1%, respectively. For this reason, proteins studied by NMR are usually produced 
isotopically labeled in 
15
N and 
13
C. The nuclei with spin I=1/2 have two possible which in 
the presence of a magnetic field will display an energy difference between them 
proportional to the intensity of the magnetic field and dependent on the properties of the 
nuclei.  
In a simple NMR experiment, the sample is irradiated with very short (μs) 
radiofrequency pulses (polychromatic radiation) at a determined power necessary to 
excite all the nuclei of a given kind under a magnetic field. In this way a net 
magnetization of the sample nuclei is created and the relaxation back to equilibrium is 
registered as an oscillating current in the coil of the spectrometer, this is the NMR signal. 
Fourier transformation of the time-domain signal yields the frequency-domain NMR 
spectrum with the signals of the different nuclei appearing at slightly different 
frequencies due to their different chemical environment (the chemical shift) [174] In 
protein NMR, the frequency of the nuclei will depend on the type of the amino acid and 
also on its particular chemical environment, which is modulated by the secondary, 
tertiary, and quaternary structure of the protein, as well as the binding of ligands and, to a 
lesser extent, by the solvent conditions (pH, salt and temperature). 
In the case of proteins and other large molecules one dimensional experiments are not 
sufficient for analysis since there is a strong signal overlap. It is, then, necessary to use 
multidimensional NMR facilitating the analysis of protein spectra when two or more 
different nuclei are combined in the study. In triple resonance experiments, 
1
H, 
13
C and 
15
N nuclei are studied generally for proteins. These experiments can provide information 
about how the atoms are chemically linked, how close they are in space and how rapidly 
they move with respect to each other. 
For this thesis work, all NMR experiments were recorded at 25 °C on a Bruker 
Avance III spectrometer operating at 18.8 T (800 MHz of 
1
H Larmor frequency) 
equipped with a triple resonance cryo-probe with z gradients. Chemical shifts were 
measured relative to internal 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt (DSS) 
for 
1
H and calculated for 
15
N and 
13
C using IUPAC references [175]. 
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7.1. Protein Backbone assignments  
One of the most useful NMR experiments in protein NMR is the Heteronuclear Single 
Quantum Coherence spectrum [176], in which the signals correspond to the correlation of 
two different nuclei that are directly bonded. The most frequently used is the 
1
H-
15
N-
HSQC, which correlates NH groups, that in the case of proteins, will give information 
about peptide bonds of amino acids and, in addition, about the side chains of arginines, 
tryptophans, glutamines, asparagines and lysines. The previous assignment of the signals 
obtained in a 
1
H-
15
N-HSQC is necessary to identify the amino acid residue to which that 
signal belongs; and this is the basis for protein-ligand interaction studies, particularly to 
map the region of interaction and measuring the affinity. Heteronuclear 
1
H-
15
N 
correlations can be measured in the Transverse Relaxation Optimized Spectroscopy 
mode, which provides increased resolution at the expense of some sensitivity loss. 
TROSY is especially suitable for slowly tumbling deuterated proteins, but also it may 
also be helpful in non-deuterated proteins as well. With this strategy the average life of 
the signals that relax very fast is increased to facilitate their observation. 
For the backbone amide assignment of ING5 Nt1-105 and PHD finger of ING5, triple 
resonance experiments were acquired. These experiments allow for the frequency 
separation of overlapping signals in the 2D experiments, and provide useful information 
to identify the secondary structure of the protein from the chemical shifts using available 
methods such as TALOS [177] RCI (Random coil index) [178] and CSI [179].  The 
backbone assignments of 
13
C,
 15
N-ING5 Nt1-105 and 
13
C,
 15
N-PHD finger of ING5 were 
obtained from 2D 
1
H-
15
N-TROSY, 
1
H-
13
C-HSQC spectra and from TROSY-based 3D 
HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HN(CA)HA, and 
HN(COCA)HA experiments, acquired with non-uniform sampling (NUS) [180] in the 
case of ING5 PHD. Backbone 
1
H- 
15
N heteronuclear NOE measurements [181] were 
performed in the case of ING5 Nt1-105 and each 
1
H-
15
N NOE spectrum (both saturated and 
nonsaturated one) was acquired with 352 scans and 64 t1 points in the indirect dimension 
with an overall recycling delay of 5 s to ensure the maximal development of NOEs before 
acquisition and to allow solvent relaxation, thus minimizing transfer of saturation to the 
most exposed amide protons of the protein from scan to scan [182]. The heteronuclear 
NOEs were calculated from the ratio of cross-peak intensities in spectra collected with 
and without amide proton saturation during the recycle delay.  
The ING5 Nt1-105 NMR sample was  250 µM protein in 50 mM MOPS pH 7.3, 1 mM 
DTT, 5% 
2
H2O, 3 µM DSS (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt) and 
protease inhibitors. ING5 PHD NMR sample was prepared at 220 µM in 20 mM Tris pH 
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8.0, 300 mM NaCl, 1 mM DTT, 5% 
2
H2O, 44 µM DSS (2,2-dimethyl-2-silapentane-5-
sulfonate sodium salt) and protease inhibitors. 
 NMR signal assignment was initially done automatically using MARS [183] and 
completed manually. Uniformly sampled data (the standard mode) spectra were 
processed with TOPSpin (Bruker) and NUS spectra with MddNMR [184]. The processed 
spectra were analyzed using Sparky [185]. 
To study the possibility of a different oligomerization mode of ING5 at acidic pH , 
titrations of pH were performed by stepwise addition of 0.4 – 4 μL of a HCl solution 
(37%) into a 400 μL sample of 15N ING5 Nt at 180 μM in 50 mM MOPS pH 8.0, 1 mM 
DTT, 5% D2O, 3μM DSS and 0.5 mg of protease inhibitors. 1H-15N- TROSY spectra 
were recorded for each step for comparisons. 
 
7.2. H3K4me3 peptide binding 
The synthetic peptide H3K4me3 corresponds to residues 1-15 of histone H3 plus an 
extra tyrosine residue at the C-terminus (ARTKQTARKSTGGKAY) to measure peptide 
concentration by ultra violet (UV) absorbance. This peptide has free N- and C-termini 
and was purchased from NeoMPS (Strasbourg). For H3K4me3 peptide preparation 3.2 
mg of lyophilized powder were dissolved into 300 μL of 20 mM Tris pH 8.0, 300 mM 
NaCl, 1 mM DTT adjusted to 8.0 with concentrated NaOH and HCl. Concentration was 
measured by UV absorbance using extinction coefficients calculated with ExPASy 
ProtParam tool [140]. 
For the analysis of the interaction of ING5 with H3K4me3 we used 
1
H-
15
N-HSQC 
spectra, which provide information of the chemical shift perturbations (CSP) of the NH 
groups caused by the presence of the peptide. For this experiment, titrations with histone 
synthetic peptide H3K4me3 were performed by stepwise addition of the concentrated 
peptide stock solution (3.8 mM) into 450-500 μL samples of 11 μM 15N ING5 or 10 μM 
15
N ING5 PHD in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT, 5% (v/v) 
2
H2O, 
0.01% NaN3, 4μM DSS. After each addition step a 
1
H-
15
N-HSQC spectrum was 
recorded. 
The measurement of the chemical shift perturbation (CSP) in a ligand concentration 
dependent manner by using 
1
H-
15
N-HSQC allowed us to fit the data points to the 
equation that describes the binding equilibrium to a single set of binding sites. The error 
in CSP, estimated from the spectral resolutions in the processed data, is 0.006 ppm. 
Dissociation constants (KD) were determined by data fitting (Origin, Microcal) to the 
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equation: CSP=(KD+[P]+[L]–sqrt((KD+[P]+[L])
2
-4·[P]·[L]))/(2·[P])·CSPmax, where [L] is 
the concentration of the peptide, [P] is the concentration of PHD, CSP is the measured 
chemical shift perturbation, and CSPmax is the maximum CSP at saturation [101]. The 
adjustable parameters are the maximum CSP (CSPmax) and the dissociation constant (KD). 
These values were determined by fitting of the data to the equation using Prism 
(GraphPad software). CSP was calculated from the equation: CSP 
=sqrt(((H)
2
+(N/5)
2
)*0.5), where H
  
and N are the chemical shift changes in the 
 
1
H and 
15
N resonances, respectively, upon peptide addition. In this thesis KD values were 
simultaneously measured for several residues with large CSP values and are reported as 
the average plus the standard deviation of those measurements. 
 
7.3. Interactions with JADE-1L 
Since the purification of soluble JADE 1L IIb domain was unsuccessful, we designed 
three peptides with overlapping sequences (Table 2) corresponding the region of the 
conserved IIb domain of JADE 1L that interacts with ING4. This sequence was 
RRLQLFTHLRQDLERVRNLTYMVTRREKIKRSVCKVQEQIFNLYTKLLE [139]. 
This strategy pretends to obtain peptides that are more soluble than the IIb domain and, 
perhaps, at least one of them containing all the necessary residues for binding. The 
peptide design was based on distributing the sequence stretches that are more 
hydrophobic (underlined in the sequence above) in three overlapping peptides with 
similar length and with a tyrosine residue to measure concentration by UV absorbance. 
Table 2. Sequences of the overlapping peptides spanning the IIb conserved domain of 
JADE1L protein. Residues underlined correspond to hydrophobic clusters of residues. 
 
name sequence 
A RRLQLFTHLRQDLERVRNLTYMVTRR 
B RQDLERVRNLTYMVTRREKIKRS 
C RREKIKRSVCKVQEQIFNLYTKLLE 
 
The peptides were purchased from Apeptide and were found to be soluble in aqueous 
buffer. The lyophilized peptides were dissolved in water and their concentration was 
measured by absorbance at 280 nm (280= 1490 M
-1
cm
-1
 for all three peptides). From each 
peptide stock solution, a sample of 100 μL at 1.5 mM was prepared and their pH was 
raised to 7.0-8.0 with NaOH before being added to the ING5 Nt sample. 
15
N labeled 
ING5 Nt sample was prepared at 150 µM in 800 µL of 20 mM Tris pH 8.0, 300 mM 
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NaCl, 1 mM DTT. From that stock, 4 different samples of 200 μL of 15N ING5 Nt at 150 
µM were obtained and, to three of them, 100 µL of a different peptide solution were 
added in order to have three different ING5 Nt / peptide (100μM: 500μM) samples of 300 
μL and a reference sample of ING5 Nt at 100μM in 300 μL without peptide. To diminish 
the possible mismatching of buffers, the four samples were dialyzed separately against 50 
mM MOPS pH 7.0, 1 mM DTT o/n @ 4°C in Float-A-Lysers of 100-500 Da cut-off 
membrane (SpectrumLabs). Prior to NMR measurements, 5% D2O and 4 μM DSS were 
added to all the samples and were introduced in 5 mm NMR tubes. 
1
H-
15
N- TROSY 
spectra were recorded for each sample.  
  
7.4.  DNA binding assays 
For the studies on ING4 binding to dsDNA, a titration of increasing amounts of a 
concentrated stock of the DNA (642 µM in 20 mM MES pH 6.5, 100 mM NaCl, 5 mM 
MgCl2 and 1mM DTT) was done into a 25 μM sample of U-
15
N- labeled ING4 in 400 µL 
of the same MES buffer with 5 % 
2
H2O in a 5 mm Shigemi NMR tube. 
1
H-
15
N-HSQC 
spectra were recorded (128 indirect points, 2 h total acquisition time) after each addition. 
To avoid differences in the chemical shifts due to changes in the ionic strength or pH in 
the DNA and protein samples, the oligonucleotides were previously desalted with a PD10 
column (GE Healthcare) into 20 mM MES pH 6.5, 100 mM NaCl, 5 mM MgCl2 and 
1mM DTT, annealed, and concentrated by ultrafiltration (3 kDa cut off), and the protein 
was dialyzed in the same batch of buffer used to prepare the DNA. The oligonucleotides 
used for the NMR experiment did not have any 6-FAM fluorescent probe. TopSpin 
(Bruker) and Sparky [185] were used for NMR data processing and spectral analysis, 
respectively. Dissociation constants were determined by the combined 
1
H and 
15
N CSP 
fitting as described above using Prism (GraphPad software). The 
1
H-
15
N-HSQC spectrum 
for the characterization of 
15
N ING4ΔNLS mutant was measured on a 27 µM sample in 
PBS pH 7.4. 
7.5. Paramagnetic relaxation enhancement  
Paramagnetic relaxation enhancement (PRE) can be employed to probe the structure 
and dynamics of proteins. One of the most used spin label reagent is the MTSL (S-(1-
oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl) methyl methanesulfonothioate). 
This compound is also known as MTSSL, methanethiosulfonate spin label), and serves to 
attach a spin label selectively to cysteine residues via a disulphide bond. The reaction will 
introduce a group at a solvent exposed region of the protein that won’t significantly alter 
the protein structure [186]. MTSL posses an unpaired electron that reduces the intensity 
of NMR signals of atoms in a distance dependent manner, with an approximate distance 
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range of around 20 Å [187]. In this thesis PRE analysis has been used to differentiate 
between two models of the ING5 Nt dimer in solution. 
For these measurements, the solvent exposed cysteine 19 was labeled with the thiol 
reactive MTSL using a modification of a previously described protocol [188].  For that 
purpose the C75S mutant was created to eliminate this other reactive thiol. The Nt1-105 
C75S protein sample was buffer exchanged to 50 mM MOPS pH 7.0 with a desalting 
PD10 column (GE Healthcare) to remove DTT that was present in the purification buffer. 
Sample was then concentrated with an amicon filtering unit of 3K cut off (Millipore) 
until 800 μL at 200μM and divided into two different samples. 1 mM DTT was added to 
one of the samples that we used as “reference” and the other sample was taken for 
labeling reaction. Site-directed spin labeling was achieved by incubating the second 
sample containing 
15
N ING5 Nt1-105 C75S with a 5-fold molar excess of the spin label 
reagent MTSL at 25 °C for 2 h in the absence of light. Prior to the NMR experiment the 
homogeneity of the sample and the presence of MTSL molecule covalently bound to 
15
N 
ING5 Nt1-105 C75S was confirmed by MALDI-TOF (the MTSL molecule increments the 
molecular weight of the polypeptide chain in 186.3 Da). 5% 
2
H2O and 4 µM DSS were 
added to the samples prior to NMR experiments and 
1
H-
15
N-TROSY spectra were 
recorded at 800 MHz and 25 ºC. Spectra were processed with TopSpin (Bruker) and the 
intensity analysis was done using Sparky [185].  
8. Ion mobility coupled to electrospray ionization mass spectrometry (ESI-IM-MS) 
experiments under non denaturing conditions 
 
With the aim of detecting the possible heterodimerization of ING4/ING5, ESI-IM-MS 
experiments under non denaturating conditions were performed. The use of ion mobility 
(IM) experiments coupled to mass spectrometry (MS) allows to differenciate molecules 
according to their charge state (CS), collision cross-section (CCS) and shape by 
measuring mass spectra and drift time distribution of m/z ions continously and 
simultaneously and thus, reflecting on the gas phase conformation of the proteins. This 
joint technique is particularly useful to get insights on the oligomerization state of 
proteins as it has the capability to separate in the gas phase ions of the same m/z, such as 
monomers, dimers, trimers or higher order aggreagates. The technique can be performed 
in experimental conditions which preserve the non covalent protein-protein complexes 
and their conformational ensemble in the gas phase and is therefore a powerful tool for 
the study of macromolecular structures and protein-protein interactions [189]. 
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ESI-IM-MS experiments were conducted on a Synapt HDMS (Waters) quadrupole-
traveling wave IMS-oaTOF mass spectrometer equipped with an Advion TriVersa 
NanoMate (Advion Biosciences). Prior to IM-MS experiments, the samples were buffer 
exchanged to 100 mM Ammonium Acetate (NH4OAc), pH 6.92 and both proteins were 
then incubated o/n @ 37°C at equal molar concentration (85 μM). Before sample 
injection, the samples were further desalted using a Micro Bio-Spin 6 column (Biorad) 
using NH4OAc 100 mM as the exchanging buffer. ESI-IM-MS spectra of ING5 Nt1-105, 
ING4 Nt and the mixture of both proteins were recorded under non denaturing 
instrumental conditions in the positive ion mode.  The Advion source was working in 
direct infusion mode allowing automated chip-based nanoelectrospray. Spray voltage was 
1.75 kV and delivery pressure 0.5 psi. Backing pressure, sampling cone voltage, trap 
collision energy, transfer collision energy, and source temperature were set to 5.83 mbar, 
40 V, 6V, 4 V and 20 °C, respectively. The IM gas flow was kept at 23 mL/min, gas 
pressure in ion mobility cell  at 4.4910-1 mbar and gas flow rate in the trap cell at 5 
mL/min. Wave height and wave velocity in the ion mobility cell were set to 9V and 350 
m·sec
−1
, respectively. External mass calibration was achieved using a cesium iodide 
solution in m/z range of 500 to 8000. Data was acquired and processed with MassLynx 
software v 4.1 (SCN 704). Mass spectra were deconvoluted to the average masses with 
integrated algorithms in Masslynx and IM-MS data was processed with Driftscope 
software vs. 2.4. Individual protein samples gave experimental molecular weights of 
12541.74 ± 4.71 Da for ING5 Nt
1-105
 and 13755.41 ± 2.86 Da for ING4 Nt, in agreement 
with the theoretical values (12545.170 Da and 13754.48 Da respectively, for the 
monomeric proteins). The ING5 Nt1-105:ING4 Nt protein mixture at molar ratio of 1:1 
was used for the analysis of the heterodimer formation. The assignment by mass to the 
heterodimer in the mixture was done based on the observed masses in the independent 
homodimer mixtures (Table 3 ). 
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Table 3. Observed masses in the spectra. 
Deconvoluted 
average masses 
detected 
Assignment 
ING4 Nt sample 
13755.41 ± 2.86 monomer ING4 
27508.17 ± 2.66 homodimer ING4 
41279.66 ± 1.63 homotrimer ING4 
ING5 Nt sample 
12541.74 ± 4.71 monomer ING5 
25087.37 ± 0.91 homodimer ING5 
37632.09 ± 2.70 homotrimer ING5 
50248.53 ± 7.34 homotetramer ING5 
ING4/ING5 sample 
12543.59 ± 2.94   Monomer ING5 
25087.37 ± 5.48 Homodimer ING5 
13755.34 ± 2.38  Monomer ING4 
27508.70 ± 2.23 Homodimer ING4 
26303.02 ± 7.55  Dimer (1:ING4-1:ING5)  
40054.93 ± 5.30  Trimer (2:ING4-1:ING5) 
38848.09 ± 2.19  Trimer (1:ING4-2:ING5) 
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9. Mammalian cell culture and transfection.  
 
Human cell line HEK-293T (embrionic kidney epitelium) and NIH3T3 cells 
(immortalized mouse fibroblasts) were cultured in DMEM (Gibco) all suplemented with 
10% FCS and 1% penicillin/ streptomycin (10.000 U/mL, Gibco) at 37 °C and 5% CO2. 
Cells were passaged when they reached 70-80% confluence at 1:8 dilution with 0.05% 
trypsin. Transfection of 293T and NIH3T3 cells was performed using a standard calcium 
phosphate method after seeding 3 × 10
6 
cells on 10 cm plates. Selection of stable 
transfected NIH3T3 cells was performed at 2 µg/mL puromycin during 2-3 weeks after 
transfection and the antibiotic was mantained on the media at a low dose (0.5 µg/mL).  
 
10. Cell proliferation assay 
 
To evaluate and compare the effect on cell proliferation stably NIH3T3 cells 
expressing ING5 or ING5 mutants were seeded at a density of 900 cells per well in 96-
well plates and incubated overnight.. Cells were rinsed with phosphate buffered saline 
and stained with crystal violet for counting after  0, 24, and 72 hours of proliferation. The 
stain was solubilized in 10% acetic acid after air drying and diluted in water for 
absorbance measurement at 595 nm. 
  
11. Cell Cycle Analysis 
 
To analyze the effect of the overexpression of ING5 and its mutants on cell cycle 
profiles, NIH3T3 cells with stable expression of the corresponding genes were harvested 
prior to confluence from a 6-well plate, fixed with 70% (vol/vol) ethanol, and stored at-
20°C for >12h. Afer ethanol was removed by centrifugation, pellets were resuspended in 
PBS buffer containing 40 µg/mL propidium iodide and 100 µg/mL RNase A and 
incubated for 30 min at room temperature. The DNA contents were measured as the 
propidum iodide signal to determine cell cycle profiles using FACSCanto (BD 
Biosciences) and then analyzed by FACS Diva software. At least 20000 cells were 
analyzed from each sample.  
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12. Immunoprecipitation and Western Blot analyisis 
 
Transiently transfected HEK-293T cells on a 10 cm plate were washed twice with 
PBS, and total cell extracts were prepared by lysis in 1 mL of cold 
radioimmunoprecipitation assay (RIPA) lysis buffer (EMD Millipore) with complete 
mini EDTA-free protease and phosphatase inhibitor cocktail tablets (Roche), 
PhosphoStop (Roche), and 0.1% SDS (Life Technologies), as previously described [190]. 
The lysates were incubated for 10 min on ice and then centrifuged for 12 min at 15,000 g. 
The supernatants were divided into fresh tubes on ice. For inmunoprecipitation, mouse 
monoclonal anti-HA (12CA5 clone, Roche) and mouse monoclonal anti-AU5 (Abcam) 
primary antibodies were used. One μg of the antibody was incubated with 1 mg of the 
lysate for 16 h at 4 °C. Then, 20 μL of BSA blocked agarose-conjugated protein A/G 
beads (Santa cruz) were incubated for 1 h at 4 °C, and after washing 3 times with RIPA 
buffer, samples were probed by Western Blotting. Samples were resolved by 12% SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred onto Protran (Whatman) 
nitrocellulose membranes of 0.45 μm. Nonspecific binding was blocked by 1 h 
incubation with blocking buffer before membranes were probed overnight at 4 °C with 
primary antibodies diluted in blocking buffer (5% milk in Tris-buffered saline without 
tween20). After extensive washing with TBS-T, specific bands were detected on 
Hyperfilm (GE Healthcare) using horseradish peroxidase (HRP)-conjugated goat anti 
mouse Fcγ fragment speciffic secondary antibody (1:10000; Jackson Inmunoresearch) 
and the ECL detection system (Biorad).  
 
13. Immunofluorescence 
 
NIH3T3 cells stably expressing ING5 and its mutants were plated in coverslips in 24-
well plates at a density of 40000 cell per well. Cells were fixed with 4% 
paraformaldehyde in PBS for 20 min at RT, then treated with 0.1% Triton X-100 in PBS 
for 10 min at RT, for membrane permeabilization and incubated for 1 h in blocking 
solution (2% BSA in PBS, 0.01% NaN3, glycine 50 mM). ING5 and mutants  were 
detected with anti-HA (12CA5 clone, Roche). Primary antibody was diluted 1:200 in 
blocking solution. The secondary antibody used was Alexa Fluor 594 antimouse 
(Invitrogen A11005, dilution 1:5000). For the nuclear shape studies of NIH3T3 cells 
stable expressing ING5 and ING5 mutants, Hoechst 33342 (reference H3570, Invitrogen) 
for the nuclei and Phalloidin-Tetramethylrhodamine B isothiocyanate (reference P-1951, 
Sigma) for the citoplasm were used. Washing between the different steps were carried out 
with PBS. Cells were finally mounted on to microscope slides using Vectashield 
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containing DAPI (Vector) in the cases where Hoechst 33342 was not used. Slides were 
examined using a Zeiss Axiimager D1 fluorescence microscope. 
 
14. Fluorescence Electrophoretic Mobility Shift Assay (EMSA) 
 
Oligonucleotides used for the EMSA assays (Table 4) were designed to generate 
single strand (ss), double strand (ds), or primed (p) DNA ligands labeled with (6-
Carboxyfluorescein (6-FAM) at the 5' end. To avoid any quenching effect the dsDNA 
was designed to have two extra bases at the 5’ end. Oligonucleotides were chemically 
synthesized and HPLC-purified by Thermo Scientific or Sigma-Aldrich, and were 
solubilized in Tris-EDTA buffer (10 mM Tris–HCl, pH 7.5, 1 mM EDTA, pH 8.0) to a 
concentration of 100 µM. For the preparation of the different dsDNA ligands 1:1.2 ratio 
of labeled: unlabeled oligonucleotides were mixed and diluted in annealing buffer (50 
mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 mM DTT, pH 
7.9) to the desired final concentration and annealed by incubation in boiling water for 5 
min and slow cooling down to room temperature. EMSA experiments were performed by 
incubating increasing concentrations of ING4, ING5 or their different domains with 
fluorescent DNA ligands at a final concentration of 0.1 µM in a 15 μl reaction mixture 
containing 20 mM Tris-HCl pH 8.0, 5 mM MgCl2, 50 mM NaCl, 2 mM DTT and 0.1 g/L 
BSA. After incubation for 10 min at room temperature, 5% glycerol was added and the 
reaction products were separated on a 6% native polyacrylamide gel run at room 
temperature in cold 0.5 X Tris-Borate-EDTA buffer for 50 min at 80 V. Labeled nucleic 
acid fragments were detected by fluorescence imaging (ImageQuant LAS4000, GE 
Healthcare) and quantification of protein-nucleic acid complexes was performed with 
ImageQuant TL image analysis software (GE Healthcare). The apparent equilibrium 
dissociation constants were determined using a Hill equation [191] with a single-site 
binding model using Prism (GraphPad software) from the mean of three independent 
experiments. 
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Table 4. Oligonucleotides (5´to 3´sequences) used for DNA binding studies. The dsDNA 
substrates with 18 bp, 32, 22, and 10 bp were obtained by annealing oligonucleotides A1 
with B1, A3 with B2, C1 with C2, and D1 with D2, respectively. The pDNA substrate 
contained an 18 bp long dsDNA region and a 12 base long ssDNA region, and was 
obtained by annealing oligonucleotides A2 and B1. The oligonucleotides used for the 
NMR experiment (dsDNA substrates of 32bp and 10bp) did not have any 6 -FAM 
fluorescent probe. 
 
Name Sequence 
A1 TGGCCTGCAGGCATGCAA 
A2 GTCCGTACGTTCTGGCCTGCAGGCATGCAA 
A3 GATGAGATTGAGGCTGGCTGGCCTGCAGGCATGCAA 
B1 6-FAM-GCTTGCATGCCTGCAGGCCA 
B2 6-FAM-GCTTGCATGCCTGCAGGCCAGCCTCAATCTCATC 
C1 GAGTGTGGTGTACATGCACTAC 
C2 6-FAM-GTAGTGCATGTACACCACACTC 
D1 ATACGATGGG 
D2 CCCATCGTAT 
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1. ING5 is a dimer and a bivalent reader of H3K4me3 mark 
 
1.1. Biophysical characterization of ING5 
To study the structural organization of ING5 the domain boundaries were defined 
based on those previously identified for ING4 [102]. ING5 and ING4 share high 
sequence homology and secondary structure predictions give very similar results: a 
conserved N-terminal domain with two long α-helices forming a coiled-coil, a long and 
disordered central region rich in positively charged amino acids that contains the Nuclear 
Localization Signal and is, therefore, named NLS, and a highly conserved C-terminal 
domain folded into a PHD finger [72]. The high sequence identity at the N-terminal 
domain suggests that ING5 will also form dimers as ING4 does. 
 
 
 
Figure 1. ING5 dimerizes in solution through its N-terminal helical domain. (A) SEC-MALS analysis 
of ING5 (black) and Nt (red). The thin line corresponds to the axis on the left and the thick line to axis on 
the right. All data were obtained in 20 mM Tris pH 8.0, 300 mM NaC, 1 mM DTT, at 25 ºC. The exclusion 
volume of the column is 8.7 mL. (B) CD spectra of ING5 (black) and Nt (red) in the same conditions as in 
A. (C) Thermal denaturation of ING5 (black) and Nt (red) in the same buffer as in A. 
 
ING5 has a molar mass of 57 kDa as measured by SEC-MALS (Figure 1A), and this 
is consistent with the theoretical calculated mass of a dimer (60 kDa). However, the 
elution volume of ING5 is smaller than the expected one for a dimer, indicating that 
ING5 has an elongated shape and/or large regions that are flexible and disordered [192]. 
In both situations, a protein with these characteristics will elute at a smaller volume than 
a globular protein of the same mass. 
The circular dichroism spectrum of ING5 shows two minima at 209 and 223 nm and a 
positive ellipticity below 200 nm, which is indicative of a high content of helical 
structure (Figure 1B). The low absolute ellipticity indicates, however, that a large part of 
the chain is not helical. The N-terminal domain of ING5 (ING51-105, hereafter named Nt) 
is also a dimer (Figure 1A) with a measured molar mass of 23 kDa (the theoretical 
calculated molar mass of the ING5 Nt dimer is 25 kDa). Both ING5 and the Nt domain 
show cooperative thermal denaturations, with similar midpoint melting temperatures (43 
and 45 ºC, respectively), indicating the presence of a defined tertiary fold for both 
proteins (Figure 1C). The denaturation is, however, more cooperative in the case of the 
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isolated Nt domain. The presence of different structural regions in ING5 is probably the 
reason for the apparent less cooperative thermal denaturation. The thermal denaturation 
of ING5 is irreversible, with all the protein precipitated in the cuvette, while the 
denaturation of the Nt domain is mostly reversible. The shape of the Nt spectrum at 25 ºC 
is recovered after renaturation by cooling down, with a small loss of signal intensity due 
to partial protein precipitation (about 15 %). 
The 
1
H-
15
N HSQC spectrum of the 60 kDa ING5 dimer is similar to that of ING4 
(Figure 2) [102]. It shows a similar pattern of a set of sharp and dispersed backbone 
amide resonances corresponding to the PHD finger (Figure 4B) and a few non-dispersed 
resonances in the 
1
H dimension (Figure 2). The small number of non-dispersed signals in 
the spectrum of ING5 is likely due to the higher pH (necessary to have it in soluble 
form), which increases the rate of exchange with the solvent of the disordered regions. 
The observation of a single set of resonances for the two PHD fingers of the dimer 
indicates that they are independent and chemically equivalent. Altogether these results 
suggest that the structural organization of ING5 is very similar to that of ING4: an N-
terminal dimeric coiled coil domain and a C-terminal PHD connected by a flexible NLS 
segment, the three regions being structurally independent with no interactions among 
them. 
 
 
Figure 2.  Structure of ING5 in solution. Superposition of 
1
H-
15
N HSQC spectra of ING5 (red) and ING4 
(black) at 25 ºC and 800 MHz. The dispersed signals belong to the PHD and there is only one set of PHD 
signals. Therefore ING5 structure is similar to ING4, a dimer with a disordered NLS domain and two PHD 
fingers chemically equivalent. The spectrum of ING5 was obtained on an 11 µM sample in 20 mM Tris pH 
8.0, 300 mM NaC, 1 mM DTT. The spectrum of ING4 was measured on a 30 µM sample in 20 mM sodium 
phosphate pH 6.5, 50 mM NaCl.  
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1.2. ING5 binds H3K4me3 
 
The binding of ING5 to H3K4me3 peptide was examined in solution by NMR as 
previously done for ING4 [102]. Due to the low solubility of ING5, we had to use 
different buffer conditions than those used for ING4 (pH 8.0 and 300 mM NaCl, while it 
was pH 6.5 and 200 mM NaCl in the ING4 sample). We measured the chemical shift 
perturbations (CSP) caused on ING5 signals upon binding to increasing concentrations of 
the peptide (Figure 3A). During the titration, many dispersed signals, corresponding to 
those of the PHD domain, suffered a CSP until the binding reaction reached the 
saturation point. Although the majority of the signals can be observed in all titration 
points, there are a few whose intensities are strongly reduced at intermediate titration 
points (Figure 3B). 
 
 
Figure 3. A. ING5 binding to
 
H3K4me3. (A) Superposition of eight 
1
H-
15
N-HSQC spectra of  
15
N ING5 
at 11 μM in 450 μL of 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT, 3% D2O , 0.01% NaN3 and 4 µM 
DSS in the presence of increasing amounts of histone H3K4me3 peptide at 25 ºC. Each point of the 
titration is shown with a different color, from 1:0 (in black) to 1:12 (in red).  (B) Zoom of the framed region 
in A with some of the signals suffering chemical shift perturbations upon the addition of increasing 
amounts of histone H3K4me3 peptide. (C) Chemical shift perturbation of the eight signals that shift the 
most (CSP higher than the average plus one standard deviation). Each dot represents a point along the 
titration and the line the fitting to a model of one set of binding sites. The numbers on the right correspond 
to the individual residues, and the dissociation constant (KD) is the average of the values calculated for 
them with the standard deviation. The error in the CSP measurement is estimated to be ± 0.006 ppm. 
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For the analysis of the data, the CSP were plotted versus ING5:H3K4me3 ratios 
(Figure 3C) and the curves were fitted to a model of one set of binding sites, as described 
in the methods section. The dissociation constant was calculated as an average of the 
eight values obtained from the fitting of eight different signals whose CSP were higher 
than the average plus the standard deviation (Figure 3C). ING5 binds H3K4me3 with a 
KD = 7.3 ± 2.6 μM, a value that is around 3 times higher that the KD measured previously 
[86] for the isolated ING5 PHD finger (KD = 2.4 ±1.0 μM by fluorescence). We have to 
take into account the differences in the experimental conditions and the used techniques. 
In addition, the peptide used in the NMR titration is a bit longer (residue 1-15 instead of 
1-12) and contains a tyrosine residue at the C-terminus to measure the concentration with 
high precision (the peptide used by Champagne et al. 2008 [86] does not contain any 
tyrosine or tryptophan and no information on how the concentration was measured is 
available). The affinity of ING5 for H3K4me3 is on the same order that measured for the 
isolated PHD and full length ING4 by NMR (3.9 ± 1.0 µM and 1.3 ± 1.0 µM, 
respectively), considering the errors and the different buffers used [85] [102]. 
 
 
2. The C-terminal PHD finger of ING5 recognises H3K4me3 
 
The crystal structure of the isolated ING5 PHD finger has been previously reported 
bound to an H3K4me3 peptide [86], and consists of the canonical PHD fold, with its 
characteristic C4HC3 zinc finger motif. We have analyzed the structure of the PHD in 
solution by MALS and NMR and found that it is a monomeric protein (Figure 4A) with 
a 
1
H-
15
N NMR spectrum (Figure 4B) very similar to the set of dispersed signals in the 
spectrum of ING5 (Figure 2 and 3A). After assignment of the backbone resonances of 
the isolated PHD it was found that for 83% of the backbone amide signals of the PHD, 
the 
1
H and 
15
N resonance frequencies closely match with those of a corresponding 
signal in the spectrum of full-length ING5 (chemical shift deviations < 0.065 ppm). 
This result indicates that the Nt and the PHD are independent and non-interacting 
domains linked by a flexible NLS segment. 
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Figure 4. (A) SEC-MALS of the PHD finger of ING5 at 25 ºC in 20 mM Tris pH 8.0, 300 mM NaCl, 0.5 
mM TCEP. The thin line corresponds to the axis on the left and the thick line to the axis on the right. (B) 
1
H-
15
N-HSQC spectrum of the ING5 PHD finger with backbone amide signal assignment. The spectrum 
was recorded at 25 ºC and the ING5 PHD sample was prepared at 220 μM in 20 mM Tris pH 8.0, 300 mM 
NaCl, 1 mM DTT, 5% 
2
H2O, 44 µM DSS (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt) and 
protease inhibitors. The signals labeled with “f” are folded in the 15N dimension and their real chemical 
shift is 18.5 ppm smaller. Non assigned peaks correspond to side chain NH resonances. 
 
We have analyzed by NMR, as it was done for full length ING5, the binding of the 
isolated ING5 PHD finger to an H3K4me3 peptide (Figure 5), and mapped the binding 
site (Figure 6). Many of the assigned dispersed signals of ING5 PHD exhibit chemical 
shift perturbations upon addition of H3K4me3 peptide which mimic those observed with 
the full length protein (Figure 5A, B). The titration curves obtained for H3K4me3 
peptide are shown in Figure 5C, together with the calculated dissociation constant (KD). 
The KD was calculated as an average of the ten values from the fitting of those different 
signals whose CSP were higher than the average plus one standard deviation (Figure 
5C). This calculation yields a dissociation constant of KD =17.9 ± 2.5 µM at 25 ºC 
(average and standard deviation; Figure 5C). This value is about two-fold larger than the 
measured for full length ING5 (KD = 7.3 ± 2.6 μM), perhaps due to the loss of avidity in 
the isolated PHD as compared with the ING5 dimer. 
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Figure 5.  A. ING5 PHD binding to
 
H3K4me3. (A) Superposition of eight 
1
H-
15
N-HSQC spectra of  
15
N 
PHD of ING5 at 10 μM in 500 μL of 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT, 3% D2O , 0.01% 
NaN3 and 4 µM DSS in the presence of increasing amounts of histone H3K4me3 peptide at 25 ºC. Each 
point of the titration is shown with a different color, from 1:0 (in black) to 1:12 (in red). (B) Zoom of the 
framed region in A with some of the signals suffering chemical shift perturbations upon the addition of 
increasing amounts of histone H3K4me3 peptide. (C) Chemical shift perturbation of the signals that shift 
the most. Each dot represents a point along the titration and the line is the fitting to a model of one set of 
binding sites. The dissociation constant (KD) is the average of the calculated values plus one standard 
deviation.  
 
The CSP measured in the presence of a 12 molar excess of peptide is represented for 
each PHD residue in Figure 6A and on the surface of the crystal structure of the PHD in 
Figure 6B. There are many residues that experience large perturbations in their chemical 
shifts, indicating a large interaction surface. There is a strong similarity with the pattern 
of changes experienced by ING4 PHD [101], indicating that the binding mode in solution 
is similar in both proteins (as suggested by the crystal structures), and that the differences 
in the calculated KD, are mostly due to the different experimental conditions and methods 
used. 
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Figure 6. ING5 PHD CSP mapping and comparison with the crystal structure of the complex with a 
histone H3K4me3 peptide. (A) Binding histograms showing the CSP observed for each residue in the 
1
H-
15
N HSQC spectrum of ING5 PHD in the presence of 1:12 excess H3K4me3 peptide. The dashed line 
represents the average plus one standard deviation. The experimental error in the CSP is estimated to be 
0.006 ppm. (B) Surface representation of the ING5 PHD finger (in light cyan). Those residues with a CSP 
upon binding to peptide H3K4me3 larger than the average plus one standard deviation (182, 188, 189, 194, 
195, 209, 210, 211, 213, 227) are highlighted in orange, and those with a CSP larger than the average (190, 
197, 200, 201, 212, 214, 215) in magenta.  
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3. DNA binding of ING4 and ING5 through the NLS disordered central region. 
 
 
 
Figure 7. The NLS region of ING4 and other ING proteins. (A) Schematic representation of the domain 
structure of human ING4 dimer: in green the N-terminal coiled-coil domain responsible for the antiparallel 
dimerization, in blue the PHD domain responsible for binding to the histone H3 tail, and in magenta the 
connecting region containing the NLS. Below the scheme are the crystal structures of a dimer of the N-
terminal domain [103] (PDB ID: 4AFL) and the PHD finger [85] (PDB ID: 2VNF). The NLS region was 
randomly built to connect the two domains, and the positions of lysine and arginine residues are indicated 
by red spheres. One of the two ING4 protomers is represented with paler colors than the other one. (B) 
Sequence alignment of the NLS regions of the ING proteins. The alignment was done with CLUSTAL W 
using the longest isoforms of the proteins (except ING1, for which p33ING1b isoform was used). The 
sequences shown correspond to the limits of ING4 NLS region as defined in A (starting at residue 106). 
The asterisk in the sequence of ING3 indicates that a long insertion (residues 112-266) is omitted for the 
sake of clarity. 
 
ING4 can be described as an elongated dimer with two PHD fingers pointing to 
opposite directions and tethered by a disordered central region approximately 85 residues 
long (Figure 7A) [102, 103]. This central region is rich in basic amino acids (Figure 7B) 
and contains the nuclear localization signal, and is commonly named the NLS region. 
Previously in the lab, it was found that human ING4 produced in bacterial cells co-
purifies with DNA (as seen by ultraviolet absorbance and native PAGE stained for 
protein or DNA), pointing to a stable interaction with DNA. This observation prompted 
us to identify the ING4 domains involved in the interaction as well as the binding 
determinants regarding structure and length of the DNA molecule [193] (Appendix IV). 
ING4 was shown to bind weakly to an 18 bp DNA duplex (dsDNA18) and the binding 
was enhanced when the longer dsDNA32 substrate was used (Figure 8). We could not 
detect any binding for the isolated N-terminal or PHD domains so these results point to 
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the central region as the binding site for the DNA. This was confirmed by the deletion 
mutant ING4ΔNLS not binding to any of the two dsDNAs (Figure 8). This mutant lacks 
residues 106-187, which encompass most of the central NLS region connecting the two 
folded domains of ING4. Biophysical characterization of the mutant shows a symmetric 
dimer with predominantly helical coiled-coil structure and C-terminal PHD fingers, as 
seen by SEC-MALS and CD (Figure 9). 
 
 
Figure 8. Titration of dsDNA32 (top) and dsDNA18 (bottom) with increasing amounts of ING4 
proteins and monitoring complex formation by EMSA. The concentration of DNA was 0.1 μM and 
the protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1 and 2 μM. 
 
An avidity effect was expected since ING4 is a dimer with two DNA binding sites and 
the long dsDNA32 can reach both sites independently in a way that binding to the first 
site will increase the likelihood for the second interaction to occur. The dimeric nature of 
ING4 makes it also possible that the long dsDNA32 binds more than one ING4 dimer, 
giving rise to multiple modalities of binding seen at high protein concentrations in Figure 
8. 
 
 
 
Figure 9.  Biophysical characterization of mutant ING4ΔNLS. (A) SEC-MALS analysis of the 
molecule. The molar mass at the centre of the chromatography peak is 40.7 kDa. The value calculated from 
the amino acid composition of the monomer is 19.5 kDa, indicating that the protein forms a dimer. (B) 
Secondary structure by far-UV circular dichroism. The ratio of the ellipticity at 222 and 208 nm is larger 
than 1, suggesting that it contains a large proportion of coiled coil structure. (C) Tertiary structure analysis 
by thermal denaturation followed by the change in the CD signal at 222 nm, showing a midpoint melting 
temperature of 45 ºC. 
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As an approach for quantifying and interpreting the affinity of the interaction we fitted 
the data to the Hill equation [191] and calculated an apparent dissociation constant of KD 
= 0.6 ± 0.03 μM (Figure 10). ING4 also binds to single stranded DNA molecules 
(Figure 11), but more weakly than it binds the corresponding duplexes (Figure 8). ING4 
also binds to a primed DNA (Figure 11), but not as strongly as to dsDNA32. All these 
results indicate that ING4 has a preference for double strand DNA binding. 
 
 
Figure 10. Quantitative analysis by gel densitometry of the binding of ING4 to fluorescent dsDNA32 
measured by EMSA. The symbols and error bars are the mean and standard deviations of three 
independent experiments. The gel shown on the right corresponds to one of these three experiments. The 
curves are the fitting to a Hill equation corresponding to a single-site binding model as implemented in 
Prism (GraphPad software). The apparent equilibrium dissociation constant (KD) and cooperativity (n) are 
indicated. 
 
 
Figure 11. Titration of fluorescent DNA molecules with increasing amounts of ING4 and monitoring 
complex formation by EMSA. From left to right: 20 base-long ssDNA, 34 base-long ssDNA, and the 
corresponding primed DNA. The concentration of DNA was 0.1 μM in the three experiments, and the 
protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1 and 2 μM. A scheme of 
the structure of the DNA probe used is drawn at the right hand side of the gels, with the asterisk indicating 
the position of the fluorescent tag. 
 
We used NMR to observe the interaction of ING4 with the dsDNA32 directly in 
solution (Figure 12) as a complementary experiment to EMSA. We can use this 
technique to do so because, although ING4 has a large size (it is a 55 kDa dimer), most of 
the signals observed at 25 ºC belong either to the small PHD finger, which has been 
specifically assigned [101], or to the central disordered region. The size and shape of the 
dimeric N-terminal domain make its NMR signals mostly unobservable unless the 
concentration and the temperature are increased [102], so this will help in identifying the 
signals to residues of the NLS region. In the experiment we measured the chemical shift 
perturbations (CSP) caused on ING4 signals upon binding to increasing concentrations of 
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the dsDNA32 (Figure 12A). Along the titration, the backbone amide signals that 
experience CSPs are in the central region of the proton frequency dimension (Figure 
12A).  
 
 
 
 
Figure 12. NMR analysis of the ING4-dsDNA32 interaction. (A) Overlay of NMR spectra of ING4 in 
the presence of increasing amounts of dsDNA32 as indicated by the color code (molar ratio ING4 
protomer:dsDNA32). The concentration of the sample was 25 μM in 20 mM MES pH 6.5, 100 mM NaCl, 5 
mM MgCl2, 1 mM DTT. Spectra were recorded at 25 ºC. The signals labeled with “f” are folded in the 
15
N 
dimension and their real chemical shift is 18.5 ppm smaller. The dashed rectangle indicates the region 
expanded in panel B. (B) Zoom of the overlaid NMR spectra of ING4 shown in panel A, which contains 
the backbone amide signals of 5 residues tentatively assigned to the 5 glycine residues of the NLS region, 
three of them experiencing large CSP in the presence of saturating amounts of dsDNA32. (C) Plot of the 
CSP of the thirteen ING4 backbone amide signals with values larger than 0.015 ppm. The lines correspond 
to the fittings to a one site binding model, and yield dissociation constants in the 0.6-3.8 μM range. 
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It is important to mention that in this region of the NMR spectrum of ING4 there are 5 
signals that are absent in the spectrum of ING4ΔNLS and that have 15N chemical shifts 
typical of glycine residues (Figure 13). We tentatively assigned these signals to 5 glycine 
residues that are present in the NLS region of ING4 (Figure 7B). Three of them 
experience relatively large shifts and the other two shift very little (Figure 12B). This is 
consistent with three of the NLS glycines being located close to lysine and arginine 
residue clusters in the central region of the NLS and two of the glycines being in the C-
terminal end of the NLS, with no positively charged residues in their vicinity (Figure 
7B).  
 
 
 
 
Figure 13. NMR spectrum of ING4∆NLS. Superposition of 1H-15N HSQC spectra of ING4 (in MES pH 
6.5) and ING4∆NLS (in PBS pH 7.0) at 25 ºC showing dispersed (PHD finger) and non-dispersed (other 
parts of the protein) signals in the proton dimension. Framed signals correspond to the 5 glycine residues 
present in the NLS region of ING4 that are absent in ING4∆NLS. The signals labelled with “f” are folded 
in the 
15
N dimension and their real chemical shift is 18.5 ppm smaller.  
 
For ratios above 1:2 (ING4 protomer:dsDNA32) the calculated CSP reached a plateau 
(Figure 12C). Since the stoichiometry of the complex is unknown, data from 13 signals 
experiencing the largest changes upon de addition of dsDNA32 was fitted to a simple one 
site binding model (one DNA duplex bound to one ING4 protomer) and apparent 
dissociation constants were calculated to be in the 0.6 – 3.8 μM range. These numbers are 
only indicative of a low micromolar apparent affinity, similar to the value derived from 
the EMSA for the same DNA molecule. Even at high ratios the CSP are small indicating 
that in the DNA-bound form the backbone of the NLS region remains, at least partially, 
disordered. This observation is consistent with a weak binding based on electrostatic 
interactions, mediated by the positively charged side chains of the NLS and the phosphate 
backbone of the DNA, as has been reported for other disordered proteins rich in 
positively charged residues [194].  
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Our results indicate that the interaction is electrostatic, favoring long duplexes and not 
particular nucleotide sequences. Experimental data with dsDNA substrates with different 
sequence and lengths is in agreement with this conclusion. A 22 bp duplex with an 
unrelated sequence binds ING4 but more weakly than dsDNA32 (Figure 14), and a short 
10 bp duplex still binds to ING4 but much more weakly (Figure 15). Therefore, the 
major determinant of DNA binding is not the nucleotide sequence but the length of the 
duplex; although we cannot exclude that there may be certain sequence preferences. 
 
Our findings on ING4 [193] can be probably extrapolated to ING5 and other ING 
proteins, because an alignment of their NLS regions shows several clusters of positively 
charged residues (Figure 7B), perhaps with the exception of ING3 whose central region 
has much less positively charged residues than the others [68, 72].  
 
Figure 14. Titration of dsDNA22 with increasing amounts of ING4 protein and monitoring complex 
formation by EMSA. The concentration of DNA was 0.1 μM and the protein concentration was (lanes 
from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1 and 2 μM. 
 
 
 
Figure 15. NMR analysis of the ING4-dsDNA10 interaction. (Left) Zoom of the overlaid NMR spectra 
of ING4 in the presence of the indicated molar ratios of dsDNA10, with the same backbone amide signals 
shown in figure 12B. (Right) Plot of the CSP of the six ING4 backbone amide signals with values larger 
than 0.005 ppm. The lines correspond to the fittings to a one site binding model, and yield dissociation 
constants in the 17-58 μM range. 
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ING5 binds dsDNA32 substrate as seen by EMSA (Figure 16); however, the binding 
is weaker than in the case of ING4 (Figure 8). The weak binding makes it difficult to 
quantify and interpret the affinity of the interaction from EMSA experiments. An attempt 
to do so using a Hill equation [191] yields an apparent dissociation constant of 1.18 ± 
0.37 μM (Figure 16) that is in the same micromolar range as the calculated for ING4 
with the same substrate. We could not detect any binding for the isolated N-terminal or 
PHD domains so these results point to the central region of ING5 as the binding site for 
the DNA as it happens for ING4 [193]. ING5 also binds to a single stranded DNA 
molecule 32 nucleotides long (Figure 16, Bottom panel), but even more weakly than it 
binds the corresponding duplexes. 
 
Figure 16. EMSA analysis of the ING5-DNA interaction. Top panels: titration of dsDNA32 with 
increasing amounts of ING5 proteins and monitoring complex formation by EMSA. The concentration of 
DNA was 0.1 μM and the protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1 
and 2 μM. Bottom left panel: titration of ssDNA32 with increasing amounts of ING5 (same concentration 
as in the top panels). Bottom right panel: quantitative analysis by gel densitometry of the binding of ING5 
to fluorescent dsDNA32 measured by EMSA. The symbols and error bars are the mean and standard 
deviations of three independent experiments. 
 
4. The Nt domain of ING5 forms a symmetric coiled-coil dimer 
 
The N-t 1-105 domain of ING5 (hereafter named Nt1-105 or Nt domain) presents a 
helical pattern in the circular dichroism spectrum that is more pronounced than that of the 
full length protein (Figure 1B), with an ellipticity ratio [Θ]222nm/[Θ]208nm > 1, typical of 
coiled-coil structures [195]. This secondary and tertiary structure would be consistent 
with both the asymmetric crystal structure [121] and with the symmetric model based on 
the homologous ING4 Nt [103]. 
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4.1. Nt domain backbone NMR assignment 
 
 In the NMR spectrum of ING5 most of the signals corresponding to the N-t domain 
can´t be observed due to the low solubility of the full length protein. However, the higher 
solubility of the isolated Nt domain allows the observation of 93 backbone amide signals 
in the 
1
H-
15
N correlation spectrum, which could be assigned to specific residues (Figure 
17A). Although there are 10 residues for which no amide signal was detected (excluding 
the two extra residues at the N-terminus), the observation of a single set of resonances 
(only one signal is observed for each residue) indicates that the dimer is symmetric. This 
result is inconsistent with the crystal structure of ING5 Nt because an asymmetric dimer 
would result in two sets of signals for each residue (due to their different chemical 
environment). 
Because the crystal of the ING5 Nt domain was obtained at pH 6.5 (lower than the 
NMR experiments, recorded at pH 7.3) we examined the spectra of the protein behaviour 
of the protein at different pH values to confirm that no major conformational changes 
occur at pH 6.5. As can be seen in Figure 18, the spectra in the range pH 7.9-6.6 are 
essentially the same (Figure 17A). At lower pH values the protein precipitated and the 
quality of the spectrum is very poor. However, the absence of two sets of signals at pH 
6.6 indicates that there is no asymmetric conformation in solution at this pH. 
The symmetric nature of the dimer in solution is, however, consistent with a structure 
similar to that of the N-terminal domain of ING4, which forms a symmetric dimer with 
an antiparallel coiled coil fold based on two long helices named α2 (17-52) and α3 (58-
103). Chemical shift analysis of the ING5 Nt residues shows two long helices spanning 
residues 18-54 and 58-100 (Figure 17B). Residues at the N-terminus (1-5) and at the C-
terminus (100-105) show systematically small heteronuclear {
1
H}-
15
N NOE values (< 
0.62) indicating flexibility on ps to ns times scales (Figure 17C).The N-terminal 6 
residues of ING5 Nt are flexible and disordered as indicated also by their chemical shifts 
(Figure 17 B), and for several of the following residues the NMR signal could not be 
observed. Therefore, the presence of the short N-terminal α1 helix between residues 0 
and 11 seen in the crystal structure of ING5 Nt could not be confirmed by NMR. The 
NMR data on ING5 suggests that this segment may be involved in conformational 
exchange equilibria that cause some of the NMR signals to become non-detectable. The 
determination of the 3D structure by NMR was precluded (or would be very difficult to 
achieve) by the low sensitivity of the NMR experiments (because of its size, helical 
structure and elongated shape). Therefore we tried to confirm by other strategies which 
was the best representative model of the structure of ING5 Nt in solution. 
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Figure 17.  Structural analysis of ING5 Nt in solution by NMR. (A)
 1
H-
15
N-TROSY NMR spectrum of 
ING5 Nt at 25 ºC  and 364 μM protein concentration in 300 μL of 50 mM MOPS pH 7.3, 5% D2O, 3μM 
DSS, 0.01% NaN3 and 0.5 mg of protease inhibitors. (B) Secondary structure analysis of ING5 Nt from 
backbone resonances chemical shift analysis and comparison with the crystal structure of both ING5 and 
ING4 Nt (see below). The black boxes indicate helical regions; the grey boxes coil regions and white boxes 
residues for which there is no NMR data. The calculated RCI is represented as a red line and the calculated 
heteronuclear NOE as black dots, with experimental error bars derived from the noise level in the two 
spectra used to measure the NOE. 
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Figure 18. Spectra of ING5 Nt at different pH values. Superposition of five 
1
H-
15
N-TROSY spectra of  
15N ING5 Nt at 180 μM in 400 μL 50 mM MOPS at the indicated pH values, with, 1 mM DTT, 5% D2O, 
3μM DSS and 0.5 mg of protease inhibitors.  
 
4.2. Paramagnetic relaxation effects 
 
The Nt domain of ING5 possesses two cysteine residues (C19 and C75) that we could 
label with the paramagnetic tag MTSL to confirm the structural organization of the ING5 
dimer in solution by means of NMR paramagnetic relaxation effects (PREs). One of them 
(C19) is solvent exposed in both the crystal structure (asymmetric dimer) and the model 
based on the ING4 Nt structure (symmetric dimer). Therefore this is an adequate site to 
introduce a paramagnetic tag like MTSL and measure paramagnetic relaxation 
enhancements.  The cysteine C75 is, however, partially buried (asymmetric model) or 
buried (symmetric model), and is not a suitable site for introducing the MTSL probe. 
Therefore, we generated the C75S mutant and labeled the only remaining cysteine 
residue (C19) with MTSL. The analysis of these experiments is shown in Figure 19. The 
pattern of signals in the 
1
H-
15
N-TROSY spectrum in the C75S mutant (Figure 19A) is 
very similar to the wild type and most of the assignments could be transferred by 
comparison of the two spectra. In the C19-MTSL labeled sample many signals 
experience large changes in intensity and/or chemical shift perturbation. The ratio of the 
intensities measured in the paramagnetic (MTSL labeled) and diamagnetic (non-labeled) 
samples are plotted in Figure 19B. The 40% of the residues whose intensities are reduced 
the most (to less than 53 %) together with the residues showing the largest CSP (larger 
than the average plus two standard deviations, Figure 19C) are mapped on the structure 
of ING5 Nt in Figure 19D and 19E). The pattern of residues whose NMR signals change 
the most in the MTSL-labeled sample is more consistent with a symmetric (Figure 19D) 
dimer than with an asymmetric one (Figure 19E). 
 82  Results 
 
 
 
  
 
  
  Results   83 
4.3. Structural analysis of ING5 Nt three mutants designed to clarify the 
structural nature of the domain. 
The crystallographic structure of the ING5 Nt domain [121] showed a dimer in which 
each protomer is folded into a helix-loop-helix structure with two long helices plus a 
short 1 helix at the N-terminus. This secondary structure is similar to that of the crystal 
structure of ING4 Nt. However, the crystal structure the ING5 Nt domain showed a 
completely different dimerization interface, being an asymmetric dimer while ING4 
forms a symmetric dimer (Figure 20A). There is a clear asymmetry between protomers 
in the dimer  and a “closed” and an “opened” conformations can be observed for each one 
depending on the relative position of helix 1 with respect to the other two (Figure 20B). 
This asymmetry in the ING5 Nt crystal structure is inconsistent with the obtained NMR 
results and previous results on ING4 N-terminal crystal structure [103].  
One possible explanation for the inconsistency is that the presence of two extra 
residues at the N-terminus favors interactions that, in the crystal conduct to the formation 
of a dimer of asymmetric dimers (Figure 20C). In this arrangement the 1 helices of one 
dimer pack against the 1 helices of the other dimer, with several polar and apolar 
interactions stabilizing the assembly, as shown in Figure 20D. Indeed, the amine group 
of the extra residue G-1 of the open protomer of one of the dimers forms a salt bridge 
with the side chain of residue E8 in the helix 1 in the closed protomer of the other 
dimer. 
At the same time, E8 forms an H-bond with the backbone amide of residue M1 of 
helix 1 in the open protomer. The E82 residue acts as an N-cap of the first turn of 1 
[196]. The same thing happens with residue D101 in 3 of the open protomer, which 
forms a salt bridge with the amine group of G-1 in the closed protomer of the other dimer 
and H-bonds with the backbone amides of M1 and A2 of this same closed protomer 
(Figure 20E). This arrangement of a dimer of dimers in the crystal is predicted by the 
PISA server to be an assembly in solution even more stable than the dimer. However in 
solution we have determined by SEC-MALS that the protein is a dimer (Figure 1). 
___________________________________________________________________________________ 
 
Figure 19. Paramagnetic relaxation effects on ING5 Nt C75S labeled with MTSL at residue C19. (A) 
Superposition of 
1
H-
15
N TROSY spectra of paramagnetic (MTSL-labeled, colored red) and diamagnetic 
(non-labeled, black) 
15
N ING5 Nt. (B) Intensity analysis of the signals measured in the spectra shown in A. 
The percentile 40 (separating 40 % of the most perturbed residues) is represented by the dashed line. (C) 
CSP measured for each residue in the presence of MTSL label. The value for the average plus 2 standard 
deviations is represented by de dashed line. (D) The ribbon of the structure modeled on the crystal structure 
of the ING4 homolog or (E) modeled on the crystal structure of the WT is shown in blue. Those residues 
experiencing the largest PREs or CSP values are in magenta, non perturbed residues in blue, and residues 
for which no data is available are in white. Ninety possible conformations of the MTSL spin label are 
represented by green lines (except the oxygen, as a small red sphere) and were calculated with the Pymol 
plugin MtsslWizard [197]. Large gray translucent spheres with a 10 Å radius, and centered at the cysteine 
sulfur atom, are shown as a visual guide for the proximity to MTSL.  
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Another possibility is that the close contact of C19 side chain of one ING5 molecule 
and the corresponding C19 side chain of a symmetry related molecule stabilizes the 
asymmetric dimer. In fact, the refinement of the structure provided two alternative 
orientations for C19 (with 70-30% occupancy) in the major one with the geometry of an 
intermolecular disulfide bridge (Figure 21A). A third possibility could be that the 
“closed” and the “open” conformations are determined by different conformations of the 
flexible helix 1 resulting in both kind of protomers being selected in the crystal in the 
form of an asymmetric dimer. To investigate the source of the inconsistency between the 
crystal and solution results we examined three mutants: an N-terminal mutant that lacks 
the two extra residues coming from the cloning procedure (ING52-105), the point mutant 
C19S and a Δα1 mutant lacking part of the flexible Nt α-helix. 
 
Figure 20.  Crystal structure of ING5 Nt. (A) View of the ING5 Nt homodimer in the asymmetric unit of 
the crystal. The two protomers are shown as ribbons with orange (open) and blue (closed) color. The three 
helices from each protomer are indicated in the open protomer. (B) Superposition of the two protomers of 
ING5. (C) Ribbon diagram of the tetrameric assembly in the crystal of ING5 Nt identified by PISA 
analysis. The tetramer is formed by two asymmetric units, with the chains of the second unit indicated with 
paler colors. (D) Zoom of the framed area in C showing interactions between residues G-1 and M1 in helix 
α1 from an open protomer with residue E8 in the helix α1 of a closed protomer of another dimer in the 
tetrameric assembly. (E) Zoom of the framed area in C showing interactions between residues G-1, M1 and 
A2 in helix α1 from a closed protomer with residue D101 in the helix α3 of an open protomer of another 
dimer in the tetrameric assembly. 
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Figure 21. Close view of residue 19 side chain of ING5 Nt and C19S mutant. (A) Partial intermolecular 
disulfide bridge in ING5 Nt. Density map 2Fo-Fc (grey mesh drawn at 1.5 ). (B) The same region as in A 
corresponding to the C19S mutant. Density map 2Fo-Fc (grey mesh drawn at 1.5 ). (C) Superposition of 
the tetramers of the wild type and the C19S mutant (on one of the open protomers) showing that the 
assembly is not identical in the two crystals. The side chains of the two C19 involved in the disulfide bridge 
and the corresponding S19 side chains are shown in sticks. In the case of C19 the two alternative 
conformations are shown. 
 
The three mutants formed dimers in solution with coiled coil structure, as seen by CD 
and SEC-MALS (Figure 22). 
The NMR spectrum of the ING52-105 construct is very similar to that of Nt, with most 
of the differences at signals close to the N-terminal residues (Figure 23). This result 
demonstrates that in solution there is no difference in the structure of the two constructs, 
both adopting a symmetric coiled coil dimer. However, this protein did not crystallize, 
indicating that the presence of two extra residues in the N-terminus favored 
crystallization and, perhaps, the formation of an asymmetric dimer and the tetrameric 
assembly suggested by PISA in the crystal lattice. 
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Figure 22. Structural analysis of three ING5 Nt mutants. CD (top panels) and SEC-MALS (bottom 
panels) analysis of ING5 Nt2-105 , Nt C19S, and Δα1 mutant. Data were measured at 25 ºC in 20 mM Tris 
pH 8.0, 300 mM NaCl, 1 mM DTT. 
 
 
Figure 23. 
1
H-
15
N-TROSY NMR spectrum of the ING5 Nt2-105 (red) overlaid on the spectrum of ING5 
Nt1-105 (black). Both spectra were recorded at 25 ºC in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT. For 
the sake of clarity only the N-terminal first four residues are labeled.  
 
Crystallization trials with the Δα1 mutant yielded crystals (Figure 6A in the materials 
and methods section) that diffracted at a very low resolution (5.09 Å or lower) so they 
were not suitable for solving the structure of this mutant (Figure 6B in the materials and 
methods section). 
Crystallization trials of ING5 Nt C19S yielded crystals (Figure 5E-F in the materials 
and methods section) that after optimization were suitable for X-ray diffraction and data 
collection at 3.1 Å resolution (Figure 6A in the materials and methods section). The 
structure was solved by molecular replacement using the crystal structure of ING5 Nt and 
refined to Rwork of 21.5 % and Rfree of 25.4 %. A summary of the crystallographic data 
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statistics is shown in Table 1. Although the C19S mutant formed crystals in slightly 
different conditions than Nt (pH 7.5 instead of 6.5), the structure is essentially the same 
as the wild type domain (Figure 24). 
 
Table 1. Crystallographic data statistics of ING5 Nt C19S refinement. 
 ING5 Nt C19S 
Construct 
 
ING5C19S 
Data collection  
Space group P6522 
 
Cell dimensions  
    a, b, c (Å) 140.94, 140.94, 92.32 
   , ,  ()  90.0, 90.0, 120.0 
Resolution (Å) 92.32 (3.27-3.10) 
Rmerge   0.17 (0.93) 
CC1/2     0.98 (0.87) 
I/(I)   9.7    (3.1) 
Completeness (%)  100    (100) 
Redundancy 18.3   (18.8) 
  
Refinement  
No. reflections 10275 
Rwork/ Rfree 21.53/25.38 
No. atoms  
    Protein 1752 
    Ions/ligands 6* 
    Water 3 
B-factors (Å
2
)  
    Protein 99.43 
    ions 81.22 
    Water 71.80 
R.m.s deviations  
    Bond lengths (Å)  0.007 
    Bond angles (º) 1.024 
Ramachandran 
favored (%) 
 
96.0 
Ramachandran 
outliers (%) 
 
0.0 
  
PDB code 5MTO 
Values in parentheses correspond to the highest resolution shell.  
* Sulfate and Na ions. 
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The asymmetric unit of the crystal is formed by two polypeptide chains that form an 
asymmetric homodimer (Figure 24A), together with several ions coming from the 
precipitant solution. The two protomers in the asymmetric unit form a dimer and 
correspond in the PDB file to A and B chains, respectively. Each of the two chains forms 
a helix-loop-helix structure with two long helices (residues 19-52 and 58-101, named 2 
and 3, respectively) plus a short 1 helix at the N-terminus (residues 0-14, with residues 
-2 and -1 being an Gly and Ala preceding M1). The two helices of each protomer form an 
antiparallel coiled-coil structure, and both helices contain sequence segments with the 
typical heptad pattern (abcdefg)n, of coiled coils. However, there is a clear asymmetry 
between the protomers, seen in the superposition based on helices 2 and 3 of both 
chains (Figure 24C). As it happens for the wild type ING5 Nt crystal structure, they 
differ in the bending of helix 3 and in the relative position of helix 1 with respect to 
the other two. In the dimer, the region of chain B (close protomer) where the short 1 is 
located  
 
 
Figure 24. ING5 Nt C19S structure analysis. (A) Structure of the ING5 Nt C19S homodimer in the 
asymmetric unit of the crystal, with the two protomers shown as ribbons with magenta (open) and cyan 
(closed protomer) color. (B) Superposition of the two protomers of ING5 C19S. (C) Superposition of the 
ING5 Nt C19S dimer (magenta and cyan) on the corresponding dimer of the wild type (orange and blue for 
the open and closed protomers, respectively). 
 
The two protomers share many intramolecular interactions, including hydrophobic, 
charged, and long range ones, like the interhelical salt bridge D32-K82 (Figure 25B). But 
there are also interactions formed only individually in each of the protomers, like the salt 
bridge H96-E20 and the H-bond N24-T89, which stabilizes de hydrophobic core of the 
open protomer (Figure 25A). The intermolecular packing at the dimerization interface 
involves the helix-loop-helix end of the open protomer and the opposite end of the close 
protomer, stabilized by H-bonds involving side chains on α3 of the open protomer and 
side chains on α2 and α3 of the closed protomer (Figure 25B). This mode of packing 
results in two different hydrophobic cores: the small three-helical hydrophobic core of the 
open protomer and the five-helical hydrophobic core formed by the two protomers. These 
hydrophobic cores are small for a protein of this size, even considering the hydrophobic 
interface of the coiled coil region, and are the same as in the ING5 crystal structure. As it 
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happens for ING5 Nt crystal, one possible explanation for this arrangement is the 
presence of two extra residues at the N-terminus, which favors interactions that, in the 
crystal, conduct to the formation of a dimer of asymmetric dimers (Figure 25C). In this 
arrangement the 1 helices of one dimer pack against the 1 helices of the other dimer 
found by PISA, as shown in Figure 25D. As it happens in the crystal structure of Nt1-105, 
the side chain of extra residue G-1, together with the backbone of residue M1 of helix 1 
in the open protomer form H-bonds with the side chain of residue E82 in the helix 1 in 
the close protomer of the other dimer, acting as N-cap of the last turn of 1 [196]. This 
arrangement of two dimers in the crystal is predicted by the PISA server to be an 
assembly in solution even more stable than the dimer. However, in solution we have 
determined by SEC-MALS that the protein is a dimer (Figure 22). 
The fact that ING5 and C19S share similar interactions in the dimerization interface, 
together with the intra and inter coiled-coil contacts indicate that the cause of the ING5 
Nt adopting an asymmetric dimer structure in the crystal is not the presence of a disulfide 
bond linking two molecules in the crystal lattice. 
 
Figure 25. Intramolecular and intermolecular interactions in the ING5 Nt C19S crystal structure. (A) 
Side chains of residues involved in hydrogen bonds (N24-T89, E20-H96) stabilizing the small hydrophobic 
core formed by the open protomer. (B) Dimerizing interface and polar contacts between the open and close 
protomers (Y10-Q69). The side chains of D32 and K82, which are involved in a salt bridge, stabilizing the 
coiled-coil structure in the closed protomer are also shown. These residues are also involved in polar 
contacts between the open and close protomers (D32-Q66 and K82-E63). (C) Ribbon diagram of the 
tetrameric assembly in the crystal of ING5 Nt C19S identified by PISA analysis. The tetramer is formed by 
two asymmetric units, with the chains of the second unit indicated with paler colors. (D) Zoom of the 
framed area in C. Interactions between the backbone amides of residues G-1 and M1 in helix α1 from an 
open protomer with the side chain of rE8 in the helix α1 of a close protomer of another dimer in the 
tetrameric assembly.  
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The crystallographic models of both ING5 Nt domain and C19S mutant present 
different symmetry and dimerization interface compared to the crystal structure of ING4. 
But the data in solution indicate a symmetric structure also for ING5 Nt. We tried to use 
SAXS to discriminate between both types of conformations in solution. SAXS data 
analysis shows that ING5 Nt and C19S are folded proteins in solution as we can observe 
from the pronounced peak in the Kratky plot of both Nt and C19S (Figure 26). The 
distance distribution function, p(r), of Nt and C19S were calculated with a maximum 
particle dimension of 89 Å (Figure 26) and a radius of gyration of 25 Å for both proteins, 
values similar to those measured for the ING4 Nt [102].  
 
 
Figure 26. Kratky plots (top panels) and distance distribution functions (bottom panels) of ING5 Nt 
and its C19S mutant. The data were derived from the SAXS measurements of ING5 Nt and its C19S 
mutant at 20 ºC  in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM TCEP. 
 
The SAXS data allowed us to generate low resolution ab initio structural models for 
ING5 Nt domain that shows an elongated molecules (Figure 27A, C).  CRYSOL was 
used as a tool for SAXS data and structural data comparison. The fitting of the ING5 Nt 
experimental SAXS data to the calculated scattering (Figure 27B) is better for the 
symmetric model based on ING4 Nt (χ2 = 1.8) than for the asymmetric crystal structure 
(χ2 = 9.8), indicating that in solution the structure of the ING5 dimer is similar to the 
symmetric model based on ING4 Nt. The SAXS data of the C19S also yields an 
elongated shape that fits better the symmetric model than the asymmetric one (χ2 = 2.0 
and 12.0, respectively; Figure 27C, D). We can conclude from these experiments, 
together with the CD and NMR data, that ING5 Nt is folded as a helix-loop-helix 
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structure that dimerizes into a symmetric four-helix coiled-coil, with flexible N-terminal 
tails that may adopt a transient helical structure. 
 
 
Figure 27. Low resolution structure of ING5 Nt dimer in solution observed by SAXS. (A) Shape 
reconstruction of the ING5 dimer showing the fit of the data to the asymmetric crystal structure (top panel, 
structure in red ribbon) or the ING4 homology based symmetric model (bottom panel, model in blue 
ribbon). (B) Comparison of the experimental scattering (grey circles) with that calculated for the dimer in 
the crystal (red, χ2 =9.8) or the homology model dimer (blue, χ2 = 1.8). (C) Same as in A for the C19S 
mutant (D) Same as in C for the C19S mutant (χ2 =12.0 and 2.0 for the crystal and the model structures, 
respectively).  
 
 
4.4. ING5 Nt domain interaction with JADE1L 
  
JADE 1L is one of the components of the HBO1 complex, and it has been proposed 
that it is the platform on which the other components assemble [94]. In pull-down 
experiments it was shown that the conserved IIb domain of JADE 1L interacts directly 
with ING4, ING5 and with an ING4 construct lacking the PHD [139]. We hypothesized 
that JADE 1L would interact with the Nt domain of ING4 and ING5. Taking advantage 
of the assignment of the NMR spectrum of ING5 Nt, we examined the possible binding 
of ING5 Nt to the IIb domain of JADE 1L by monitoring the perturbations caused on 
ING5 signals in the presence of the IIb domain of JADE 1L. Since the expression and 
purification of the JADE domain was unsuccessful we used for this experiment three 
designed peptides with overlapping sequences corresponding to the IIb domain of JADE 
1L (see materials and methods, Table 2). The ING5 Nt domain precipitated in the 
presence of peptide A, indicating an interaction, but it was not possible to ascertain if the 
interaction was specific. 
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Figure 28. (A) ING5 Nt 
15
N in the absence (black) or in the presence of Jade peptide B (red) of a 1:5 
molar ratio. Samples were prepared in 50 mM MOPS pH 7.0, 1 mM DTT @ 298K. (B) CSP analysis for 
each residue in the presence of JADE 1L peptide B. 
 
 
 
Figure 29. (A) ING5 Nt 
15
N in the absence (black) or in the presence of Jade peptide C (red) in a 1:5 molar 
ratio. Samples were prepared in 50 mM MOPS pH 7.0, 1 mM DTT @ 298K. (B) CSP analysis for each 
residue in the presence of JADE 1L peptide C. 
 
In Figures 28 and 29 we can see the results in the presence of peptides B and C, 
respectively. The CSP measured in the presence of the other two peptides are very small 
and suggest that there is no specific interaction or that the interaction is extremely weak 
(Figure 28B and 29B). Therefore, we cannot identify which is the region of ING5 
involved in the interaction with IIb domain of JADE 1L. 
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5. Oligomerization of ING5 inside living cells 
 
5.1. Homodimerization of ING5 
To confirm that ING5 forms homodimers not only as a pure protein in solution but 
also inside the cell, we performed co-inmunoprecipitation experiments in human 
embryonic kidney epithelial 293T (HEK293T) cells transiently expressing ING5 with 
different N-terminal tags: HA or AU5. We have observed that HA-ING5 co-precipitated 
with AU5-ING5 by using an antibody anti-AU5 tag (Figure 30). These results were 
reproducible (see appendix I) and indicate that at least two ING5 molecules interact 
inside living cells. 
 
 
Figure 30. Analysis of ING5 homodimerization inside cells by co-immunoprecipitation. Lysates from 
cells transiently transfected with vectors expressing AU5-ING4 (left lanes) or both AU5-ING4 and HA-
ING5 (right lanes) were immunoprecipitated (IP) with αAU5 or αHA, antibodies against the AU5 tag and 
HA tag, respectively. The presence of each protein in the immunocomplexes was analyzed by Western 
blotting (WB) with antibodies against the HA (αHA, upper panels) or AU5 (αAU5, lower panels) tag.  
 
 
5.2. Heterodimerization of ING5 
 
As it has been discussed in the introduction, the high sequence identity of ING5 and 
ING4 at their Nt domains (75%), and that both may form part of the HBO1 complex [92], 
raises the possibility that ING5 and ING4 form heterodimers. Since ING5 is a symmetric 
dimer in solution, as ING4, some inter helical interactions could be conserved in the 
ING5/ING4 heterodimer stabilization. An ING5/ING4 heterodimer model based on ING4 
crystal structure has an overall distribution of hydrophobic and polar residues [103] and 
an heptad pattern of the coiled coil that is  the same as in the modeled structure of ING5 
homodimer and the crystal structure of ING4. Moreover, the intermolecular salt bridge 
and hydrogen bond between residues at positions 32/39 and 94/69 present in the ING4 
homodimer could also be established in the heterodimer [103]. The formation of 
heterodimers inside cells was observed by co-immunoprecipitation experiments. Extracts 
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from HEK293T cells transiently expressing both ING5 and ING4 with the two different 
tags (HA or AU5), were co-immunoprecipitated against the AU5 tag and blotted with the 
HA tag (or vice versa). With this strategy, co-precipitation of ING5 or ING4 will only 
occur if they interact. The detection of HA-ING4 by western blotting with anti-HA 
antibody in inmunocomplexes for AU5-tagged ING5 (Figure 31) shows that ING5 and 
ING4 can form heterodimers, or at least that they form part of the same complex inside 
the cells. These results were reproducible (see appendix I). 
 
 
Figure 31. Analysis of ING4/ING5 heterodimerization in cells by co-immunoprecipitation. Lysates 
from cells transiently transfected with vectors expressing HA-ING5 and AU5-ING4 (lanes with number 3) 
or HA-ING4 and AU5-ING5 (lanes with number 4) were immunoprecipitated (IP) with αHA or αAU5, 
antibodies against the HA tag and AU5 tag, respectively. The presence of each protein in the 
immunocomplexes was analyzed by Western blotting (WB) with antibodies against HA (αHA, upper 
panels) or against AU5 (αAU5, lower panels) tag.  
 
The formation of heterodimers of the recombinant Nt domains was also observed by 
ion mobility coupled to electrospray ionization mass spectrometry (ESI-IM-MS) on 
samples of the pure Nt domains mixed and incubated at 37 ºC (Figure 32 and Table 3 in 
the materials and methods section). However, the proportion of the heterodimers is very 
low  relative to the dimers or dissociated monomers,  and is comparable to heterotrimers 
(which were unexpectely seen in the mass spectrum). This result suggest that isolated  Nt 
domains can form heterodimers, although they are not the most stable species. This is 
consistent with the unsuccessful attempts of copurificacion of ING5 heterodimers from 
mixtures of the two proteins [121]. 
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Figure 32. ESI-IM mass spectra analysis of ING5 Nt and ING4 Nt mixture. (Top) Ion mobility drift 
time versus m/z plot of the data acquired for the mixture of ING4 and ING5 Nt domains. The interpretation 
of the signals in terms of the different monomeric, dimeric, and trimeric forms of the ING4 and ING5 Nt 
domains (4 and 5, respectively) are indicated with arrows of different colors. (Bottom) ESI–MS spectrum 
of the mixture of ING4 and ING5 Nt domains. The signals consistent with the ING4/ING5 dimer are 
indicated. 
 
Altogether these results suggest that the isolated  Nt domains can form heterodimers. 
The heterodimer might be much less stable in solution than the homodimer, but in the 
cells the heterodimer may be stabilized by other proteins or by post-translational 
modifications. 
 
6. Structural impact of ING5 N-terminal mutants detected in primary tumors 
 
In the ING5 Nt domain, three tumor specific somatic mutations have been described in 
oral squamous cell carcinoma [117] (Figure 33A). These mutants, the three of them 
located in the long helices 2 and 3, are Q33R, I68V and C75R and form dimers in 
solution (Figure 33B). The CD spectra of all of them are typical of coiled-coil structures, 
indicating that they adopt helical structures similar to that of the wild type (Figure 33B). 
However, their stability is markedly different as measured by thermal denaturation 
(Figure 33C). While the Q33R mutant behaves similarly to the WT, as expected for a 
solvent exposed polar residue mutated into another polar residue, both I68V and C75R 
mutants cause a dramatic structural destabilization. The fact that I68V and C75R 
mutations involve buried or partially buried residues that are changed to a smaller or a 
 96  Results 
larger and more polar residue, respectively, is consistent with the observed 
destabilization.  
To analyse the effect of the mutations on dimer formation in a more quantitative way, we 
calculated the dissociation constants of the coiled-coil dimerization at 25°C. Assuming a 
two state transition as indicated by the single transition observed in the melting curves, 
(Figure 34) it is possible to calculate the KD at a given temperature from the variation of 
the mid-point denaturation temperatures with the protein concentration [146, 147]. The 
calculated KD for the WT and the three mutants at 25 ºC are presented in Table2. 
 
 
Figure 33. ING5 cancer mutants dimerize in solution through its N-terminal helical domain. (A) 
View of the ING5 Nt homodimer in the asymmetric unit of the crystal. The two protomers are shown as 
ribbons with orange (open) and blue (closed) color. The position of the three mutants detected in primary 
tumors are colored and indicated in the closed protomer. (B) SEC-MALS analysis of ING5Nt and its 
mutants Q33R, I68V and C75R. All data were obtained in 20 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT, 
at 25 ºC. The exclusion volume of the column is 8.7 mL. (C) CD spectra of ING5 molecules at 40 µM in 
the same buffer as in B. (D) Thermal denaturation of ING5 molecules in the same buffer as in C. 
 
For ING5 Nt the calculated value of KD is 4.1 ± 0.7 nM, In the case of Q33R mutant, 
the introduction of a polar and positively charged residue in a solvent exposed position is 
consistent with the measured stabilization (KD = 0.4 ± 0.3 nM). Furthermore, Q33 residue 
is close to E36 and D37 residues, and the introduced arginine will make helical 
stabilizing contacts (i,i+3 and i,i+4 interactions), not only in the symmetric but also in the 
asymmetric structural model. However, for the I68V and C75R mutants the KD values are 
three orders of magnitude larger (1.4 ± 0.2 μM and 2.7 ± 0.5 μM, respectively). The 
strong destabilization caused by these mutations is consistent with both residues being 
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completely buried in the symmetric model, while they are only partially buried in the 
asymmetric one. 
 
 
 
 
Figure 34. Thermal denaturation curves for ING5 Nt and its cancer mutants at different 
concentrations. The normalized ellipticity at 222 nm at each temperature is represented : 40 µM protein in 
magenta, 20 µM in blue, 10 µM in red, 4 µM in olive, and 2 µM in black (except ING5 Nt I68V, which is 1 
µM). 
 
Table 2. Dissociation constant KD for ING5 Nt and its mutants at 25 ºC. 
 
Protein KD (M) 
ING5                
Q33R                
I68V                 
C75R                
 
  
 98  Results 
7. Functional impact of  ING5 N-terminal mutants 
 
7.1. Cell morphology 
 
To study the functional impact of the expression of ING5 cancer-associated mutants, 
we first analyzed cell morphology by immunofluorescence. Cells expressing ING5 
mutants showed an aberrant morphological phenotype. This can be observed in the 
immunofluorescence micrographs of Figure 35. Cells expressing WT ING5 displayed a 
cell shape and nuclei/cytoplasm distribution similar to control cells. Cells expressing the 
Q33R mutant were the most similar to the WT cells, although they were rounder and 
smaller. However, cells expressing I68V and C75R mutants, the most structurally 
unstable proteins, displayed features similar to each other but different from control and 
WT cells: they had large nuclei and were distributed in clusters and/or showed 
multinuclear cells. 
 
 
 
Figure 35. Micrographs of NIH3T3 cells with stable expression of ING5 or its mutant forms. Cells 
were co-stained with Hoechst 33342 for DNA (blue) and Rhodamine–phalloidin for actin (red) to mark 
nuclei and cytoplasm, respectively. 
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7.2. ING5 N-terminal mutants sublocalization in cells 
 
We confirmed by immunofluorescence that all the ING5 protein variants were 
efficiently expressed (Figure 36). ING5 showed a predominantly nuclear localization in 
speckles, possibly nucleoli, while the mutant forms of ING5 displayed a subcellular 
distribution slightly different, accumulated on a region of the nuclei close to the 
cytoplasm. 
 
 
Figure 36. Immunofluorescence analysis of the expression level and subcellular localization of WT 
and mutant forms of ING5 in stably transfected NIH3T3 cells. An antibody against the HA tag at the N-
terminal part of the ING5 proteins was used to visualize ING5 proteins (red). Cells were mounted onto 
microscope slides using DAPI containing Vectashield to visualize the nuclei (blue). 
 
7.3. Cell proliferation effect of ING5 N-terminal mutants 
 
The functional impact when expressing the ING5 cancer-associated mutants was 
further examined by proliferation assays in NIH3T3 fibroblasts stably expressing the WT 
protein and the Q33R, I68V and C75R mutants. The cells were plated and analyzed after 
20, 68 and 92 h in culture (Figure 37). Cells expressing ING5 displayed a proliferative 
 100  Results 
behavior that was indistinguishable from control cells (pLPC vector). In contrast, cells 
expressing the mutant versions of ING5 showed compromised growth. In particular, 
expression of C75R and I68V mutants markedly reduced cell proliferation, while Q33R 
mutant exerted a more modest effect.  
 
 
 
Figure 37. Proliferation assay of NIH3T3 cells expressing ING5 constructs at different times. The data 
represent the mean ± S.D. of three independent experiments done in quadruplicates. * p< 0.05 by t-test. 
 
 
7.4. Cell cycle profile of ING5 N-terminal mutants expressing cells 
 
The aberrant cell phenotype of the ING5 mutants was further examined by flow 
cytometry analyzing their cell cycle distribution using stably transfected cells (Figure 
38). ING5 expressing cells displayed a cell cycle phase distribution that is 
indistinguishable from the control. However, Q33R mutant expressing cells showed 
increased S phase arrest (Figure 38A, left column), which has been shown in breast 
cancer to occur under DNA-damage [198]. I68V and C75R mutants produced a 
significant reduction of cells going through G0/G1 phase due to the increased population 
of cells showing a G2/M arrest and aneuploidy, even in the absence of external stress 
conditions (Figure 38B, Top). To assess the capacity of mutated ING5 to affect the cell 
response to DNA damage, cells were treated with doxorubicin, which intercalates with 
DNA. Induction of DNA damage with a low (100 ng/mL) or a high (400 ng/mL) dose of 
doxorubicin, resulted in a clear accumulation of WT and Q33R cells in the G2/M phase 
of the cell cycle and subsequently showed a progressive decline in the G1- and S-phase 
populations (Figure 38A, second and right columns). In contrast, cells expressing C75R 
and I68V ING5 variants seemed to be unable to arrest in the G2/M check point, leading 
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to significant accumulation of replicated DNA, as observed in the huge levels of 
aneuploidy (Figure 38B, middle and bottom). These results suggest that those cells 
expressing Q33R mutant are still able to proceed with their cell cycle and be functional, 
as ING5, while the expression of C75R and I68V mutants makes the cells unable to arrest 
the cell cycle under DNA damage leading to aneuploidy. This aberrant behavior could be 
related to their destabilized structure, which may affect ING5 function. 
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Figure 38. (A) Cell cycle profiles of cells stable expressing ING5 or mutants. (B) Analysis of cell cycle 
distribution in the presence of ING5 and its mutants.
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Previous studies on the structural characterization of ING5 have reported on the 
biochemical and structural features of the PHD as a trimethylated histone binding 
module, leaving out the N-terminal domain and, the most important, the overall structure 
of ING5. I started this thesis work soon after our group found that the crystal structure of 
the N-terminal domain of ING5 showed a dimer with α-helical secondary structure [121], 
as it had been observed for ING4. However, the crystal structure of the Nt of ING5 
revealed a different dimerization interface to that described for the highly homologous 
ING4, being the former an asymmetric dimer, and the latter a symmetric one.  
In this thesis work, we have been able to express and purify the full length version of 
ING5, which has been very challenging because of the low purification yields and the 
low solubility of the recombinant protein. Despite of the difficulties, we prepared a good 
quality sample that allowed us to perform structural analysis by SEC-MALS, circular 
dichroism and NMR.  
The circular dichroism spectrum of ING5 is indicative of a high content of helical 
structure, similar to the spectrum of its isolated Nt. However, the low absolute ellipticity 
indicates that a large part of the chain is not helical, which is consistent with the presence 
of other different structural domains in the molecule. ING5 shows cooperative thermal 
denaturations with a midpoint melting temperature of 42°C, which is similar to that of its 
isolated N-terminal domain (45°C). However, the calculated Tm are smaller compared to 
those of the corresponding ING4 molecules (56°C) [102]. There are differences in the 
experimental conditions, in which the thermal denaturations of both proteins were 
measured (Tris pH 8.0 for ING5 molecules and sodium phosphate pH 6.5 for ING4 
molecules). The different experimental conditions might possibly be the reason for the 
differences in Tm; however, there is data in which the midpoint melting temperature of 
ING5 Nt does not vary with these pH values [121]. 
We have been able to experimentally determine a molar mass of 57 kDa for ING5 in 
solution by SEC-MALS, which is consistent with the theoretical calculated mass of a 
dimer (60 kDa). The dimerization of ING5 has been shown to occur also in cells, as it 
was proved by co-inmunoprecipitation experiments. Thus, ING5 is a dimer in solution 
and the dimerization site is at the N-terminal domain, with α-helical coiled-coil structure. 
The NMR spectrum of ING5 shows a single set of dispersed signals that matches that of 
the PHD domain, indicating that the two PHD finger of the dimer are chemically 
equivalent. Therefore, ING5 is a bivalent reader of the H3K4me3 mark, as is ING4. We 
have determined the dissociation constant of ING5 binding to H3K4me3 peptide by 
NMR, yielding a KD of 7.3 ± 2.6 μM, in the same micromolar range but around 2.5 times 
smaller than the KD of the isolated PHD finger bound to the same peptide and measured 
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by the same method (KD =17.9 ± 2.5 µM). This difference in the measured affinity is 
similar to that observed between ING4 and its isolated PHD (KD values of 1.3 ± 1.0 µM 
and 3.9 ± 1.0 µM, respectively). Perhaps this difference is due to a loss of avidity in the 
case of the PHD finger alone, which lacks the bivalent mode of reading H3K4me3 of the 
full length proteins, as it happens for ING5 and ING4 dimers. 
Our structural characterization on the N-terminal domain of ING5 in solution by CD, 
SEC-MALS, NMR and SAXS unequivocally shows that the N-terminal domain folds 
into a dimeric, symmetric, coiled-coil structure, probably antiparallel as it was found for 
ING4. Therefore, the crystal structure of this domain, previously determined [121], is 
likely a crystallization artefact. It probably happens that under the crystallization 
conditions (a buffer with pH 6.5 and a high concentration of poly-alcohols like MPD and 
PEG) the asymmetric dimer conformation (or the symmetric tetramer identified by PISA 
analysis) exists in solution and forms crystals while the symmetric dimer does not 
crystallize. The reasons for this arrangement in the crystal could be either the presence of 
two extra residues at the N-terminus, or a close contact between the C19 side chain of 
one ING5 molecule and the corresponding C19 side chain of a symmetry related 
molecule, forming a disulfide bridge that stabilizes the asymmetric dimer. However, 
structural analysis of the Nt2-105 construct by NMR and the C19S mutant by 
crystallography, confirms that the crystal structure artefact is not a consequence of the 
presence of extra residues at the N-terminus or the intermolecular disulfide bridge 
formation between two molecules in the crystal lattice.  
The ING5 homodimer is an elongated protein complex similar to ING4. The PHD 
fingers are connected to the Nt dimerization domain by the long and disordered NLS 
segment, and in a head-to-tail dimer, the most probable dimerization form, are directed to 
opposite sides of the molecule. The two C-terminal PHD fingers are chemically 
equivalent and autonomous from the rest of the molecule and able to interact with two 
nearby H3K4me3 from the same nucleosome.  
Interestingly, due to the length (85 residues long, ~255Å) and flexibility of the NLS 
region, one ING5 dimer would be able to bind histone H3 tails not only in the same, but 
in two different nucleosomes at the same time. This hypothesis has been already 
suggested for ING4 [103]. The structural information available for polynucleosomal 
states, as the tetranucleosome structure [199], sheds a light on the association between 
nucleosomes and their relative orientation, and provides a reliable model to test this 
hypothesis. An estimation of the separation between the N-terminal tails of histone H3 
were obtained from the tetranucleosome model and the distance between two tails in two 
consecutive nucleosomes was calculated to be in the range of 79–112 Å [103], which is 
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smaller than the length of the NLS region in extended conformation (~255 Å). Thus, as 
well as ING4, the ING5 dimer could bind the two histone H3 tails of the same or adjacent 
consecutive or non-consecutive nucleosomes, if they are close enough (Figure 16 of the 
introduction).  
In the context of chromatin, ING5, as well as the other INGs, will bind the nucleosome 
by the recognition of the H3K4me3 mark and recruit HATs or HDACs to these sites. 
These protein-protein interactions will promote epigenetic changes by the HAT or HDAC 
complexes that associate with INGs, but it remains unclear the mechanism by which 
modifications of histones within the same or nearby nucleosomes are favored. The 
possibility that ING proteins contribute to nucleosome binding through direct protein 
binding to DNA had not been explored, but in this thesis work, for the first time, we have 
analyzed the function of the central intrinsically disordered region (IDR) of ING4, which 
was previously identified as a nuclear localization sequence (NLS) containing nucleolar-
targeting signals. Other intrinsically disordered proteins (IDP) or proteins containing 
IDRs [200] have been described to interact directly with DNA with relatively low affinity 
but collectively contributing to avidity for the DNA. We have shown that the NLS region 
of ING4 directly binds preferentially dsDNA substrates of different nucleotide sequences 
with an affinity in the low micromolar range [193]. The measured affinity is three orders 
of magnitude lower than the low nanomolar range measured for transcription factors such 
as p53 [201] or c-myc [202]. This is consistent with ING4 being a reader of H3K4me3 
and not a transcription factor recognizing a specific DNA sequence. Our results can be 
probably extrapolated to ING5 and the other ING proteins since the alignment of their 
NLS region (IDP) sequences shows several clusters of positively charged residues, 
maybe ING3 being an exception because it has much less positively charged residues in 
this region compared to the others [72]. In the case of ING5 we have found that it also 
binds preferentially dsDNA, but with lower affinity than ING4. 
The results presented in this thesis reveal a novel role for the central disordered NLS 
region of ING proteins as a modulator of the interaction with the nucleosome. Moreover, 
the bivalent recognition of two H3K4me3 by two PHD fingers and the bivalent binding to 
two DNA regions by ING4 or ING5 dimers will result in cooperativity and a strong 
nucleosome binding [203] (Figure 1). This will have an impact on the recruitment of the 
HAT complexes, so that the HBO1 or MOZ/MORF complexes will be more efficiently 
recruited to the chromatin sites with the H3K4me3 mark. Although clusters of positively 
charged residues are conserved among the NLS regions of ING proteins, they vary in 
length and sequence, which could lead to subtle differences in the selectivity or avidity of 
the HATs and HDAC complexes recruited by INGs. Recently, a new model of 
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scaffolding in HBO1 acetyltransferase complex has been proposed in which BRPF or 
JADE scaffold subunits interchange for different histone acetylation specificity [94]. This 
observation, together with the possible differences in the DNA binding of the different 
ING proteins, suggests that the NLS-DNA interaction may have a biological function in 
the ING family of proteins further from the role of nuclear localization and strengthening 
the nucleosome binding. The NLS regions of the ING proteins could provide flexibility to 
allow for multiple protein interactions in HAT and HDAC complexes. 
 
Figure 1. Model of ING4 dimer binding to chromatin. The bivalent recognition of two H3K4me3 by 
two PHD fingers and the bivalent binding to two dsDNA regions by two NLS regions of ING4 result in 
cooperativity and a strong binding either to the same (A) or different nucleosomes (B). Figure B has been 
modified from Tallen and Riabowol 2017 [204]. 
  
The alignment of the ING protein sequences with the structure of the N-terminal 
domain of ING4 showed a high level of homology that suggested that the conservation of 
many of the residues is due to the structural constraints [205]. Interestingly, the regions of 
highest homology keep the same or similar amino acid residue in positions a, d and g, 
essential for the formation of the heptad pattern typical of coiled- coil structures in the 
leucine-zipper-like domain. ING4 and ING5 have been shown to be part of the same 
chromatin remodeling complex, the HBO1 HAT [92]. Taking into account the high 
sequence homology with the N-terminal domain of ING4 (75% identity), we could 
hypothesize the formation of a heterodimer between ING4 and ING5. The possibility of 
heterodimer formation was already evaluated by molecular modelling with the prediction 
that ING4/ING5 heterodimers may be as stable as the corresponding homodimers [103]. 
This prediction was based on a homology model of the ING5 dimer showing a 
distribution of hydrophobic and polar residues that matched, to a large extent, the 
intermolecular contacts in the crystal structure of ING4 [205]. Indeed, our results, for the 
first time, show by immunoprecipitation that ING5 and ING4 can form heterodimers, or 
at least that they form part of the same complex inside the cells. As it has been for some 
transcription factors, heterodimerization could have a regulatory role [130]. Moreover, it 
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could provide a different way of scaffolding leading to an exchange of recruited subunits 
that might result in specificity changes regarding histone acetylation. The observation, for 
the first time, that ING4 and ING5 can form heterodimers, indicates that the function of 
these proteins is more complicated than thought at first sight. It would be interesting to 
further study how the members of the ING family of epigenetic readers impose order on 
the local epigenetic status within different nucleosomes by the interplay of different 
members of the family and their conserved regions. 
The analysis of three tumor specific somatic mutations described in oral squamous cell 
carcinoma [117] for ING5 Nt domain (Q33R, I68V and C75R), revealed that they form 
dimers in solution and showed typical CD spectra of coiled-coil structures (Figure 2A). 
Therefore these mutants adopt similar structures to that of the wild type; however, their 
thermal stability is markedly different, and the effect of each mutation is more consistent 
with an Nt domain forming a symmetric dimer than an asymmetric one, in agreement 
with the structural information described above. The Q33R mutant is more stable than the 
wild type (with a measured KD of 0.4 ± 0.3 nM and 4.1 ± 0.7 nM,  respectively), which is 
consistent with the fact that the Q33 residue is close to E36 and D37 residues, and the 
introduced arginine will make helical stabilizing contacts (i+3 and i+4 interactions) 
(Figure 2B). This will occur not only in the symmetric but also in the asymmetric 
structural model. However, the most unstable mutations, I68V and C75R, involve a 
change to a smaller or a larger and more polar residue (Figure 2B), respectively. The 
calculated dissociation constants for these mutants (KD = 1.4 ± 0.2 μM and 2.7 ± 0.5 μM, 
respectively) are three orders of magnitude higher than the one of ING5 (KD = 4.1 ± 0.7 
nM). These two positions are buried in the symmetric dimer, but only partially buried in 
the asymmetric one; therefore, the strong destabilization is more consistent with the 
symmetric than with the asymmetric dimer. 
 
Figure 2. Mutated residues described in cancer for ING5. A. General view of the position of the 
mutations in the symmetric model of the N-terminal domain of ING5. B. Mutations (dark colors) and wild 
type residues (paler colors) displayed as sticks (Q33R in cyan, I68V in green and C75R in magenta).  
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In the context of the cell, the expression of these mutants leads to a different cell 
phenotype. Cells expressing Q33R mutant were the most similar ones to the WT 
expressing cells, although a bit rounder and smaller. However, Q33R displayed a 
subcellular distribution similar to I68V and C75R, accumulated on a region of the nuclei 
close to the cytoplasm. Cells expressing Q33R mutant presented an increased proportion 
of cells in S phase arrest, which has been shown in cancer to occur under DNA-damage 
or replicative stress [198]. Indeed, there is experimental data indicating that ING5 is 
essential for DNA replication, and in the absence of ING5, MCF7 cells showed a high 
proportion of cells in S-phase arrest [92]. In our model, NIH3T3 cells, the expression of 
Q33R mutant might interfere with the WT in complexes that are unable to form necessary 
interactions and mimic what it happens in the absence of ING5. Cells expressing this 
mutant might be unable to overcome cell cycle checkpoints, arresting cells in S-phase. 
However, the effect of this mutation on ING5 stability is not as drastic as the other two, 
as expected for a solvent exposed polar residue mutated into another polar residue, and 
cells expressing this mutant present only a modest effect in cell proliferation. This is 
consistent with Q33R mutant being similar to ING5 that has been shown to have little 
effect in proliferation when expressed in other cell types [115 1091]. On the contrary, 
cells expressing I68V and C75R mutants, the most unstable ones, were morphologically 
similar to each other but very different to ING5 expressing ones: they had large nuclei 
and were distributed in clusters and/or showed multinuclear cells. Indeed, they displayed 
a subcellular distribution that was slightly different to that of ING5, which is probably 
related with the fact that the cells expressing these mutants display an aberrant cell cycle 
profile with an increased cell population arrested at G2/M. Moreover, these cells appear 
to have lost control on their cell cycle, accumulating high amounts of aberrantly 
duplicated DNA. Dysregulation of cell cycle checkpoints can increase susceptibility to 
mutations, genomic instability and tumorigenesis [206, 207]. There is strong evidence in 
the literature for a high frequency of aneuploidy in cancer [208] and this can be related to 
what we saw in our model, in which cells expressing I68V and C75R mutants seem to be 
unable to overcome cell cycle checkpoints, accumulating DNA aberrantly and showing 
aneuploidy. In the presence of genotoxic insult (doxorubicin), this situation aggravates in 
the case of I68V and C75R mutants, displaying huge levels of aneuploidy. However, this 
is not the case for Q33R mutant, whose cell cycle profile is similar to ING5 and control 
cells. 
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Our results suggest that the expression of ING5 mutants described in oral squamous 
cell carcinoma [117], in NIH3T3, cells have drastic effects in the cell cycle in the case of 
I68V and C75R, which correlates with tumorigenic activity. However, there are still 
some questions to address regarding the proliferation of the cells expressing these 
mutants. Their cell cycle is completely out of control which is the typical scenario in 
cancer cells that are able to skip cell cycle checkpoints and keep proliferating, but these 
mutants showed a markedly reduced cell proliferation more typical of tumor suppressive 
activity. There is not many published data about ING5 functions but there are conflicting 
views of ING5 as a tumor suppressor or oncogene, which are context specific. In fact, 
there are experimental evidences that suggest that ING family of proteins may play dual 
roles, as tumor suppressors or oncogenes, under different cellular conditions [83]. In 
particular, ING5 showed oncogenic activity in MEFs cultured in 0.1% FCS medium 
[209]. Therefore, further functional experiments in cancer cell lines should be done to 
better understand the effects of ING5 in DNA replication and in cell cycle, and how it 
contribute to its tumor suppressor or oncogenic functions depending on the cell context. 
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CONCLUSIONS 
 
- The ING5 protein forms an elongated dimer in solution with three structurally 
autonomous domains: the N-terminal dimerization domain, a central disordered 
region and a C-terminal PHD finger. This structural organization of ING5 is similar 
to that of its homolog ING4. 
 
- ING5 forms homodimers inside living cells and can also form heterodimers with 
ING4.  
 
- ING5 binds the histone H3 peptide trimethylated at lysine 4 with a KD of 7.3 ± 2.6 
μM at 25 ºC. Because of is dimeric nature ING5 is a bivalent reader of the H3K4me3 
mark. 
 
- The PHD finger alone binds H3K4me3 with a slightly less affinity, KD = 17.9 ± 2.5 
μM at 25ºC, perhaps due to avidity loss in the isolated PHD. 
 
- The central NLS region of ING4 binds preferentially double stranded DNA with 
micromolar affinity. The NLS region of ING5 also binds preferentially double 
stranded DNA but with less affinity than ING4.  
 
- The N-terminal domain of ING5 forms in solution a symmetric coiled-coil dimer 
similar to that of ING4, in contrast with the asymmetric dimer in the crystal, which is 
likely an artefact of crystallization. 
 
- The crystal structure artefact is not a consequence of the presence of extra residues at 
the N-terminus or the intermolecular disulfide bridge formation between two 
molecules in the crystal lattice.  
 
- The thermal stability of ING5 is similar to that of its N-terminal domain, and smaller 
than the corresponding ING4 molecules. 
 
- The dissociation constant of the N-terminal dimeric domain of ING5 is 4.1 ± 0.7 nM 
at 25 ºC, which is around three orders of magnitude smaller than the value measured 
for mutants I68V and C75R, and one order of magnitude larger than for mutant 
Q33R. 
 
- The ING5 Q33R mutant has little impact on NIH3T3 cell proliferation, but the 
mutation causes S phase arrest of the cell cycle. 
 
- The I68V and C75R mutations reduce cell proliferation and induce an aberrant 
behaviour in the cell cycle, with many cells showing aneuploidy. 
 
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
REFERENCES 
  
 
 
 
 
  
  References   119  
REFERENCES 
 
[1] Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol. 
2003;15:172-83. 
[2] Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. 
Eur J Cancer. 2005;41:2381-402. 
[3] Kan PY, Caterino TL, Hayes JJ. The H4 tail domain participates in intra- and 
internucleosome interactions with protein and DNA during folding and oligomerization 
of nucleosome arrays. Mol Cell Biol. 2009;29:538-46. 
[4] Groth A, Rocha W, Verreault A, Almouzni G. Chromatin challenges during DNA 
replication and repair. Cell. 2007;128:721-33. 
[5] Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 
2007;128:707-19. 
[6] Ordu O, Lusser A, Dekker NH. Recent insights from in vitro single-molecule studies 
into nucleosome structure and dynamics. Biophysical Reviews. 2016;8:33-49. 
[7] Figueiredo LM, Cross GAM, Janzen CJ. Epigenetic regulation in African 
trypanosomes: a new kid on the block. Nat Rev Micro. 2009;7:504-13. 
[8] Widom J. Role of DNA sequence in nucleosome stability and dynamics. Q Rev 
Biophys. 2001;34:269-324. 
[9] Nightingale KP, O'Neill LP, Turner BM. Histone modifications: signalling receptors 
and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 
2006;16:125-36. 
[10] Bowman GD, Poirier MG. Post-Translational Modifications of Histones That 
Influence Nucleosome Dynamics. Chemical Reviews. 2015;115:2274-95. 
[11] Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev 
Biochem. 2009;78:273-304. 
[12] Sheinin MY, Li M, Soltani M, Luger K, Wang MD. Torque modulates nucleosome 
stability and facilitates H2A/H2B dimer loss. Nat Commun. 2013;4:2579. 
[13] Andrews AJ, Luger K. Nucleosome structure(s) and stability: variations on a theme. 
Annu Rev Biophys. 2011;40:99-117. 
[14] Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and 
chromatin structure: an ordered state or a disordered affair? Nat Rev Mol Cell Biol. 
2012;13:436-47. 
[15] Talbert PB, Henikoff S. Histone variants--ancient wrap artists of the epigenome. Nat 
Rev Mol Cell Biol. 2010;11:264-75. 
[16] Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part I: Covalent 
histone modifications. Trends Mol Med. 2007;13:363-72. 
[17] Xu YM, Du JY, Lau AT. Posttranslational modifications of human histone H3: an 
update. Proteomics. 2014;14:2047-60. 
[18] Huynh JL, Casaccia P. Epigenetic mechanisms in multiple sclerosis: implications for 
pathogenesis and treatment. Lancet neurology. 2013;12:195-206. 
[19] Latham JA, Dent SY. Cross-regulation of histone modifications. Nat Struct Mol 
Biol. 2007;14:1017-24. 
[20] Zhang Y, Reinberg D. Transcription regulation by histone methylation: interplay 
between different covalent modifications of the core histone tails. Genes Dev. 
2001;15:2343-60. 
[21] Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev 
Mol Cell Biol. 2005;6:838-49. 
[22] Bannister AJ, Kouzarides T. Reversing histone methylation. Nature. 2005;436:1103-
6. 
[23] Bedford MT, Richard S. Arginine methylation an emerging regulator of protein 
function. Mol Cell. 2005;18:263-72. 
[24] Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome 
structure and dynamics. Nat Rev Mol Cell Biol. 2014;15:703-8. 
 120   References   
[25] Casadio F, Lu X, Pollock SB, LeRoy G, Garcia BA, Muir TW, et al. H3R42me2a is 
a histone modification with positive transcriptional effects. Proc Natl Acad Sci U S A. 
2013;110:14894-9. 
[26] Patel DJ. A Structural Perspective on Readout of Epigenetic Histone and DNA 
Methylation Marks. Cold Spring Harb Perspect Biol. 2016;8:a018754. 
[27] Kuo M-H, Allis CD. Roles of histone acetyltransferases and deacetylases in gene 
regulation. BioEssays. 1998;20:615-26. 
[28] Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes 
Dev. 1998;12:599-606. 
[29] Bode AM, Dong Z. Inducible covalent posttranslational modification of histone H3. 
Sci STKE. 2005;2005:re4. 
[30] Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between 
chromosome condensation and transcriptional activation. Trends Genet. 2004;20:214-20. 
[31] Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074-80. 
[32] Hyland EM, Cosgrove MS, Molina H, Wang D, Pandey A, Cottee RJ, et al. Insights 
into the role of histone H3 and histone H4 core modifiable residues in Saccharomyces 
cerevisiae. Mol Cell Biol. 2005;25:10060-70. 
[33] Watanabe S, Resch M, Lilyestrom W, Clark N, Hansen JC, Peterson C, et al. 
Structural characterization of H3K56Q nucleosomes and nucleosomal arrays. Biochim 
Biophys Acta. 2010;1799:480-6. 
[34] Ye J, Ai X, Eugeni EE, Zhang L, Carpenter LR, Jelinek MA, et al. Histone H4 lysine 
91 acetylation a core domain modification associated with chromatin assembly. Mol Cell. 
2005;18:123-30. 
[35] Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding 
modules interpret histone modifications: lessons from professional pocket pickers. Nat 
Struct Mol Biol. 2007;14:1025-40. 
[36] Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, 
neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13:673-91. 
[37] Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693-705. 
[38] Khorasanizadeh S. The nucleosome: from genomic organization to genomic 
regulation. Cell. 2004;116:259-72. 
[39] Filippakopoulos P, Knapp S. The bromodomain interaction module. FEBS Lett. 
2012;586:2692-704. 
[40] Eissenberg JC. Structural biology of the chromodomain: form and function. Gene. 
2012;496:69-78. 
[41] Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, Kim Y, et al. 
Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature. 
2005;438:1181-5. 
[42] Sims RJ, Chen C-F, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg* D. Human 
but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 
via its tandem chromodomains. The Journal of biological chemistry. 2005;280:41789-92. 
[43] Blus BJ, Wiggins K, Khorasanizadeh S. Epigenetic virtues of chromodomains. Crit 
Rev Biochem Mol Biol. 2011;46:507-26. 
[44] Capili AD, Schultz DC, Rauscher IF, Borden KL. Solution structure of the PHD 
domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM 
zinc-binding domains. Embo J. 2001;20:165-77. 
[45] Bienz M. The PHD finger, a nuclear protein-interaction domain. Trends Biochem 
Sci. 2006;31:35-40. 
[46] Champagne KS, Kutateladze TG. Structural insight into histone recognition by the 
ING PHD fingers. Curr Drug Targets. 2009;10:432-41. 
[47] Shindo H, Suzuki R, Tsuchiya W, Taichi M, Nishiuchi Y, Yamazaki T. PHD finger 
of the SUMO ligase Siz/PIAS family in rice reveals specific binding for methylated 
histone H3 at lysine 4 and arginine 2. FEBS Lett. 2012;586:1783-9. 
 
  
  References   121  
[48] Zeng L, Zhang Q, Li S, Plotnikov AN, Walsh MJ, Zhou MM. Mechanism and 
regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature. 
2010;466:258-62. 
[49] Leung CC, Glover JN. BRCT domains: easy as one, two, three. Cell Cycle. 
2011;10:2461-70. 
[50] Wu Q, Jubb H, Blundell TL. Phosphopeptide interactions with BRCA1 BRCT 
domains: More than just a motif. Prog Biophys Mol Biol. 2015;117:143-8. 
[51] Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, et al. Structure 
and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with 
implications for cancer. Nat Struct Mol Biol. 2004;11:512-8. 
[52] Chen C, Nott TJ, Jin J, Pawson T. Deciphering arginine methylation: Tudor tells the 
tale. Nat Rev Mol Cell Biol. 2011;12:629-42. 
[53] Cote J, Richard S. Tudor domains bind symmetrical dimethylated arginines. J Biol 
Chem. 2005;280:28476-83. 
[54] Lee J, Thompson JR, Botuyan MV, Mer G. Distinct binding modes specify the 
recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor. Nat Struct Mol 
Biol. 2008;15:109-11. 
[55] Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70. 
[56] Ponder BA. Cancer genetics. Nature. 2001;411:336-41. 
[57] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 
2011;144:646-74. 
[58] Adamson ED. Oncogenes in development. Development. 1987;99:449-71. 
[59] Weinstein IB, Joe AK. Mechanisms of disease: Oncogene addiction--a rationale for 
molecular targeting in cancer therapy. Nat Clin Pract Oncol. 2006;3:448-57. 
[60] Ythier D, Larrieu D, Brambilla C, Brambilla E, Pedeux R. The new tumor 
suppressor genes ING: genomic structure and status in cancer. Int J Cancer. 
2008;123:1483-90. 
[61] Coles AH, Jones SN. The ING gene family in the regulation of cell growth and 
tumorigenesis. J Cell Physiol. 2009;218:45-57. 
[62] Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. 
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common 
hallmark of human cancer. Nat Genet. 2005;37:391-400. 
[63] Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. 
MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to 
DNA double-strand breaks. Cell. 2005;123:1213-26. 
[64] Hirota T, Lipp JJ, Toh BH, Peters JM. Histone H3 serine 10 phosphorylation by 
Aurora B causes HP1 dissociation from heterochromatin. Nature. 2005;438:1176-80. 
[65] Ahn SH, Cheung WL, Hsu JY, Diaz RL, Smith MM, Allis CD. Sterile 20 kinase 
phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in 
S. cerevisiae. Cell. 2005;120:25-36. 
[66] Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone 
deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001;1:194-202. 
[67] Carlson S, Glass KC. The MOZ histone acetyltransferase in epigenetic signaling and 
disease. J Cell Physiol. 2014;229:1571-4. 
[68] Russell M, Berardi P, Gong W, Riabowol K. Grow-ING, Age-ING and Die-ING: 
ING proteins link cancer, senescence and apoptosis. Exp Cell Res. 2006;312:951-61. 
[69] Piche B, Li G. Inhibitor of growth tumor suppressors in cancer progression. Cell 
Mol Life Sci. 2010;67:1987-99. 
[70] Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth 
inhibitor p33ING1 promotes neoplastic transformation. Nat Genet. 1996;14:415-20. 
[71] Gong W, Suzuki K, Russell M, Riabowol K. Function of the ING family of PHD 
proteins in cancer. Int J Biochem Cell Biol. 2005;37:1054-65. 
[72] He GH, Helbing CC, Wagner MJ, Sensen CW, Riabowol K. Phylogenetic analysis 
of the ING family of PHD finger proteins. Mol Biol Evol. 2005;22:104-16. 
 122   References   
[73] Scott M, Boisvert FM, Vieyra D, Johnston RN, Bazett-Jones DP, Riabowol K. UV 
induces nucleolar translocation of ING1 through two distinct nucleolar targeting 
sequences. Nucleic Acids Res. 2001;29:2052-8. 
[74] Tallen G, Riabowol K. Keep-ING balance: tumor suppression by epigenetic 
regulation. FEBS Lett. 2014;588:2728-42. 
[75] Soliman MA, Riabowol K. After a decade of study-ING, a PHD for a versatile 
family of proteins. Trends Biochem Sci. 2007;32:509-19. 
[76] Scott M, Bonnefin P, Vieyra D, Boisvert FM, Young D, Bazett-Jones DP, et al. UV-
induced binding of ING1 to PCNA regulates the induction of apoptosis. J Cell Sci. 
2001;114:3455-62. 
[77] Han X, Feng X, Rattner JB, Smith H, Bose P, Suzuki K, et al. Tethering by lamin A 
stabilizes and targets the ING1 tumour suppressor. Nat Cell Biol. 2008;10:1333-40. 
[78] Peña PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O, et al. Molecular 
mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature. 
2006;442:100-3. 
[79] Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, et al. ING2 PHD 
domain links histone H3 lysine 4 methylation to active gene repression. Nature. 
2006;442:96-9. 
[80] Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Lugovskoy AA, et al. The PHD 
finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide 
receptor. Cell. 2003;114:99-111. 
[81] Kaadige MR, Ayer DE. The polybasic region that follows the plant homeodomain 
zinc finger 1 of Pf1 is necessary and sufficient for specific phosphoinositide binding. J 
Biol Chem. 2006;281:28831-6. 
[82] Feng X, Hara Y, Riabowol K. Different HATS of the ING1 gene family. Trends Cell 
Biol. 2002;12:532-8. 
[83] Unoki M, Kumamoto K, Takenoshita S, Harris CC. Reviewing the current 
classification of inhibitor of growth family proteins. Cancer Sci. 2009;100:1173-9. 
[84] Peña PV, Hom RA, Hung T, Lin H, Kuo AJ, Wong RP, et al. Histone H3K4me3 
binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. 
J Mol Biol. 2008;380:303-12. 
[85] Palacios A, Munoz IG, Pantoja-Uceda D, Marcaida MJ, Torres D, Martin-Garcia 
JM, et al. Molecular basis of histone H3K4me3 recognition by ING4. J Biol Chem. 
2008;283:15956-64. 
[86] Champagne KS, Saksouk N, Pena PV, Johnson K, Ullah M, Yang XJ, et al. The 
crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. 
Proteins. 2008;72:1371-6. 
[87] Marks PA. The clinical development of histone deacetylase inhibitors as targeted 
anticancer drugs. Expert opinion on investigational drugs. 2010;19:1049-66. 
[88] Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine 
acetylation targets protein complexes and co-regulates major cellular functions. Science. 
2009;325:834-40. 
[89] Zhang H, Shang YP, Chen HY, Li J. Histone deacetylases function as novel 
potential therapeutic targets for cancer. Hepatol Res. 2016. 
[90] Parthun MR, Widom J, Gottschling DE. The major cytoplasmic histone 
acetyltransferase in yeast: links to chromatin replication and histone metabolism. Cell. 
1996;87:85-94. 
[91] Wapenaar H, Dekker FJ. Histone acetyltransferases: challenges in targeting bi-
substrate enzymes. Clin Epigenetics. 2016;8:59. 
[92] Doyon Y, Cayrou C, Ullah M, Landry AJ, Cote V, Selleck W, et al. ING tumor 
suppressor proteins are critical regulators of chromatin acetylation required for genome 
expression and perpetuation. Mol Cell. 2006;21:51-64. 
[93] Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P, Reinberg D. Role of the 
Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor 
p33(ING1). Mol Cell Biol. 2002;22:835-48. 
 
  
  References   123  
[94] Lalonde ME, Avvakumov N, Glass KC, Joncas FH, Saksouk N, Holliday M, et al. 
Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail 
specificity. Genes Dev. 2013;27:2009-24. 
[95] Iizuka M, Sarmento OF, Sekiya T, Scrable H, Allis CD, Smith MM. Hbo1 Links 
p53-dependent stress signaling to DNA replication licensing. Mol Cell Biol. 
2008;28:140-53. 
[96] Hung T, Binda O, Champagne KS, Kuo AJ, Johnson K, Chang HY, et al. ING4 
mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate 
cellular transformation. Mol Cell. 2009;33:248-56. 
[97] Avvakumov N, Cote J. The MYST family of histone acetyltransferases and their 
intimate links to cancer. Oncogene. 2007;26:5395-407. 
[98] Contzler R, Regamey A, Favre B, Roger T, Hohl D, Huber M. Histone 
acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration. 
Biochem Biophys Res Commun. 2006;350:208-13. 
[99] Cui S, Gao Y, Zhang K, Chen J, Wang R, Chen L. The Emerging Role of Inhibitor 
of Growth 4 as a Tumor Suppressor in Multiple Human Cancers. Cellular Physiology and 
Biochemistry. 2015;36:409-22. 
[100] Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, 
et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer 
Res. 2003;63:2373-8. 
[101] Palacios A, Garcia P, Padro D, Lopez-Hernandez E, Martin I, Blanco FJ. Solution 
structure and NMR characterization of the binding to methylated histone tails of the plant 
homeodomain finger of the tumour suppressor ING4. FEBS Lett. 2006;580:6903-8. 
[102] Palacios A, Moreno A, Oliveira BL, Rivera T, Prieto J, Garcia P, et al. The dimeric 
structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 
suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin. J Mol 
Biol. 2010;396:1117-27. 
[103] Culurgioni S, Munoz IG, Moreno A, Palacios A, Villate M, Palmero I, et al. The 
crystal structure of the inhibitor of growth 4 (ING4) dimerization domain reveals the 
functional organization of the ING family of chromatin binding proteins. J Biol Chem. 
2012. 
[104] Gunduz M, Nagatsuka H, Demircan K, Gunduz E, Cengiz B, Ouchida M, et al. 
Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 
12p13, in head and neck squamous cell carcinomas. Gene. 2005;356:109-17. 
[105] Li M, Jin Y, Sun WJ, Yu Y, Bai J, Tong DD, et al. Reduced expression and novel 
splice variants of ING4 in human gastric adenocarcinoma. J Pathol. 2009;219:87-95. 
[106] Tapia C, Zlobec I, Schneider S, Kilic E, Guth U, Bubendorf L, et al. Deletion of the 
inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal 
growth factor 2 (HER2)-positive breast cancer. Hum Pathol. 2011;42:983-90. 
[107] Wang QS, Li M, Zhang LY, Jin Y, Tong DD, Yu Y, et al. Down-regulation of 
ING4 is associated with initiation and progression of lung cancer. Histopathology. 
2010;57:271-81. 
[108] Moreno A, Palacios A, Orgaz JL, Jimenez B, Blanco FJ, Palmero I. Functional 
impact of cancer-associated mutations in the tumor suppressor protein ING4. 
Carcinogenesis. 2010;31:1932-8. 
[109] Li XH, Kikuchi K, Zheng Y, Noguchi A, Takahashi H, Nishida T, et al. 
Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and 
progression of head and neck squamous cell carcinoma. Oral Oncol. 2011;47:217-23. 
[110] Raho G, Miranda C, Tamborini E, Pierotti MA, Greco A. Detection of novel 
mRNA splice variants of human ING4 tumor suppressor gene. Oncogene. 2007;26:5247-
57. 
[111] Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. The 
candidate tumour suppressor protein ING4 regulates brain tumour growth and 
angiogenesis. Nature. 2004;428:328-32. 
 124   References   
[112] Ozer A, Wu LC, Bruick RK. The candidate tumor suppressor ING4 represses 
activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A. 
2005;102:7481-6. 
[113] Li J, Martinka M, Li G. Role of ING4 in human melanoma cell migration, invasion 
and patient survival. Carcinogenesis. 2008;29:1373-9. 
[114] Walzak AA, Veldhoen N, Feng X, Riabowol K, Helbing CC. Expression profiles of 
mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene 
family in normal and neoplastic tissues. Exp Cell Res. 2008;314:273-85. 
[115] Linzen U, Lilischkis R, Pandithage R, Schilling B, Ullius A, Luscher-Firzlaff J, et 
al. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of 
p53. PLoS One. 2015;10:e0123736. 
[116] Chen W-T, Yang Y-J, Zhang Z-D, An Q, Li N, Liu W, et al. MiR-1307 promotes 
ovarian cancer cell chemoresistance by targeting the ING5 expression. Journal of Ovarian 
Research. 2017;10:1. 
[117] Cengiz B, Gunduz E, Gunduz M, Beder LB, Tamamura R, Bagci C, et al. Tumor-
specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma. 
Int J Cancer. 2010;127:2088-94. 
[118] Zhao S, Yang XF, Shen DF, Gao Y, Shi S, Wu JC, et al. The down-regulated ING5 
expression in lung cancer: a potential target of gene therapy. Oncotarget. 2016;7:54596-
615. 
[119] Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y. The nuclear to cytoplasmic 
shift of ING5 protein during colorectal carcinogenesis with their distinct links to 
pathologic behaviors of carcinomas. Hum Pathol. 2011;42:424-33. 
[120] Xing YN, Yang X, Xu XY, Zheng Y, Xu HM, Takano Y, et al. The altered 
expression of ING5 protein is involved in gastric carcinogenesis and subsequent 
progression. Hum Pathol. 2011;42:25-35. 
[121] Rodriguez JA. Caracterización estructural del supresor tumoral ING5. Doctoral 
Thesis, Universidad del País Vasco/ Euskal Herriko Unibertsitatea. 2014. 
[122] Levy ED, Pereira-Leal JB, Chothia C, Teichmann SA. 3D complex: a structural 
classification of protein complexes. PLoS Comput Biol. 2006;2:155. 
[123] Goodsell DS, Olson AJ. Structural symmetry and protein function. Annu Rev 
Biophys Biomol Struct. 2000;29:105-53. 
[124] Levy ED, Boeri Erba E, Robinson CV, Teichmann SA. Assembly reflects evolution 
of protein complexes. Nature. 2008;453:1262-5. 
[125] Robert X, Gouet P. Deciphering key features in protein structures with the new 
ENDscript server. Nucleic Acids Research. 2014;42:W320-W4. 
[126] Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature. 
2003;423:145-50. 
[127] Arents G, Moudrianakis EN. Topography of the histone octamer surface: repeating 
structural motifs utilized in the docking of nucleosomal DNA. Proc Natl Acad Sci U S A. 
1993;90:10489-93. 
[128] Pingoud A, Jeltsch A. Structure and function of type II restriction endonucleases. 
Nucleic Acids Res. 2001;29:3705-27. 
[129] Marianayagam NJ, Sunde M, Matthews JM. The power of two: protein 
dimerization in biology. Trends Biochem Sci. 2004;29:618-25. 
[130] Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG. Choose your partners: 
dimerization in eukaryotic transcription factors. Trends Biochem Sci. 2008;33:220-9. 
[131] Renatus M, Stennicke HR, Scott FL, Liddington RC, Salvesen GS. Dimer 
formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci U 
S A. 2001;98:14250-5. 
[132] Jiang G, den Hertog J, Hunter T. Receptor-like protein tyrosine phosphatase alpha 
homodimerizes on the cell surface. Mol Cell Biol. 2000;20:5917-29. 
[133] Hebert TE, Bouvier M. Structural and functional aspects of G protein-coupled 
receptor oligomerization. Biochem Cell Biol. 1998;76:1-11. 
 
  
  References   125  
[134] Culurgioni S. Structural and functional characterization of the dimerization domain 
of tumor suppressor ING4. Madrid: Autónoma de Madrid; 2010. 
[135] Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV, Fersht AR. 
Structural evolution of p53, p63, and p73: Implication for heterotetramer formation. 
Proceedings of the National Academy of Sciences of the United States of America. 
2009;106:17705-10. 
[136] Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web 
server: an online force field. Nucleic Acids Res. 2005;33:W382-8. 
[137] Van Durme J, Delgado J, Stricher F, Serrano L, Schymkowitz J, Rousseau F. A 
graphical interface for the FoldX forcefield. Bioinformatics. 2011;27:1711-2. 
[138] Rogov VV, Rozenknop A, Rogova NY, Lohr F, Tikole S, Jaravine V, et al. A 
universal expression tag for structural and functional studies of proteins. Chembiochem. 
2012;13:959-63. 
[139] Avvakumov N, Lalonde ME, Saksouk N, Paquet E, Glass KC, Landry AJ, et al. 
Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate 
cell proliferation. Mol Cell Biol. 2011;32:689-703. 
[140] Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: 
The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 
2003;31:3784-8. 
[141] Studier FW. Protein production by auto-induction in high density shaking cultures. 
Protein Expr Purif. 2005;41:207-34. 
[142] Tyler RC, Sreenath HK, Singh S, Aceti DJ, Bingman CA, Markley JL, et al. Auto-
induction medium for the production of [U-15N]- and [U-13C, U-15N]-labeled proteins 
for NMR screening and structure determination. Protein Expr Purif. 2005;40:268-78. 
[143] Marley J, Lu M, Bracken C. A method for efficient isotopic labeling of 
recombinant proteins. J Biomol NMR. 2001;20:71-5. 
[144] Greenfield NJ. Using circular dichroism spectra to estimate protein secondary 
structure. Nat Protoc. 2006;1:2876-90. 
[145] Greenfield N, Fasman GD. Computed circular dichroism spectra for the evaluation 
of protein conformation. Biochemistry. 1969;8:4108-16. 
[146] Marky LA, Breslauer KJ. Calculating thermodynamic data for transitions of any 
molecularity from equilibrium melting curves. Biopolymers. 1987;26:1601-20. 
[147] Thomas F, Boyle AL, Burton AJ, Woolfson DN. A Set of de Novo Designed 
Parallel Heterodimeric Coiled Coils with Quantified Dissociation Constants in the 
Micromolar to Sub-nanomolar Regime. Journal of the American Chemical Society. 
2013;135:5161-6. 
[148] Wyatt PJ. Light scattering and the absolute characterization of macromolecules. 
Analytica Chimica Acta. 1993;272:1-40. 
[149] Folta-Stogniew E, Williams KR. Determination of molecular masses of proteins in 
solution: Implementation of an HPLC size exclusion chromatography and laser light 
scattering service in a core laboratory. J Biomol Tech. 1999;10:51-63. 
[150] Weber PC. [2] Overview of protein crystallization methods. Methods Enzymol. 
1997;276:13-22. 
[151] Putnam CD, Hammel M, Hura GL, Tainer JA. X-ray solution scattering (SAXS) 
combined with crystallography and computation: defining accurate macromolecular 
structures, conformations and assemblies in solution. Quarterly Reviews of Biophysics. 
2007;40:191-285. 
[152] Powell HR. The Rossmann Fourier autoindexing algorithm in MOSFLM. Acta 
Crystallogr D Biol Crystallogr. 1999;55:1690-5. 
[153] Evans P. Scaling  and  assessment  of  data  quality. Acta  Crystallogr  D  Biol 
2006;62:10. 
[154] Vagin A, Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr D 
Biol Crystallogr. 2010;66:22-5. 
[155] Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta 
Crystallogr D Biol Crystallogr. 2004;60:2126-32. 
 126   References   
[156] Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, et 
al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr 
D Biol Crystallogr. 2011;67:355-67. 
[157] Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of 
polypeptide chain configurations. J Mol Biol. 1963;7:95-9. 
[158] Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, et 
al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta 
Crystallogr D Biol Crystallogr. 2010;66:12-21. 
[159] Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline 
state. J Mol Biol. 2007;372:774-97. 
[160] Alva V, Syamala Devi DP, Sowdhamini R. COILCHECK: an interactive server for 
the analysis of interface regions in coiled coils. Protein Pept Lett. 2008;15:33-8. 
[161] Walshaw J, Woolfson DN. Socket: a program for identifying and analysing coiled-
coil motifs within protein structures. J Mol Biol. 2001;307:1427-50. 
[162] Schrödinger. The PyMOL Molecular Graphics System, Version 1.5.0.4 
Schrödinger, LLC. In: 1.5.0.4, editor. 1504 1.5.0.4 ed2010. 
[163] Mertens HDT, Svergun DI. Structural characterization of proteins and complexes 
using small-angle X-ray solution scattering. Journal of Structural Biology. 2010;172:128-
41. 
[164] Pernot P, Round A, Barrett R, De Maria Antolinos A, Gobbo A, Gordon E, et al. 
Upgraded ESRF BM29 beamline for SAXS on macromolecules in solution. J 
Synchrotron Radiat. 2013;20:660-4. 
[165] Petoukhov MV, Konarev PV, Kikhney AG, Svergun DI. ATSAS 2.1 - towards 
automated and web-supported small-angle scattering data analysis. Journal of Applied 
Crystallography. 2007;40:s223-s8. 
[166] Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI. PRIMUS: a 
Windows PC-based system for small-angle scattering data analysis. Journal of Applied 
Crystallography. 2003;36:1277–82. 
[167] Svergun DI. Determination of the regularization parameter in indirect-transform 
methods using perceptual criteria. Journal of applied crystallography. 1992;25:495-503. 
[168] Svergun DI, Petoukhov MV, Koch MH. Determination of domain structure of 
proteins from X-ray solution scattering. Biophys J. 2001;80:2946-53. 
[169] Volkov VV, Svergun DI. Uniqueness of ab-initio shape determination in small-
angle scattering. J Appl Cryst. 2003;36:860-4. 
[170] Svergun DI, Barberato C, Koch MHJ. CRYSOL a Program to Evaluate X-ray 
Solution Scattering of Biological Macromolecules from Atomic Coordinates. J Appl 
Cryst. 1995;28:768-73. 
[171] Kozin MB, Svergun DI. Automated matching of high- and low-resolution structural 
models. Journal of Applied Crystallography. 2001;34:33-41. 
[172] Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. 
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput 
Chem. 2004;25:1605-12. 
[173] Sørensen OW. James Keeler. Understanding NMR Spectroscopy. Magnetic 
Resonance in Chemistry. 2006;44:820-. 
[174] Claridge TDW. High-resolution NMR Techniques in Organic Chemistry. 1999. 
[175] Harris RK, Becker ED, Cabral De Menezes SM, Granger P, Hoffman RE, Zilm 
KW, et al. Further conventions for NMR shielding and chemical shifts IUPAC 
recommendations 2008. Solid State Nucl Magn Reson. 2008;33:41-56. 
[176] Bodenhausen G, Ruben DJ. Natural abundance nitrogen-15 NMR by enhanced 
heteronuclear spectroscopy. Chemical Physics Letters. 1980;69:185-9. 
[177] Shen Y, Delaglio F, Cornilescu G, Bax A. TALOS+: a hybrid method for 
predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR. 
2009;44:213-23. 
[178] Berjanskii MV, Wishart DS. A simple method to predict protein flexibility using 
secondary chemical shifts. J Am Chem Soc. 2005;127:14970-1. 
 
  
  References   127  
[179] Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, et al. 1H, 13C 
and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995;6:135-
40. 
[180] Kazimierczuk K, Orekhov V. Non-uniform sampling: post-Fourier era of NMR 
data collection and processing. Magnetic Resonance in Chemistry. 2015;53:921-6. 
[181] Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, et al. 
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain 
studied by 15N NMR relaxation. Biochemistry. 1994;33:5984-6003. 
[182] Renner C, Schleicher M, Moroder L, Holak TA. Practical aspects of the 2D 15N-
[1h]-NOE experiment. J Biomol NMR. 2002;23:23-33. 
[183] Jung YS, Zweckstetter M. Mars -- robust automatic backbone assignment of 
proteins. J Biomol NMR. 2004;30:11-23. 
[184] Kazimierczuk K, Orekhov VY. Accelerated NMR spectroscopy by using 
compressed sensing. Angew Chem Int Ed Engl. 2011;50:5556-9. 
[185] Goddar TK, DG. Sparky-NMR assignment and 
integration software. 2008. 
[186] Bolin KA, Hanson P, Wright SJ, Millhauser GL. An NMR investigation of the 
conformational effect of nitroxide spin labels on Ala-rich helical peptides. J Magn Reson. 
1998;131:248-53. 
[187] Bomar MG, Pai MT, Tzeng SR, Li SS, Zhou P. Structure of the ubiquitin-binding 
zinc finger domain of human DNA Y-polymerase eta. EMBO Rep. 2007;8:247-51. 
[188] Berliner LJ, Grunwald J, Hankovszky HO, Hideg K. A novel reversible thiol-
specific spin label: papain active site labeling and inhibition. Anal Biochem. 
1982;119:450-5. 
[189] Lorenzi M, Sylvi L, Gerbaud G, Mileo E, Halgand F, Walburger A, et al. 
Conformational selection underlies recognition of a molybdoenzyme by its dedicated 
chaperone. PLoS One. 2012;7:e49523. 
[190] Bengoa-Vergniory N, Gorroño-Etxebarria I, González-Salazar I, Kypta RM. A 
Switch From Canonical to Noncanonical Wnt Signaling Mediates Early Differentiation of 
Human Neural Stem Cells. STEM CELLS. 2014;32:3196-208. 
[191] Pagano JM, Clingman CC, Ryder SP. Quantitative approaches to monitor protein-
nucleic acid interactions using fluorescent probes. RNA. 2011;17:14-20. 
[192] Uversky VN. Size-exclusion chromatography in structural analysis of intrinsically 
disordered proteins. Methods Mol Biol. 2012;896:179-94. 
[193] Ormaza G, Medagli B, Ibáñez de Opakua A, Rodríguez JA, Merino N, Villate M, 
et al. The tumor suppressor inhibitor of growth 4 binds double-stranded DNA through its 
disordered central region. FEBS Letters. 2017;591:425-32. 
[194] De Biasio A, de Opakua AI, Mortuza GB, Molina R, Cordeiro TN, Castillo F, et al. 
Structure of p15PAF–PCNA complex and implications for clamp sliding during DNA 
replication and repair. Nature Communications. 2015;6:6439. 
[195] Dutta K, Alexandrov A, Huang H, Pascal SM. pH-induced folding of an apoptotic 
coiled coil. Protein Sci. 2001;10:2531-40. 
[196] Doig AJ. Recent advances in helix–coil theory. Biophysical Chemistry. 2002;101–
102:281-93. 
[197] Hagelueken G, Ward R, Naismith JH, Schiemann O. MtsslWizard: In Silico Spin-
Labeling and Generation of Distance Distributions in PyMOL. Applied Magnetic 
Resonance. 2012;42:377-91. 
[198] Zhang W-H, Poh A, Fanous AA, Eastman A. DNA damage-induced S phase arrest 
in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, 
Chk2 or MAPKAPK2. Cell Cycle. 2008;7:1668-77. 
[199] Schalch T, Duda S, Sargent DF, Richmond TJ. X-ray structure of a 
tetranucleosome and its implications for the chromatin fibre. Nature. 2005;436:138-41. 
[200] Vuzman D, Levy Y. Intrinsically disordered regions as affinity tuners in protein-
DNA interactions. Mol Biosyst. 2012;8:47-57. 
 128   References   
[201] Weinberg RL, Veprintsev DB, Bycroft M, Fersht AR. Comparative binding of p53 
to its promoter and DNA recognition elements. J Mol Biol. 2005;348:589-96. 
[202] Jung KC, Rhee HS, Park CH, Yang CH. Determination of the dissociation 
constants for recombinant c-Myc, Max, and DNA complexes: the inhibitory effect of 
linoleic acid on the DNA-binding step. Biochem Biophys Res Commun. 2005;334:269-
75. 
[203] Ruthenburg AJ, Li H, Patel DJ, Allis CD. Multivalent engagement of chromatin 
modifications by linked binding modules. Nat Rev Mol Cell Biol. 2007;8:983-94. 
[204] Tallen G, Riabowol K. DisorderING promotes epigenetic order. FEBS Lett. 
2017;591:257-9. 
[205] Culurgioni S, Munoz IG, Moreno A, Palacios A, Villate M, Palmero I, et al. Crystal 
structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional 
organization of ING family of chromatin-binding proteins. J Biol Chem. 
2012;287:10876-84. 
[206] Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic 
instability of cancer cells. Cell.71:543-6. 
[207] Weinert T. DNA Damage and Checkpoint Pathways: Molecular Anatomy and 
Interactions with Repair. Cell. 1998;94:555-8. 
[208] Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. 
Nat Rev Genet. 2012;13:189-203. 
[209] Zhang F, Baumer N, Rode M, Ji P, Zhang T, Berdel WE, et al. The inhibitor of 
growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects. 
PLoS One. 2011;6:10. 
 
 
 
 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
APPENDIX 
   
 
 
 
  
131   Appendix 
APPENDIX I 
 
 
 
Figure I.1. Analysis of ING5 homodimerization inside cells by co-immunoprecipitation. Lysates from 
cells transiently transfected with vectors expressing AU5-ING4 (left lanes) or both AU5-ING4 and HA-
ING5 (right lanes) were immunoprecipitated (IP) with αAU5 or αHA, antibodies against the AU5 tag and 
HA tag, respectively. The presence of each protein in the immunocomplexes was analyzed by Western 
blotting (WB) with antibodies against the HA (αHA, upper panels) or AU5 (αAU5, lower panels) tag. 
Panels A and B are reproducible experiments from the one showed in results, figure 30. 
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Figure I.2. Analysis of ING4/ING5 heterodimerization in cells by co-immunoprecipitation. Lysates 
from cells transiently transfected with vectors expressing HA-ING5 and AU5-ING4 (left lanes) or HA-
ING4 and AU5-ING5 and (right lanes) were immunoprecipitated (IP) with αHA or αAU5, antibodies 
against the HA tag and AU5 tag, respectively. The presence of each protein in the immunocomplexes was 
analyzed by Western blotting (WB) with antibodies against HA (αHA, upper panels) or against AU5 
(αAU5, lower panels) tag 
 
.   
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APPENDIX II 
 
Table I.1. Chemical shifts of the assigned nuclei of ING5 Nt1‐105 backbone and 
13Cβ. 
Residue nº AA 13Cα 13Cβ 13CO 1Hα 1HN 15N 
-1 GLY - - - - - - 
0 ALA 68.748 - 177.87 4.266 - - 
1 MET 55.593 33.014 176.227 4.367 8.507 119.722 
2 ALA 52.966 19.366 177.989 4.264 8.406 125.385 
3 THR 62.217 69.668 174.464 4.164 8.028 112.689 
4 ALA 52.871 19.101 177.529 4.189 8.211 125.382 
5 MET 55.989 - 177.802 - 8.27 118.826 
6 TYR 57.972 - - - 7.914 117.725 
7 LEU - - - - - - 
8 GLU - - - - - - 
9 HIS - - - - - - 
10 TYR - - 177.411 - - - 
11 LEU 56.937 - 177.86 - 8.001 119.75 
12 ASP 55.879 - - - 7.858 117.756 
13 SER - - - - - - 
14 ILE - - - - - - 
15 GLU - - - - - - 
16 ASN 53.252 - 174.793 - - - 
17 LEU 53.216 - - - 7.954 121.754 
18 PRO - - - - - - 
19 CYS - - 176.787 - - - 
20 GLU 59.843 - 178.323 - 9.645 120.197 
21 LEU 57.36 - 177.965 - 7.094 118.221 
22 GLN 60.049 - 178.866 - 7.91 118.465 
23 ARG 58.895 - 178.34 4.025 8.148 118.421 
24 ASN 56.255 - - 4.241 7.572 120.293 
25 PHE 59.039 - 178.845 - 8.185 118.6 
26 GLN 59.105 - 178.788 - 8.016 120.151 
27 LEU 57.768 - 180.021 - 8.464 121.17 
28 MET 60.998 - 177.413 - 8.412 119.197 
29 ARG 59.547 - 179.777 - 7.586 118.477 
30 GLU 59.545 - 179.364 3.984 8.185 121.318 
31 LEU 58.325 - 180.42 - 8.376 121.087 
32 ASP 57.973 - 178.589 4.388 8.262 122.728 
33 GLN 58.89 - 178.133 3.918 8.007 121.535 
34 ARG 59.471 - 180.058 3.972 8.39 118.866 
35 THR 67.933 - 175.863 - 8.194 117.191 
36 GLU 59.625 - 179.949 3.938 8.227 122.615 
37 ASP 57.382 40.092 179.269 4.408 8.649 120.809 
38 LYS 56.569 - 178.248 - 8.079 121.852 
39 LYS 60.519 - 178.751 - 8.635 120.54 
40 ALA 55.038 - 180.412 4.185 7.89 121.327 
41 GLU 59.454 - 179.027 - 7.732 119.85 
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42 ILE 66.504 - 176.75 - 8.347 120.289 
43 ASP 57.981 - 179.51 4.432 7.823 118.769 
44 ILE 64.825 - 0 - 7.546 121.102 
45 LEU 57.768 - 180.839 4.052 8.449 121.105 
46 ALA 55.685 - 179.027 3.871 9.487 123.241 
47 ALA 55.351 - 180.843 - 7.732 119.85 
48 GLU 59.687 - 178.866 3.813 8.134 119.326 
49 TYR 61.832 - 176.417 - 8.345 121.59 
50 ILE 63.793 - 177.418 - 8.581 117.49 
51 SER 60.955 63.974 176.083 4.176 7.819 111.06 
52 THR 69.86 - 176.927 - 7.519 109.157 
53 VAL 65.864 - 175.743 - 7.793 123.365 
54 LYS 59.21 - 177.504 - 8.427 119.116 
55 THR 61.534 69.86 174.793 4.382 8.1 107.341 
56 LEU 54.216 - 177.292 4.484 7.25 122.416 
57 SER 56.808 - - - 8.915 119.545 
58 PRO 66.877 - 178.843 - - - 
59 ASP 57.053 40.072 179.252 4.334 8.442 114.703 
60 GLN 58.402 - 179.226 4.127 7.709 120.311 
61 ARG 61.165 - 178.198 - 8.567 120.481 
62 VAL 66.664 32.028 178.38 3.581 7.717 118.139 
63 GLU 59.67 - 179.488 3.98 7.642 119.926 
64 ARG 58.51 - 179.385 3.958 8.108 117.608 
65 LEU 58.013 - 179.104 - 8.18 120.193 
66 GLN 58.847 28.005 178.694 3.964 8.308 118.996 
67 LYS 59.899 - 180.296 3.963 7.751 119.23 
68 ILE 66.492 - 177.176 - 7.769 121.821 
69 GLN 60.13 - 179.164 3.756 8.62 120.358 
70 ASN 55.89 38.154 177.689 4.369 8.751 117.845 
71 ALA 55.517 - 180.38 4.22 7.864 124.304 
72 TYR 63.695 - 179.758 - 8.537 119.139 
73 SER 62.44 - 177.113 - 8.645 116.626 
74 LYS 57.082 - 176.917 - 7.964 122.977 
75 CYS 64.365 - 177.218 - 8.014 116.998 
76 LYS 59.524 - 177.511 4.055 8.013 120.684 
77 GLU 59.634 - 179.203 3.992 7.673 120.867 
78 TYR 58.093 - 179.008 - 8.092 117.044 
79 SER 61.867 - 177.089 - 8.273 114.606 
80 ASP 57.565 - 179.585 - 8.872 123.905 
81 ASP 57.385 40.086 179.131 4.372 8.504 122.184 
82 LYS 60.063 - 177.878 - 8.479 121.999 
83 VAL 67.112 - 177.404 - 8.067 119.004 
84 GLN 59.03 - 178.914 - 7.634 117.879 
85 LEU 57.409 - 180.235 3.982 8.004 120.104 
86 ALA 56.015 - 178.744 - 9 126.405 
87 MET 57.699 - 179.965 - 8.143 114.696 
88 GLN 58.778 - 178.946 - 7.852 117.983 
89 THR 67.893 - 176.42 4.103 8.313 118.261 
90 TYR 63.138 - 178.755 - 8.582 120.377 
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91 GLU 59.998 - 178.693 - 7.802 119.391 
92 MET 59.177 - 179.456 - 8.08 118.983 
93 VAL 67.416 - 176.755 - 8.535 121.346 
94 ASP 58.088 - 177.46 - 7.836 119.474 
95 LYS 59.465 - 178.718 - 7.925 116.337 
96 HIS 59.477 - 177.197 - 8.134 118.782 
97 ILE 63.025 - 177.841 - 8.283 119.072 
98 ARG 58.135 - 177.751 - 8.088 119.73 
99 ARG 57.685 - 177.413 4.12 7.787 120.024 
100 LEU 56.102 41.932 178.112 4.141 8.007 121.136 
101 ASP 55.018 41.007 176.579 4.47 8.063 119.736 
102 ALA 53.052 19.387 177.693 4.197 7.947 122.92 
103 ASP 54.744 40.985 176.235 4.525 8.223 118.623 
104 LEU 55.03 42.413 176.183 4.286 7.935 121.891 
105 ALA 53.933 20.32 182.549 4.034 7.782 109.146 
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Table I.2. Chemical shifts of the assigned nuclei of the PHD finger of ING5 backbone 
and 
13Cβ. 
Residue nº AA 13Cα 13Cβ 13CO 1Hα 1HN 15N 
175 GLY - - - - - - 
176 ALA - - - - - - 
177 MET 55.461 - 175.898 4.479 - - 
178 ASP 54.425 41.072 175.676 4.582 8.164 120.95 
179 MET 53.236 32.584 174.025 4.787 8.116 121.397 
180 PRO 63.004 32.096 176.733 4.462 - - 
181 VAL 62.058 33.169 175.751 4.056 8.225 120.73 
182 ASP 51.765 41.703 - 4.909 8.546 126.265 
183 PRO 63.667 - 176.865 - - - 
184 ASN 53.26 39.131 174.964 4.695 8.572 117.39 
185 GLU 54.469 30.187 174.042 4.557 7.836 122.642 
186 PRO 63.045 32.173 175.326 4.306 - - 
187 THR 59.659 71.323 173.015 4.13 7.55 109.179 
188 TYR 57.158 43.624 174.218 - 8.282 118.424 
189 CYS 59.431 30.335 175.158 3.676 7.136 115.547 
190 LEU 56.834 42.666 177.924 4.342 9.965 126.242 
191 CYS 57.902 31.184 175.89 4.624 7.619 114.276 
192 HIS 56.986 26.901 173.962 4.372 7.652 119.967 
193 GLN 54.253 33.077 176.218 5.073 8.1 117.113 
194 VAL 61.597 33.171 176.139 4.563 8.19 113.529 
195 SER 59.523 63.352 174.12 4.065 8.888 115.365 
196 TYR 57.993 - 174.701 4.634 7.412 120.159 
197 GLY 45.725 - 173.265 - 8.673 109.028 
198 GLU 56.651 28.413 176.086 - 8.281 122.302 
199 MET 53.063 34.577 175.17 5.505 8.322 124.114 
200 ILE 58.434 42.532 172.088 4.763 9.69 121.9 
201 GLY 43.302 - 172.927 - 8.352 116.26 
202 CYS 60.381 32.337 176.956 4.552 8.446 126.286 
203 ASP 56.736 40.921 176.611 4.681 8.986 127.028 
204 ASN 50.992 38.702 175.066 5.185 8.899 123.368 
205 PRO 64.433 32.062 176.774 4.416 - - 
206 ASP 53.367 41.176 175.02 4.79 7.243 115.259 
207 CYS 59.335 31.289 176.321 4.052 7.705 126.633 
208 PRO 63.908 - 176.737 4.593 - - 
209 ILE 63.162 40.333 177.636 4.145 8.575 124.099 
210 GLU 63.147 30.148 176.022 3.743 9.56 120.291 
211 TRP 56.122 33.373 174.836 5.362 7.943 120.478 
212 PHE 56.205 42.825 176.143 - 9.201 117.238 
213 HIS 57.928 30.829 178.16 5 9.41 122.788 
214 PHE 60.869 37.854 178.544 3.951 8.44 124.375 
215 ALA 55.186 18.445 181.063 4.358 9.006 116.148 
216 CYS 62.323 30.645 176.654 4.282 7.437 116.982 
217 VAL 60.01 31.235 173.818 4.664 7.38 108.156 
218 ASP 55.739 39.427 174.773 4.308 7.656 115.955 
219 LEU 53.782 44.581 177.299 4.671 7.886 117.711 
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220 THR 62.259 70.09 174.446 - - - 
221 THR 60.158 71.043 172.573 4.55 7.465 114.943 
222 LYS 55.275 33.055 174.628 4.016 8.662 126.102 
223 PRO 62.9 - 176.289 - - - 
224 LYS 56.606 32.775 177.345 4.314 8.538 121.442 
225 GLY 44.377 - 173.245 - 8.092 110.382 
226 LYS 56.277 33.809 176.443 4.294 8.197 120.499 
227 TRP 59.038 31.284 172.123 4.344 9.677 126.516 
228 PHE 54.096 41.904 173.333 5.071 6.91 123.785 
229 CYS 57.139 30.894 172.974 3.536 8.769 125.978 
230 PRO 65.514 32.238 179.319 4.108 - - 
231 ARG 58.23 29.805 178.687 4.22 8.105 117.618 
232 CYS 64.538 29.361 178.449 3.957 8.868 126.114 
233 VAL 65.814 31.683 177.547 3.425 8.554 120.146 
234 GLN 57.872 28.609 177.845 4.008 7.486 118.661 
235 GLU 57.999 29.938 177.801 4.044 7.905 119.339 
236 LYS 57.231 32.185 177.418 4.086 7.814 119.051 
237 ARG 56.786 30.67 176.523 - 7.742 119.339 
238 LYS 56.734 - 176.449 - 7.847 120.995 
239 LYS 56.438 33.052 175.588 4.295 8.115 122.89 
240 LYS 57.882 33.679 181.364 4.128 7.939 128.219 
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APPENDIX III 
Table II.1. Calculated dissociation constants (KD) for ING5 binding H3K4me3 peptide. 
The maximum chemical shift perturbation for 
1
H y 
15
N (CSPmax, is a fitted value as the 
KD) is indicated together with the fitting error. 
residue KD CSPmax KD error 
182 7.65101 0.14011 1.49454 
188 10.45822 0.12878 3.70238 
194 5.22382 0.14579 1.87883 
209 2.73544 0.11502 0.81456 
210 10.77235 0.16492 2.37274 
213 7.23825 0.15378 3.39289 
215 6.39435 1.01951 0.10985 
227 7.55817 2.35624 0.18192 
 
Table II.2. Calculated dissociation constants (KD) for PHD binding H3K4me3 peptide. 
The maximum chemical shift perturbation for 
1
H y 
15
N (CSPmax, is a fitted value as the 
KD) is indicated together with the fitting error. 
residue KD CSPmax KD error 
182 15.1875 0.12712 3.14088 
188 15.8785 0.15373 1.72860 
189 20.1679 0.15004 3.06208 
194 19.4489 0.16597 2.28157 
195 16.7430 0.12412 2.87740 
209 14.5452 0.13729 3.24088 
210 16.3068 0.15064 2.80955 
211 22.2633 0.19292 3.42671 
213 19.5692 0.16511 5.51463 
227 18.6875 0.17360 2.64424 
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The tumor suppressor inhibitor of growth 4 (ING4) regulates chromatin structure 
by recruiting the histone acetyl transferase complex HBO1 to sites with histone 
H3 trimethylated at K4. ING4 dimerizes through its N-terminal domain and 
recognizes H3K4me3 by the C-terminal plant homeodomain (PHD). The central 
region of ING4 is disordered and contains the nuclear localization signal. Here, 
utilizing electrophoresis and nuclear magnetic resonance, we show that ING4 
binds double-stranded DNA through its central region with micromolar affinity. 
Our findings suggest that the cooperativity arising from the presence of two 
DNA-binding regions in the ING4 dimer, as well as two H3K4me3-binding PHD 
fingers, may strengthen nucleosome binding and HBO1 complex recruitment. 
 
 
Keywords: chromatin remodeling; DNA binding; electrophoretic mobility shift 
assay; inhibitor of growth 4; nuclear magnetic resonance; tumor suppressor 
 
 
 
 
 
In eukaryotic organisms, the DNA is packed into 
chromatin, a highly regulated and dynamic structure, with 
the nucleosome as its fundamental unit. In the nucleosome, 
super helical turns of DNA wrap a core histone octamer. 
The structural organization of chromatin is also modulated 
by nonhistone proteins, and has a functional impact in 
DNA replication, repair, and transcription [1]. The main 
chromatin remodeling process is driven by covalent core 
histone modifications on their N-terminal tails, which can 
be recognized and modified by specific protein domains 
with different functions [2]. These modifications regulate 
the accessibility of the DNA and affect the structure of 
chromatin in a direct way or, indirectly, by recruiting 
chromatin remodeling complexes. Inhibitor of growth 
 
 
 
 
 
4 (ING4) belongs to the ING family of tumor suppressors, 
composed of five homologous proteins [3], and is involved 
in the regulation of the transcriptional state of the 
chromatin by recruiting the histone acetyl transferase 
(HAT) complex HBO1 to sites with the H3K4me3 mark 
[4]. This modification is recognized by its conserved C-
terminal plant homeodomain (PHD) with micromolar 
affinity [5–7]. The N-terminal region of ING4 is folded 
into a coiled-coil domain, forming an antiparallel dimer in 
solution and in living cells [8,9]. Therefore, ING4 can be 
described as an elongated dimer with two PHD fingers 
pointing to opposite directions and tethered by a disordered 
central region approximately 85 residues long (Fig. 1A). 
As this central region is rich in basic amino acids and 
 
Abbreviations  
CD, circular dichroism; CSP, chemical shift perturbation; DSS, 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt; DTT, dithiothreitol; EMSA, 
electrophoretic mobility shift assay; HAT, histone acetyl transferase; HSQC, heteronuclear single quantum coherence; ING, inhibitor of growth; 
NLS, nuclear localization signal; NMR, nuclear magnetic resonance; PHD, plant homeodomain; SEC-MALS, size exclusion chromatography–
multiangle light scattering; UV, ultraviolet; WT, wild-type. 
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Fig. 1. (A) Schematic representation of the domain structure of human ING4 dimer: in green, the N-terminal coiled-coil domain responsible for 
the antiparallel dimerization; in blue, the PHD domain responsible for binding to the histone H3 tail; and in magenta, the connecting region 
containing the NLS. Below the scheme are the crystal structures of a dimer of the N-terminal domain [9] (PDB ID: 4AFL) and the PHD finger 
[7] (PDB ID: 2VNF). The NLS region was randomly built to connect the two domains and the positions of lysine and arginine residues are 
indicated by red spheres. One of the two ING4 protomers is represented with paler colors than the other one. (B) Sequence alignment of the 
NLS regions of the ING proteins. The alignment was done with CLUSTAL W using the longest isoforms of the proteins (except ING1, for 
which p33ING1b isoform was used). The sequences shown correspond to the limits of ING4 NLS region as defined in A (starting at residue 
106). The asterisk in the sequence of ING3 indicates that a long insertion (residues 112–266) is omitted for the sake of clarity. 
 
 
contains the nuclear localization signal (NLS), it is 
commonly named the NLS region. We found that human 
ING4 produced in bacterial cells copurifies with DNA, 
pointing to a stable interaction with DNA. Here, we show 
that ING4 preferentially binds double-stranded DNA with 
micromolar affinity, and that the central NLS region is 
responsible for this binding. These results suggest that 
although ING4 binds the nucleosome specifically at the 
H3K4me3 sites, this binding is strengthened by the affinity 
of the positively charged NLS region for the DNA 
backbone. We believe that this multipronged interaction of 
ING4 with the nucleosome is relevant because the 
increased avidity of ING4 for the DNA will favor the 
 
 
recognition and recruitment of the HAT HBO1 com-plex 
to chromatin sites enriched in the H3K4me3 mark. 
 
 
Materials and methods 
 
Cloning 
 
The synthetic gene of the full-length untagged human ING4 
(residues 1–249; Uniprot Q9UNL4, isoform 1) cloned into vector 
pET11d has been previously described [8]. The N-terminal 
construct (Nt) used in this study consists of ING4 residues 1–108 
with a Strep-tag (WSHPQFE), inserted after the initial methionine 
by PCR. 
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A clone of full-length ING4 with the same Strep-tag inserted after 
the initial methionine was produced in the same way. The 
construct for the C-terminal PHD finger of ING4 (residues 188–
249 with an extra methionine at the N-terminus), was previously 
described [6]. The synthetic gene of the ING4 central region 
deletion mutant (named ING4DNLS and lacking residues 106–
187) was purchased from Eurofins Genomics (Ebersberg, 
Germany), and it was modified with the insertion of a His-tag and 
a TEV pro-tease site at the N-terminus. All constructs have been 
codon-optimized for expression in Escherichia coli. 
 
 
Protein expression and purification 
 
The proteins were produced in E. coli BL21 (DE3) cells grown in 
autoinduction medium [10]. Uniformly, 
15
N-enriched ING4 
protein was produced in a modified autoinduction medium [11] 
and in minimal media as described [12]. Cultures were harvested 
by centrifugation and resuspended in lysis buffer [20 mM Tris pH 
8.0, 1 mM dithiothreitol (DTT)], with the addition of 150 and 300 
mM NaCl in the case of Nt and ING4∆NLS, respectively, and in 
the presence of protease inhibitors (one tablet complete EDTA-
free per 50 mL). After sonication and ultracentrifugation, proteins 
were predominantly found in the insoluble (ING4, PHD, and 
ING4DNLS) or in the soluble (Nt) fraction. Insoluble proteins 
were solubilized in lysis buffer with 8 M urea and separated by 
ultracentrifugation at 4 °C and 142 000 g for 3 h. Supernatant was 
refolded by a 1 : 10–1 : 100 dilution into cold 20 mM Tris pH 8.0, 
1 mM DTT, and 50 μM ZnCl2 (needed for PHD finger folding). 
 
 
Refolded ING4 was loaded onto a HiLoad 26/10 Q Sepharose 
anion exchange column equilibrated in 20 mM Tris pH 8.0, 1 mM 
DTT, and elution was carried out with a 0–0.5 M NaCl gradient in 
4.7 column volumes. Eluted fractions were diluted three times in 
20 mM Tris pH 8.0, 1 mM DTT, and loaded onto a Hi-Trap SP 
FF column equilibrated in 20 mM Tris pH 8.0, 50 mM NaCl, and 
1 mM DTT for cation exchange chromatography. Elution was 
done with a 0.05–1 M NaCl gradient in 20 CV. Selected fractions 
were concentrated and separated by gel filtration in a Superdex 75 
26/60 column equilibrated in 20 mM Tris pH 8.0, 300 mM NaCl, 
and 1 mM DTT. The degree of purity of this sample is higher than 
90% as illustrated in Fig. S1. Soluble Strep-ING4 was purified on 
a Streptactin 5 mL column (IBA-Lifesciences, Goettingen, 
Germany) equilibrated in 100 mM Tris-HCl, pH 8.0, 150, or 300 
mM NaCl, and eluted with 2.5 mM desthiobiotin. Selected 
fractions were concentrated and loaded onto Superdex 75 16/60 
equilibrated with 20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 1 
mM DTT. Soluble Strep-ING4 Nt was purified on a Streptactin 5 
mL column in the same way as the full-length protein. Refolded 
PHD was purified as previously described [6]. Refolded His-
ING4∆NLS was loaded into a 
 
 
His-Trap FF crude 5 mL column equilibrated in 20 mM Tris, pH 
8, 300 mM NaCl, 1 mM DTT, and washed with 50 mM imidazol. 
Elution was done with a 50–300 mM gradient in 20 CV. Selected 
fractions were diluted 1 : 2 in 20 mM Tris, pH 8.0, and 1 mM 
DTT, and loaded onto a HiTrap Q HP 5 mL column equilibrated 
with 20 mM Tris, pH 8, 30 mM NaCl, and 1 mM DTT. Protein 
was eluted with a 0.05–1 M NaCl gradient in 50 CV. Selected 
fractions were concentrated and loaded on a Superdex 200 26/60 
column equilibrated in 20 mM Tris, pH 8, 300 mM NaCl, and 1 
mM DTT. Pure proteins were concentrated by ultrafiltration, 
flash-frozen in liquid N2, and stored at 80 °C until used. The 
identity and purity of each protein was confirmed by MALDI-
TOF and SDS/PAGE. Protein concentration was measured by UV 
absorbance using extinction coefficients calculated using the 
Expasy Protparam tool [13]. 
 
 
 
Fluorescence electrophoretic mobility shift assay 
(EMSA) 
 
Oligonucleotides (Table S1) were designed to generate sin-gle-
strand (ss), double-strand (ds), or primed (p) DNA ligands labeled 
with [6-Carboxyfluorescein (6-FAM)] at the 5´ end. To avoid any 
quenching effect, the dsDNA has two extra bases at the 5´ end. 
Oligonucleotides were chemically synthesized and HPLC-purified 
by Thermo Fisher Scientific (Waltham, MA, USA) or Sigma-
Aldrich (Saint Louis, MO, USA), and were solubilized in Tris-
EDTA buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) to a 
concentration of 100 μM. For the preparation of the different 
dsDNA, ligands labeled : unlabeled oligonucleotides (in a 1 : 1.2 
molar ratio) were mixed and diluted in annealing buffer (50 mM 
potassium acetate, 20 mM Tris-acetate, 10 mM magnesium 
acetate, 1 mM DTT, pH 7.9) to the desired final concentration. 
Annealing was performed by incubation in boiling water for 5 min 
followed by slow cooling to room temperature. EMSA 
experiments were performed by incubating increasing 
concentrations of ING4 or the different domains of ING4 with 
fluorescent DNA ligands at a final concentration of 0.1 μM in a 15 
μL reaction mixture containing 20 mM Tris-HCl pH 8.0, 5 mM 
MgCl2, 50 mM NaCl, 2 mM DTT, and 0.1 g L 
-1
 BSA. After 
incubation for 10 min at room temperature, 5% glycerol was 
added and the reaction products were separated on a 6% native 
polyacrylamide gel run at room temperature in cold 0.5X Tris-
Borate-EDTA buffer for 50 min at 80 V. Labeled nucleic acid 
fragments were detected by fluorescence imaging (ImageQuant 
LAS4000; GE Healthcare, Chicago, IL, USA) and quantification 
of protein–nucleic acid complexes was performed with 
IMAGEQUANT TL image analysis soft-ware (GE Healthcare). The 
apparent equilibrium dissociation constant (KD) was determined 
using a Hill equation with a single-site binding model (as 
implemented in Prism, GRAPHPAD software, La Jolla, CA, USA) 
from the mean of three independent experiments. 
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Circular dichroism (CD) 
 
Circular dichroism measurements were performed with a JASCO 
J-810 spectropolarimeter. The spectrum was recorded on a 35 μM 
protein sample in PBS (10 mM phosphate, 140 mM chloride, 153 
mM sodium ion, and 4.5 mM potassium ion at pH 7.4) using a 0.1 
cm path length quartz cuvette at 25 °C. Thermal denaturation 
from 5 to 95 °C was recorded on a 2 μM protein sample using a 
stoppered 2 mm path length cuvette by increasing temperature at 
a rate of 1 °C min -
1
 and measuring the change in ellipticity at 222 
nm. 
 
 
 
Size exclusion chromatography-multiangle light 
scattering (SEC-MALS) 
 
Static light scattering experiments were performed at 25 °C using 
a Superdex 200 10/300 GL column (GE HealthCare) attached in-
line to a DAWN-HELEOS light scattering detector and an Optilab 
rEX differential refractive index detector (Wyatt Technology, 
Goleta, CA, USA). The column was equilibrated with running 
buffer (PBS + 0.03% NaN3, 0.1 μm filtered) and the SEC-MALS 
system was calibrated with a sample of BSA at 1 g L 
-1
 in the 
same buffer. Then, a 100 μL protein sample at 35 μM (0.7 g L-
1
) 
in PBS was injected into the column at a flow rate of 0.5 mL min
-
1
. Data acquisition and analysis were performed using the ASTRA 
software (Wyatt Technology). Based on numerous measurements 
on BSA samples at 1 g L
-1
 under the same or similar conditions, 
we estimate that the experimental error in the molar mass is 
around 5%. 
 
 
 
NMR spectroscopy 
 
NMR experiments were recorded at 25 °C on a Bruker Avance III 
spectrometer operating at 18.8 T (800 MHz of 
1
H Larmor 
frequency) equipped with a cryoprobe and z gradients. The 
spectrum of ING4DNLS was measured on a 27 μM sample in 
PBS pH 7.4. ING4 binding to dsDNA was investigated by adding 
increasing amounts of a concentrated stock of the DNA (642 μM 
in 20 mM MES pH 6.5, 100 mM NaCl, 5 mM MgCl2, and 1 mM 
DTT) to a 25 μM sample of U-
15
N-labeled ING4 in 400 μL of the 
same MES buffer with 5% 
2
H2O in a 5 mm Shigemi NMR tube. 
1
H-
15
N-HSQC spectra were recorded (128 indirect points, 2 h 
total acquisition time) after each addition and the chemical shift 
of the observed signals was measured. To avoid resonance shifts 
due to different ionic strength or pH in the DNA and protein 
samples, the oligonucleotides were column-desalted into the MES 
buffer, annealed, and concentrated by ultrafiltration (3 kDa cut 
off), and the protein was dialyzed in the same batch of buffer used 
to prepare the DNA. The oligonucleotides used for the NMR 
experiment did not have any 6-FAM fluorescent probe. TOPSpin 
(Bruker) and Sparky (University of California) were used 
 
 
for NMR data processing and spectral analysis, respectively. 
Chemical shifts were measured relative to internal 2,2-dimethyl-
2-silapentane-5-sulfonate (DSS) for 
1
H and calculated for 
15
N 
[14]. Dissociation constants (KD) were determined by the 
combined 
1
H and 
15
N chemical shift perturbations (CSP) fitting 
as described [6] using Prism (GRAPHPAD software). 
 
 
Results 
 
We have previously studied the structure of human ING4 
protein purified from inclusion bodies without any affinity 
purification tag [8]. When a construct with a Strep-tag at 
the N-terminus was used, a small amount of soluble full-
length human ING4 could be isolated from  lysed bacterial 
cells, but the protein copurified with DNA, as seen by 
ultraviolet absorbance and by native PAGE stained for 
protein or DNA (data not shown). This prompted us to 
identify the ING4 domains involved in the interaction as 
well as the binding determinants regarding structure and 
length of the DNA molecule. Because pure untagged ING4 
was more soluble than pure Strep-ING4 (and could be 
obtained with higher yields), untagged refolded ING4 was 
used throughout this study. 
 
ING4 weakly binds to an 18 bp DNA duplex 
(dsDNA18) and the binding is enhanced when the longer 
dsDNA32 substrate is used (Fig. 2). No binding can be 
detected for the isolated N-terminal or PHD domains. 
These results point to the central region as the binding site 
for the DNA, and this is confirmed by the deletion mutant 
ING4DNLS not binding to any of the two dsDNAs (Fig. 
2). This mutant lacks residues 106–187, which encompass 
most of the central NLS region connecting the two folded 
domains of ING4. Biophysical characterization of the 
mutant shows a symmetric dimer with predominantly 
helical coiled-coil structure and C-terminal PHD fingers, 
as seen by SEC-MALS, CD and NMR (Fig. 3). 
 
As ING4 is a dimer with two DNA-binding sites, an 
avidity effect may be expected in the presence of the long 
dsDNA32 that can reach both sites independently, in such 
a way that binding to the first site increases the likelihood 
for the second interaction to occur. The ING4 dimer is 
head-to-tail, with the two NLS DNA-binding regions 
pointing to opposite sides of the dimerization domain. The 
length of this domain  
is approximately 70 Å, whereas the length of an 18 bp 
 
dsDNA is only about 60 Å. The dimeric nature of ING4 
makes it also possible that the long dsDNA32 binds more 
than one ING4 dimer. This may explain the second band 
shift seen at high protein concentrations with dsDNA32 in 
Fig. 2. The multiple modalities 
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Fig. 2. Titration of dsDNA32 (top) and dsDNA18 (bottom) with increasing amounts of ING4 proteins and monitoring complex formation by 
EMSA. The concentration of DNA was 0.1 lM and the protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1, and 2 
lM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Biophysical characterization of mutant ING4DNLS. (A) SEC-MALS analysis of the dimerization. The molar mass (thick line) at the 
center of the chromatography peak (thin line) is 40.7 kDa. The value calculated from the amino acid composition of the monomer is 19.5 kDa, 
indicating that the protein forms a dimer. (B) Secondary structure by far-UV circular dichroism. The ratio of the ellipticity at 222 and 208 nm is 
larger than 1, suggesting that it contains a large proportion of coiled-coil structure. (C) Tertiary structure analysis by thermal denaturation 
followed by the change in the CD signal at 222 nm, showing a midpoint melting temperature of 45 °C. (D) 
1
H-
15
N HSQC NMR spectrum 
showing dispersed (PHD finger) and nondispersed (other parts of the protein) signals in the proton dimension. The signals labeled with ‘f’ are 
folded in the 
15
N dimension and their real chemical shift is 18.5 ppm smaller. 
 
of binding make it difficult to quantify and interpret the 
affinity of the interaction. An attempt to do so using a Hill 
equation [15] yields an apparent dissociation constant of 
0.6 0.03 μM (Fig. S2). ING4 also binds to single stranded 
DNA molecules (Fig. 4), but more weakly than it binds the 
corresponding duplexes (Fig. 2). ING4 also binds to a 
primed DNA (Fig. 4), but not as strongly as to dsDNA32. 
All these results indicate that ING4 has a preference for 
double-strand DNA binding. 
 
Because of the flexible nature of the central region, 
ING4 yields an NMR spectrum where certain structural 
features can be recognized in spite of its large size (55 kDa 
dimer). In particular, the chemically equivalent C-terminal 
PHD finger gives a pattern of well resolved signals in the 
1
H-
15
N HSQC NMR spectrum while the central region 
and the N-terminal domain mainly contribute signals that 
are non-dispersed in the proton dimension [8]. Most of the 
signals 
 
observed at 25 °C belong either to the small PHD finger, 
which has been specifically assigned [6], or to the central 
disordered region, because the size and shape of the 
dimeric N-terminal domain make its NMR signals mostly 
unobservable unless temperature is increased [8]. 
Therefore, we can use NMR to observe the interaction with 
the dsDNA32 directly in solution (Fig. 5), a 
complementary experiment to EMSA. As shown in Fig. 5, 
the backbone amide signals that experience CSP are in the 
central region of the proton frequency dimension. In this 
region of the NMR spectrum of ING4, there are five 
signals that are absent in the spectrum of ING4DNLS and 
that have 
15
N chemical shifts typical of glycine residues. 
These signals are highlighted with a dashed rectangle in the 
spectra of Fig. 5, and very likely correspond to the 5 
glycine residues present in the NLS region (Fig. 1B). Three 
of them experience relatively large shifts and the other two 
shift very little. This is consistent with three 
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Fig. 4. Titration of fluorescent DNA molecules with increasing amounts of ING4 and monitoring complex formation by EMSA. From left to right: 
20 base-long ssDNA, 34 base-long ssDNA, and the corresponding primed DNA. The concentration of DNA was 0.1 lM in the three 
experiments, and the protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 0.5, 0.75, 1, and 2 lM. A scheme of the structure of 
the DNA probe used is drawn at the right hand side of the gels, with the asterisk indicating the position of the fluorescent tag. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Overlay of NMR spectra of ING4 in the presence of 
increasing amounts of dsDNA32 as indicated by the color code 
(molar ratio ING4 protomer: dsDNA32). The concentration of the 
sample was 25 lM and spectra were recorded at 25 °C. The signals 
labeled with ‘f’ are folded in the 
15
N dimension and their real 
chemical shift is 18.5 p.p.m. smaller. The dashed rectangle 
indicates the region expanded in Fig. S3. 
 
of the NLS glycines being located closed to Lys and Arg 
clusters in the central region of the NLS and two of the 
glycines being in the C-terminal end of the NLS, with no 
positively charged residues (Fig. 1B). The measured CSP 
reach a plateau for all residues at ratios above 1 : 2 (Fig. 
S3). Fitting the data of the 13 resonances experiencing the 
largest relative changes to a simple model of one site 
binding model (one DNA duplex bound to one ING4 
protomer) yield apparent dissociation constants in the 0.6–
3.8 μM range. Since the stoichiometry of the complex is 
unknown, these numbers are only indicative of a low 
micromolar apparent affinity, similar to the value derived 
from the EMSA for the same DNA molecule. A further 
com-pounding issue is that the first addition of DNA 
caused a slight protein precipitation in the NMR tube, 
 
which was partially reversed at high ING4 : dsDNA32 
ratios. At these high ratios, the CSP change very little, 
indicating that the protein is saturated with DNA. 
However, the shifted signals remain sharp and poorly 
dispersed in the proton dimension, indicating that in the 
DNA-bound form the backbone of the NLS region 
remains, at least partially, disordered. This observation is 
consistent with a weak binding based on electro-static 
interactions, mediated by the positively charged side 
chains of the NLS and the phosphate backbone of the 
DNA, as has been reported for other disordered proteins 
rich in positively charged residues [16,17]. Therefore, our 
results indicate that the interaction is primarily 
electrostatic, favoring long duplexes, and not particular 
nucleotide sequences. In agreement with this, a 22 bp 
duplex with an unrelated sequence binds ING4 but more 
weakly than dsDNA32 (Fig. S4), and a short 10 bp duplex 
still binds to ING4 but much more weakly (Fig. S5). These 
observations indicate that the major determinant of DNA 
binding is not the nucleotide sequence but the length of the 
duplex, although we cannot exclude that there may be 
certain sequence preferences. 
 
 
Discussion 
 
Intrinsically disordered proteins (IDP) and intrinsically 
disordered regions (collectively referred to as IDP) are 
abundant in cells, and their frequency rises as the 
complexity of the organism increases [18]. Many IDP have 
functional roles [19], frequently related to molecular 
recognition, and often coupled with disorder-to-order 
transitions [20]. However, disordered proteins may also 
remain partly disordered, in the bound state [21]. Many 
DNA-binding proteins have disordered regions [22] which 
may interact with the DNA through multiple segments 
with relatively low DNA affinity but collectively 
contributing to avidity for the DNA. 
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ING proteins have been described as tumor suppressors 
that recognize the histone H3K4me3 modification through 
their C-terminal PHD fingers [23]. In this way, they bind 
the nucleosome and recruit HAT or histone deacetylase 
complexes to chromatin sites enriched in the H3K4me3 
mark [4]. The possibility that ING proteins contribute to 
nucleosome binding through direct protein binding to 
DNA has not been explored, but our work shows that the 
central disordered NLS region of ING4 directly binds 
DNA substrates with different nucleotide sequences, with a 
preference for double-stranded DNA, and an affinity in the 
low micromolar range. This affinity is three orders of 
magnitude lower than the low nanomolar range measured 
for transcription factors like p53 [24] or c-myc [25], and 
the same as reported for the lysine specific histone 
demethylase 1 [26]. Our results are consistent with ING4 
being a reader of the H3K4me3 mark and not a 
transcription factor recognizing a specific DNA sequence. 
However, two isoforms of ING4 lacking the PHD finger 
have been described [27], and it is possible that the DNA-
binding activity of the NLS region plays a role other than 
strengthening nucleosome binding. 
 
 
Our findings on ING4 can be probably extrapolated to 
other ING proteins, because an alignment of their NLS 
regions shows several clusters of positively charged 
residues (Fig. 1B), perhaps with the exception of ING3 
whose central region has much less positively charged 
residues than the others [3,28]. It has been proposed that 
ING1 binds an AT-motif in the enhancer region of the a-
fetoprotein promoter, repressing transcription through 
effects on p53 [29]. This observation is consistent with the 
ING proteins directly inter-acting with DNA. 
 
Our results point to a novel role of the central disordered 
NLS region of ING proteins as modulator of the 
interaction with the nucleosome (and their associated HAT 
and HDAC complexes). The cooperativity arising from the 
presence of two H3K4me3 binding PHD fingers and two 
DNA-binding regions in the ING4 dimer will result in 
strong nucleosome binding [30] and therefore efficient 
HBO1 complex recruitment. 
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Supporting information 
 
Additional Supporting Information may be found online in 
the supporting information tab for this article: 
 
Fig. S1. SDS/PAGE purity analysis of ING4. 
 
Fig. S2. Quantitative analysis by gel densitometry of the 
binding of ING4 to fluorescent dsDNA32 measured by 
EMSA. 
 
Fig. S3. (Left) Zoom of the overlaid NMR spectra of ING4 
shown in Fig. 5, which contains the backbone amide 
signals of five residues tentatively assigned to the five 
glycine residues of the NLS region, three of them 
experiencing large CSP in the presence of saturating 
amounts of dsDNA32. (Right) Plot of the CSP of the 13 
ING4 backbone amide signals with values larger than 
0.015 p.p.m. 
 
Fig. S4. Titration of dsDNA22 with increasing amounts of 
ING4 protein and monitoring complex formation by 
EMSA. 
 
Fig. S5. (Left) Zoom of the overlaid NMR spectra of ING4 
in the presence of the indicated molar ratios of dsDNA10, 
with the same backbone amide signals shown in 
supplementary Fig. 3. (Right) Plot of the CSP of the six 
ING4 backbone amide signals with values larger than 
0.005 p.p.m.  
Table S1. Oligonucleotides (5´ to 3´ sequences) used in 
this study. 
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Supplementary table 1. Oligonucleotides (5´to 3´sequences) used in this study. 
 
Name Sequence 
A1 TGGCCTGCAGGCATGCAA 
A2 GTCCGTACGTTCTGGCCTGCAGGCATGCAA 
A3 GATGAGATTGAGGCTGGCTGGCCTGCAGGCATGCAA 
B1 6-FAM-GCTTGCATGCCTGCAGGCCA 
B2 6-FAM-GCTTGCATGCCTGCAGGCCAGCCTCAATCTCATC 
C1 GAGTGTGGTGTACATGCACTAC 
C2 6-FAM-GTAGTGCATGTACACCACACTC 
D1 ATACGATGGG 
D2 CCCATCGTAT 
 
The dsDNA substrates with 18 bp, 32, 22, and 10 bp were obtained by annealing 
oligonucleotides A1 with B1, A3 with B2, C1 with C2, and D1 with D2, respectively. 
The pDNA substrate contained an 18 bp long dsDNA region and a 12 base long ssDNA 
region, and was obtained by annealing oligonucleotides A2 and B1. 
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Supplementary figure 1. SDS-PAGE. A 12 % gel was loaded with 15 (left lane) or 3 
(right lane) µg of ING4 protein and run at room temperature and 220 volts for 45 min. 
The gel was stained with coomassie brilliant blue and destained with 30% acetic acid in 
ethanol. Densitometry analysis of the gel indicates that the major, corresponding to 
ING4, represents between 90 (left lane) and 94 % (middle lane) of the total protein. 
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Supplementary figure 2. Quantitative analysis by gel densitometry of the binding of 
ING4 to fluorescent dsDNA32 measured by EMSA. The symbols and error bars are the 
mean and standard deviations of three independent experiments. The gel shown on the 
right corresponds to one of these three experiments. The curves are the fitting to a Hill 
equation corresponding to a single-site binding model as implemented in Prism 
(GraphPad software). The apparent equilibrium dissociation constant (KD) and 
cooperativity (n) are indicated. 
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Supplementary figure 3. (Left) Zoom of the overlaid NMR spectra of ING4 shown in 
figure 5, which contains the backbone amide signals of 5 residues tentatively assigned 
to the 5 glycine residues of the NLS region, three of them experiencing large CSP in the 
presence of saturating amounts of dsDNA32. (Right) Plot of the CSP of the thirteen 
ING4 backbone amide signals with values larger than 0.015 ppm. The lines correspond 
to the fittings to a one site binding model, as described in the text. 
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Supplementary figure 4. Titration of dsDNA22 with increasing amounts of ING4 
protein and monitoring complex formation by EMSA. The concentration of DNA was 
0.1 µM and the protein concentration was (lanes from left to right) 0, 0.05, 0.1, 0.25, 
0.5, 0.75, 1 and 2 µM. 
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Supplementary figure 5. (Left) Zoom of the overlaid NMR spectra of ING4 in the 
presence of the indicated molar ratios of dsDNA10, with the same backbone amide 
signals shown in supplementary figure 3. (Right) Plot of the CSP of the six ING4 
backbone amide signals with values larger than 0.005 ppm. The lines correspond to the 
fittings to a one site binding model, and yield dissociation constants in the 17 - 58 µM 
range. 
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